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Abstract
The role of proline residues in transport catalysis mediated by GLUTS has been 
investigated using site-directed mutagenesis. PCR methodology was used to construct a 
series of eight mutant GLUTS cDNAs in which individual proline residues were replaced 
with alanine. Heterologous expression of the GLUTS Pro-Ala mutants in Xenopus laevis 
oocytes was achieved by microinjection of in vitro transcribed mRNA and has enabled an 
extensive analysis of the kinetic properties of these mutants. Km values for the zero-trans 
influx of 2-deoxy-D-glucose into mutant-injected oocytes have been determined, and 
compared to the values obtained for wild type GLUTS expressed in the same system. The 
effect of each proline substitution on the integrity of the exofacial and endofacial binding 
sites was investigated by determining Ki values for the inhibition of 2-deoxy-D-glucose 
ZQro-trans influx by maltose and cytochalasin B, respectively. Although no individual 
proline residue was observed to be absolutely essential for GLUTS catalytic activity, 
mutation of Pro^06, Pro^^l, Pro^^^ and Pro^^l to alanine resulted in an increase in the Ki 
for maltose. Replacement of prolines at positions 381, 383 and 385, located within putative 
transmembrane helix 10 of GLUTS, resulted in a reduction in the Ki for cytochalasin B. The 
small but significant changes observed in the nature of exofacial substrate binding indicate 
that proline residues are important for transporter function. In addition, the prolines located 
within helix 10 are important in the confonnational changes of the protein.
Measurement of transporter turnover numbers in Xenopus oocytes has not 
previously been possible due to the lack of an accurate and reproducible method for the 
isolation of a pure plasma membrane fraction. In order to further characterise the kinetics of 
the Pro-Ala mutants, a protocol was designed, based on a number of previous attempted 
methods, for the isolation of a clean plasma membrane fraction from Xenopus oocytes. 
Results from dot blot and Western blot analysis of plasma membrane fractions isolated from 
GLUTS-expressing oocytes, indicated that the preparation of a plasma membrane fraction 
free from other cellular contaminants was extremely problematic, despite various attempts at 
optimisation. This was attributed to the abundance of glutinous yolk protein and to the 
extremely fragile nature of the plasma membrane of the oocyte. Consequently, it was
. ' ,' ■ ..
concluded that this methodology was not suitable for the accurate quantitation of cell surface 
transporters and the subsequent determination of turnover numbers in this system.
To address the problem of quantitation of cell surface transporters, stable expression 
of GLUT transporters in a mammalian cell-culture line was investigated as an alternative to 
expression in oocytes. Simple and reproducible subcellular fractionation procedures are 
available for this cell line which would enable measurement of transporter turnover numbers. 
Additionally, this system is more convenient for use in photolabelling studies using ATB- 
BMPA and cytochalasin B, since large amounts of plasma membranes from cultured 
mammalian cells can be easily obtained without the need for repeated mRNA injections.
m
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CHAPTER 1
Introduction
1.1 General Background.
Glucose is possibly the most abundant biological molecule on earth. It is a basic 
source of energy and, together with other sugars, it represents a very important nutrient for 
many cells types, not only in mammals and other higher organisms, but also in microbes. 
Glucose metabolism in mammalian cells provides ATP under both aerobic and anaerobic 
conditions. Its importance as a cellular metabolite is exemplified in certain tissues such as 
brain which is almost entirely dependent upon glucose as an energy source. A variety of 
mechanisms have naturally evolved to enable cells to selectively catalyse the movement of 
molecules and ions, including glucose, across their plasma membrane (reviewed in 
Carruthers, 1991).
Mammalian cell plasma membranes possess two general mechanisms by which 
glucose can enter the cell. The first is a protein mediated event which is not coupled to an 
energy requiring component such as ATP hydrolysis or a H+ gradient. Transport is driven 
only by the concentration gradient and can be bidirectional. It is therefore referred to as 
facilitative diffusion and is possible due to the maintenance of a relatively constant high 
physiological blood glucose concentration of 5-lOmM which is achieved by complex 
homeostatic mechanisms. A second distinctive transport mechanism exists in those cells that 
require movement of glucose against its concentration gradient, for example the 
transepithelial cells of the kidney and small intestine. Here transport is mediated by the 
Na+/glucose cotransporter that utilizes a Na+ gradient to couple the transport of glucose 
against its concentration gradient. Active transporters are also found in many bacterial 
systems which may need to take up sugars that are present at very low concentrations. Like 
their mammalian counterparts, these active sugar transporters are symport or antiport 
systems that exploit the electrochemical gradient of H+ or Na+ across the membrane.
In 1952, Widdas, investigating the nature of glucose transport in human erythrocytes 
and sheep placenta, demonstrated that the mechanism conformed to simple Michaelis- 
Menton kinetics (Widdas, 1952). This important discovery suggested that the catalytic 
properties of the glucose transport system were comparable to those of enzyme-mediated 
reactions in which the transporter acts as an enzyme and D-glucose acts as the substrate at
the exofacial side of the membrane and the product at the endofacial side (or vice versa). 
Saturation of the transport system can occur indicating that the erythrocyte contains a finite 
number of transport sites. A further observation stemming from this study was that different 
tissues displayed distinct kinetics of sugar uptake, alluding to the possibility that tissue 
specific transporter isoforms may exist.
The first evidence locating the glucose transport system to the erythrocyte plasma 
membrane was provided by Jung in 1971. Bilayers formed from purified erythrocyte lipids 
were demonstrated to be incapable of catalysing glucose transport, whereas lipid membranes 
made from crude total lipid extracts (erythrocyte ghosts, largely devoid of intracellular 
material) were approximately 100 times more permeable to glucose, possibly due to protein 
contaminants present in the crude lipid preparation (Jung, 1971). In addition to confirming 
the location of the transport system, this study also provided evidence that the movement of 
glucose across membranes was facilitated by a protein moiety. Further evidence in support 
of this view came from the demonstration that glucose transport could be inhibited by veiy 
low concentrations of cytochalasin B and phloretin. These compounds act at the intracellular 
and extracellular moieties of the transport system respectively to inhibit transport with 
apparent Ki values of ^ -140 and 200nM (Bloch, 1973, LeFevre, 1961, Zoccoli et al., 1978).
Due to the easy availability of red blood cells and the fact that they are replete with 
glucose transporters, constituting approximately 5% of the total membrane protein (Allard & 
Lienhard, 1985), much of the early work to determine the structural requirements and 
kinetics of glucose binding to its earner protein were carried out using the erythrocyte 
system. Several studies from the early 1970's predicted that D-glucose binds to its carrier via 
hydrogen bonding. Inhibition of the stereospecific uptake of D-glucose by various 
derivatives identified the pyranose ring oxygen and the hydroxyl groups at the Cl, €3 and 
C4 positions of D-glucose to be important in the formation of hydrogen bonds between 
glucose and the transporter protein (Barnett ef at., 1973, Kahlenberg & Dolansky, 1972).
Based on these studies a model was proposed for the formation of a glucose-carrier complex 
in human erythrocytes (Figure 1.1).
Purification of the erythrocyte transporter protein was achieved independently by two 
research groups. The first group used reconstitution of D-glucose transport activity as an
I
assay to identify an active protein extracted from detergent solubilised erythrocyte 
membranes (Kasahara & Hinkle, 1977). The second approach relied upon an assay for the 
binding of cytochalasin B as a tool for purification (Baldwin et al., 1979). Both methods 
identified one major protein with an apparent molecular mass of 55kDa as determined by 
SDS-polyacrylamide gel electrophoresis. Treatment with endoglycosidase E reduced the 
apparent molecular mass to 46kDa revealing that the protein is heterogeneously glycosylated. 
Reconstituted purified protein exhibited a dissociation constant for cytochalasin B that was 
comparable to that of the native protein in erythrocytes and was later found to bind 
cytochalasin B with a stoichiometry of 1:1 (Baldwin & Lienhard, 1989). When reconstituted 
into liposomes, the purified transporter exhibited the same kinetic parameters as observed in 
the native red blood cell system (Wheeler, 1981). Thus, purification of the transporter 
protein represented a key advance in the characterisation of this important system and 
subsequently led to the elucidation of partial protein sequence information enabling the 
generation of specific antibody probes. The use of specific antisera revealed that membranes 
from a variety of cell types contained similar immunoreactive proteins, consistent with the 
hypothesis that a number of cell types contain structurally similar, but distinct glucose 
transporter proteins. This would account for the differences observed in glucose transport 
capacity between cell types. Availability of antibody probes and partial sequence infonnation 
led to the isolation of a cDNA clone from human HepG2 hepatoma cells in 1985 ((Mueckler, 
1985) and to the subsequent isolation of the gene (Fukumoto et al., 1989, Williams & 
Bimbaum, 1988). The availability of GLUTl cDNA clones has led to the rapid identification 
of homologous isoforms in other mammalian tissues through low-stringency screening of 
appropriate cDNA libraries. A further six isoforms have been identified, five of which are 
functional facilitative transporters. They have been named GLUTs 2-7 according to the
I-
terminology introduced by Fukumoto and co-workers in 1989, based on the chronological
identification of their cDNAs.
1 .2  Tissue-specific Distribution of the Facilitative Glucose
Transporters.
1.2.1 Introduction.
The specific requirements of different mammalian tissues for glucose is reflected in 
the complexity of the facilitative glucose transport system. This family of transport proteins 
constitutes, to date, six structurally related proteins exhibiting different kinetic and 
biochemical properties with overlapping, but distinct, tissue distributions. Such diversity 
presumably exists to allow for the precise disposal of glucose under varying physiological 
conditions and efficient cellular uptake of glucose in the presence of a concentration gradient. 
Individual tissues may express more than one facilitative glucose transporter isoform and, in 
some cases, may also express the Na+/glucose cotransporter, SGLTl.
1 . 2.2  GLUTl.
The GLUTl isoform is commonly referred to as the erythrocyte/brain or HepG2 
transporter. This is due to the initial isolation of clones encoding GLUTl by screening 
human hepatocellular carcinoma cell line (HepG2) and rat brain cDNA libraries with 
antibodies generated against the human erythrocyte glucose transporter. Comparison of the 
predicted amino acid sequence of the HepG2 glucose transporter with partial amino acid 
sequence obtained for the erythrocyte transporter revealed that these proteins were in fact 
identical. Isolation of the protein in the early 1980's represented a major advance in the 
elucidation of the glucose transport mechanism (Baldwin et al., 1981 ; Baldwin et al., 1982). 
GLUTl transporters of humans, rats (Birnbaum, 1989), mice (Kaestner et al., 1989), 
rabbits (Asano et al., 1988) and pigs (Weiler-Guttler et a l, 1989) are all proteins of 492 
amino acids in length and are more than 97% identical in sequence.
Kinetic studies of the purified protein in defined lipid environments and also in the 
native human erythrocyte revealed that GLUTl has a very broad substrate specificity 
(reviewed in LeFevre, 1961), transporting a range of hexoses and pentoses. However,
i
GLUTl has a very low affinity for the metabolically important ketose, fructose, with a Km 
of approximately 1.5M. The implications are that GLUT 1 is not the normal route of fructose
:uptake and that other isoforms mediate its transport (sections 1.2.3 and 1.2.6).
With the purified protein and cDNA leading to the generation of antibody probes, 
many studies have demonstrated that the GLUTl protein and its mRNA are widely 
distributed in many tissue types (Flier et al, 1987a). It is especially abundant in foetal heart, 
liver and brown fat (Asano et al., 1988, Santalucia et al., 1992). These tissues in adults 
however, possess only small levels of GLUTl with highest levels occurring in erythrocytes |
(Allard & Lienhard, 1985). The Km for ZQio-trans uptake (section 1.5.2) of D-glucose by
'V:"GLUTl at 37®C is approximately 7mM which is close to physiological blood-glucose 
concentrations. At plasma glucose concentrations of 5mM, the maximum transport capacity 
is 12,000 times the rate of cellular glucose utilisation. The red blood cells of most foetal 
animals have a similar transport capacity which is soon lost after birth (Widdas, 1955). The 
physiological importance of this high transport capacity is unclear. It is possible that the 
intracellular space of mammalian foetal erythrocytes available for distribution of glucose,
ffacilitates its transfer across the placenta and that this occurs to a lesser extent across the
blood-tissues barriers in adult primates (Jacquez, 1984), however, conclusive evidence for
. . . ithis theory is lacking. Interestingly, GLUTl has been identified in muscle and fat tissue iwhich exhibit acute insulin-stimulated glucose transport (Rier et al., 1987b), however, the 
predominant transporter expressed in these tissues is GLUT4. Only very low levels were
detected in the liver, the other major tissue involved in regulation of whole body glucose §
homeostasis. Immunocytochemical studies show an abundance of GLUTl in endothelial and | |,1;epithelial cells that form the blood-brain and blood-nerve barriers, various blood-eye barriers
and the placental syncytiotrophoblast. It may be that the kinetic properties of GLUTl have |
evolved to facilitate transendothelial and transepithelial transport.
■IAll cell culture lines exhibit pronounced elevation of GLUT 1 protein and mRNA §|
levels upon transformation. Most mitogens result in stimulation of GLUTl transcription and 
glucose starvation is reported to stimulate GLUTl expression. A potential explanation of the $
cell increasing GLUTl levels may be related to the kinetic asymmetry of this isoform (Craik
. 1 "& Elliott, 1979, Diamond & Carruthers, 1993) described in section 1.5.2d, and the 'j|
s’ 1. .^1 '-I'* ■ C- ” i- '-"fl
observation that asymmetry appears to be allosterically regulated by the binding of 
intracellular metabolites. Intracellular ATP is known to allosterically inhibit GLUT 1 function 
in human erythrocytes and AMP and ADP are competitive inhibitors of ATP inhibition of 
transport (Diamond & Carruthers, 1993). This may allow GLUTl to function as a 
unidirectional transporter when the extracellular glucose concentration is low and the 
intracellular demand for glucose is high, e.g. glucose starvation of cells in culture.
1.2 .3  GLUT2
The liver plays a crucial role in the maintenance of blood glucose homeostasis. Large 
amounts of glucose are taken up by the liver after feeding for conversion into glycogen 
stores. These stores are subsequently broken down and glucose is released into the blood. 
The liver can also form glucose de novo. So, the fact that GLUTl is detected only at very 
low levels in hepatocytes, in addition to the distinct glucose transport kinetics observed in 
these cells, led to the proposal that a distinct transporter is expressed in hepatocytes. For 
example, the reported dissociation constant for cytochalasin B, and the apparent for 
glucose transport mediated by the liver-type glucose carrier is approximately 10-fold greater 
than those observed in erythrocytes (Axelrod & Pilch, 1983). Availability of the GLUTl 
cDNA enabled its use as a probe to screen cDNA libraries from hepatocytes, among other 
cell types, under low stringency conditions in order to identify GLUT 1-like cDNAs. Two 
groups independently isolated such a cDNA from human (Thorens, 1988) and rat 
(Fukumoto et al., 1988) hepatocytes. Analysis of the predicted amino acid sequences 
revealed high homology to GLUTl. Hydropathy analyses of the predicted sequences gave 
virtually superimposable plots and therefore, the two isoforms are predicted to adopt a 
similar topology in the membrane. cDNA clones encoding GLUT2, the liver-type 
transporter, have been isolated from human, rat and mouse cDNA libraries. The proteins are 
522, 523 and 524 amino acid residues in length respectively and share 80% homology. 
Human GLUT2 has 55% sequence identity to GLUTl. Most of the sequence divergence 
occurs at the extreme C-terminus and in the extracellular loop connecting putative 
transmembrane helices 1 and 2. In GLUT2 this loop is 64 amino acids long compared to 32
7
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amino acids in GLUTl, and shares no sequence identity. The only similarity between the
two isoforms in this region of the proteins is an N-linked glycosylation site. Expression of
-
the liver transporter cDNA in E.coli mutants defective in glucose uptake revealed that the 
encoded protein was incorporated into the bacterial membrane. Glucose uptake was 
increased as a result and transport was shown to be stereospecific for D-glucose and 
inhibited by phloretin and Mercury Chloride (Thorens, 1988).
GLUT2 is kinetically quite distinct from GLUTL It does not appear to bind 
forskolin (Hellwig & Brown, 1992) and only weakly binds cytochalasin B with a Kd of 
approximately IjuM (Axelrod & Pilch, 1983, Ciaraldi et al., 1986), an order of magnitude 
higher than the same parameters determined in previous studies of facilitative glucose 
transport. Equilibrium exchange studies for 3-O-methyl-D-glucose reveal that this 
transporter has a Km of 42mM when expressed in Xenopus laevis oocytes (Gould et al.,
1991). This supra-physiological value agrees with the high Km of 6 6 mM reported 
previously in oocytes, (Elliott & Craik, 1983), and is significantly higher than the normal 
blood glucose concentration, and also the value of approximately 7mM reported for zero- 
trans entry by GLUTl at 37°C in the human erythrocyte. The physiological role of glucose 
transport in the liver is different from most other tissues as this organ participates in both 
uptake and release of glucose to maintain normal blood glucose levels. The presence of a 
high capacity and high Km transporter in hepatocytes would allow rapid glucose efflux 
following gluconeogenesis. In addition, GLUT2 is abundant in these cells increasing their 
transport capacity such that the actual transport process is not the rate-limiting step in either 
metabolism or supply of glucose to the blood. The fact that transport mediated by this 
isoform is symmetrical and is characterised by a high Km will no doubt reflect its specific 
location to the liver, allowing glucose transport into and out of the hepatocyte to respond 
linearly to changes in glucose concentration.
There are other sites of high GLUT2 expression including the islets of Langerhans of 
the pancreas, where expression is exclusive to the p-cells (Orci, 1989, Thorens, 1988), the 
basolateral surfaces of the kidney and the small intestine epithelia. GLUT2 expression 
therefore seems to be restricted to tissues involved in net release of glucose during fasting 
(liver), glucose sensing (P-cells) and transepithelial transport (kidney and small intestine).
8
Pancreatic p-cells are the site of insulin production, which depends upon the uptake and 
metabolism of glucose. Glucose concentrations in the range of 5-15mM stimulate insulin 
secretion. At these concentrations it is the metabolism of glucose by the high enzyme 
(/-6mM) glucokinase rather than the transport of glucose across the plasma membrane that is 
the rate-limiting step. The high Km of GLUT2 therefore allows glucokinase to effectively act 
as a glucose sensor by ensuring that the intracellular glucose concentration changes rapidly 
in response to the extracellular levels. Carruthers pointed out that the key to rapid 
equilibration of the cytosol with interstitial sugar is a high capacity of transport rather than a 
low affinity. A study in 1990 illustrated the importance of GLUT2 expression where 
glucose-induced insulin secretion occurs, and involved the use of two mouse insulinoma cell 
lines. One line expresses GLUTs 1 and 2 at high levels whereas the other only expresses 
GLUT2. Only the later was found to exhibit glucose-induced insulin secretion compared to
normal mouse islet cells (Miyazaki etal., 1990).
Glucose transport in the kidney and small intestinal epithelial cells is a two step
process. The Na+-linked glucose transporter located on the apical side of the small intestine 
mediates active glucose accumulation against its concentration gradient by cotransporting 
Na+ inward down its electrochemical gradient. GLUT2 present at the basolateral surfaces of 
the transepithelial cells of the intestine and of the proximal tubule of the kidney facilitate its 
subsequent release into the capillaries, thus playing a specific role in glucose absorption and 
reabsorption (Hediger etal, 1987). In addition, this isoform is also predicted to mediate the 
exit of fmctose from the basolateral membrane of enterocytes
1.2 .4  GLUT3.
Application of the low-stringency hybridisation approach to other tissues as a method 
for detecting glucose transporter cDNAs resulted in the isolation of a novel cDNA, GLUTS, 
from a human foetal muscle library (Kayano et al., 1988; Nagamatsu, 1992). Northern blot 
analysis yielded the rather surprising observation that GLUTS is barely detectable in human 
adult skeletal muscle but is abundant in the brain, with lower levels of expression in fat, 
kidney, liver and muscle. GLUTS cDNA clones have, to date, been isolated from humans,
monkeys, rabbits, rats and mice - in addition to an avian homologue. In monkeys, rabbits, 
rats and mice, GLUTS mRNA is expressed exclusively in the brain (Maher et aL, 1992; 
Nagamatsu, 1992; Yano, 1991) whereas in humans GLUTS protein can be immunologically 
detected at highest levels in the brain, with lower levels in the liver, heart, kidney and 
placenta ((Kayano et al., 1988). It is not, however, detectable in three different muscle 
groups:- soleus, vastus lateralis and psoas major (Shepherd, 1992a). The lack of any 
immunological detection of GLUTS in these tissues does not agree with the levels of mRNA 
which can be detected by Northern blot analysis. For example, mRNA levels in kidney and 
placenta are 50% of that detected in brain, but the level of GLUTS protein in these tissues is 
much lower. So, there seems to be some disparity between the levels of GLUTS mRNA and 
protein. One possible explanation may be the presence of significant neural contamination in 
the tissue preparations used for the Northern analysis. Alternatively, it is possible that these 
tissues exhibit negative post-transcriptional regulation of GLUTS.
Human GLUTS shares 64% and 52% identity with human GLUTl and GLUT2 
respectively, and some 83% amino acid sequence identity with its mouse counterpart. As in 
the case with GLUT2, the GLUTS sequence is not as highly conserved among species as the 
GLUTl sequence. Portions of the transporter containing the regions of most sequence 
divergence occur within the large extracellular loop and the intracellular C-terminal domain.
When expressed in Xenopus oocytes GLUT3 exhibits a substantially lower Km 
(about lOmM) for 3-0  -methyl-D-glucose exchange transport than GLUTl (Colville et al., 
1993b; Gould et al., 1991). The observation that GLUTS is expressed at high levels in the 
brain indicates a requirement for two facilitative glucose transporter isoforms to mediate 
glucose uptake and disposal across the blood-brain barrier. Since GLUTl is the major 
isoform expressed at the blood-nerve and blood-brain barrier, it is likely that GLUTS 
mediates glucose uptake into neuronal cells which lie beyond the GLUT 1 -enriched blood- 
tissue barriers of the brain and peripheral nerve. Comparison of the kinetic parameters for 
these two isoforms is compatible for a role for both GLUTs 1 and 3. Under normal 
conditions in the brain, the capacity of hexokinase for its preferred energy source, glucose, 
is much greater than the capacity of the glucose transport system and so transport is rate 
limiting. Under hypoglycaemic conditions, the expression of a low capacity, high affinity
10
transporter ensures successful utilisation of low blood sugar concentrations. In fact GLUTS 
has the lowest Km for hexoses of all the isoforms of the family. Thus, co-expression of 
GLUTS with GLUTl in the brain allows a high efficiency of glucose transport over the 
entire physiological range of blood glucose concentrations, with GLUTl working at 
maximum capacity at high blood glucose levels, and GLUTS mediating efficient transport at 
lower levels.
1.2 .5  GLUT4.
The observation that GLUTS mRNA levels are relatively low in adult muscle, 
coupled to the realisation that this isoform is not the major protein responsible for glucose 
uptake by this tissue, led to the exciting possibility of an additional isoform to add to the 
expanding family of GLUTs. Furthermore, fat and muscle were observed to exhibit insulin- 
responsive glucose transport properties, thus leading to an extensive effort to identify the 
insulin-responsive glucose transporter. In 1989, five separate reports of cloning and 
sequencing of GLUT4 were published (Bimbaum, 1989; Charron et al., 1989; Fukumoto et 
al., 1989; James ef a/., 1989; Kaestner a/., 1989). A monoclonal antibody that specifically 
recognised GLUT4 revealed that this isoform is specific to muscle and adipose tissue (James 
etal., 1988). mRNA levels were found to be highest in brown and white adipose tissue in 
addition to cardiac and skeletal muscle, i.e. tissues that are regulated by insulin (James et al., 
1989).
The cDNA for human GLUT4 was found to encode a protein of 509 amino acids in 
length which shared 65%, 54% and 58% identity with human GLUTs 1, 2 and 3 
respectively, with 95% and 96% sequence identity between the human and rat or mouse 
proteins. Major differences in sequence are found at the N-terminal hydrophilic region, 
which has an additional twelve amino acids compared to GLUTl, the central cytoplasmic 
loop and the C-terminus.
Studies on rat adipocytes reported a 20- to 30-fold increase in D-glucose uptake upon 
insulin stimulation, while rat muscle cells exhibited a 7-fold increase (Ploug, 1987). The 
effect observed in human skeletal muscle cells and human adipocytes in response to insulin
11
was even lower, with a 2-fold (Dohm et aL, 1988) and 2- to 4-fold (Pederson & Gliemann, 
1981) increase in glucose uptake. In terms of the kinetics, the increase in transport capacity 
observed in these cells in response to insulin is a result of an increase in the V^ax not a 
change in the Km (Holman et aL, 1990; May & Mikulecky, 1982; Simpson & Cushman, 
1986; Taylor & Holman, 1981; Whitesell & Gliemann, 1979). There is some speculation as 
to whether this increase in Vmax is a result of intrinsic activation of the transporter protein. 
However, it is now largely established that the increase in transport capacity is achieved by 
recruitment of a large number of transporters to the plasma membrane from an intracellular 
pool in response to insulin. The exact nature of the intracellular pool remains unknown at 
present. This has been demonstrated to occur in both fat (Cushman & Wardzala, 1980; 
Suzuki & Kono, 1980) and skeletal muscle (Hirshman et aL, 1990; Klip et a l, 1987).
Kinetically, GLUT4 differs substantially from GLUTl in that it appears symmetrical 
and does not exhibit trans -acceleration, (Taylor & Holman, 1981; Whitesell & Gliemann, 
1979)) described in section 1.5.2d. Under equilibrium exchange conditions for 3-O-methyl- 
D-glucose transport, Km values of 1.8mM (Keller et aL, 1989) and 4.3mM (Nishimura, 
1993) have been reported in oocytes, compared to the value of 26.2mM obtained for 
GLUTl (Nishimura, 1993). This would indicate that at low substrate concentrations, 
GLUT4 would be responsible for the majority of glucose uptake in human tissues. Upon 
insulin stimulation, the number of GLUT4 transporters at the plasma membrane increases 
resulting in an increase in the transport capacity of the cell.
1.2 .6  GLUTS.
The most divergent member of the facilitative glucose transporter family, GLUTS, is 
a 501 amino acid residue protein that exhibits only 40% sequence identity to GLUTl. This 
isoform is expressed at high levels in the small intestine, as revealed by Northern blot 
analysis (Kayano et aL, 1990), and studies using human small intestine have shown that the 
protein is located in the brush-border membrane (Davidson et aL, 1992). Obviously, the 
small intestine is an important site for hexose transport, making a significant contribution to 
maintaining whole body glucose homeostasis. It is not so surprising, then, to find a
12
facilitative glucose transporter system located in this important tissue. What is surprising 
however is the exclusive localisation of GLUT5 to the apical brush border of the luminal 
side of epithelial cells (Davidson et aL, 1992), considering that under normal circumstances 
glucose transport is mediated by SGLTl, the Na+-dependent glucose transporter. The 
rationale for the presence of a passive transporter in addition to an active transporter is 
unclear, especially since GLUTS has been demonstrated to be a relatively poor glucose 
transporter (Kayano et aL, 1990). One possible explanation has been provided by the a
demonstration that GLUTS is a high affinity D-fructose transporter. When expressed in 
Xenopus oocytes, GLUTS transports D-fructose with a Km of 6mM, i.e. with a much 
higher affinity than for D-glucose and its analogues (Burant et aL, 1992). Therefore its 'I
primary role at the luminal surface of the small intestine could be the uptake of dietary 
fructose. In fact, fructose has been recommended as a substitute for glucose and sucrose in f
the diets of both diabetic and obese people as it is sweeter, more soluble and less glycogenic. |
The adaptation of intestinal fructose transport in response to diabetes has been largely 
neglected with studies mainly concentrating on glucose adaptation. A recent study in rat 
small intestine was undertaken to address this aspect of diabetes (Corpe et aL, 1996). In this 
study it was concluded that adaptation to diabetes involved significant enhancement in levels 
of GLUTS and GLUT2 at their specific sites of expression. Also, the intrinsic activity of '0
GLUTS was diminished. Thus, the regulation of fructose transport is clearly an important
aspect of diabetes.
' I :
Northern and immunoblot analyses reveal that GLUTS is expressed in a range of 
Other human tissues including muscle (all major types), brain, adipose tissue and testis 
(Burant gf uA, 1992; Kayano et aL, 1990; Shepherd, 1992b). Again, GLUTS may act to
'é ■provide these tissues with fructose. It is unknown at present if other fructose transporters 
exist in addition to GLUTS and it seems unlikely that this transporter undergoes insulin- 
stimulated translocation. This is consistent with the lack of insulin-stimulated fructose 
transport observed in human adipocytes (Shepherd, 1992b).
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1 .2 .7  GLUTS
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The extensive application of the homology screening approach to many tissues 
identified a further transporter-like sequence that appeared to be ubiquitously distributed.
Further analysis of the base sequence revealed a high level of identity to GLUTS (-80%).
The cDNA was however found to contain multiple frame shifts and stop codons and so is |
S'unlikely to encode a functional transporter. The extent of the sequence identity suggests that 
the transcript may have arisen by insertion of a reverse-transcribed copy of GLUTS into a 
non-coding region of a ubiquitously expressed gene (Kayano et aL, 1990).
1.2.8 GLUT?
The most recent member of the GLUT family to be identified is GLUT? which 
exhibits 6 8% amino acid sequence identity to GLUT2. Interestingly these two isoforms are 
virtually identical throughout the first four transmembrane domains and also in the region of 
helices 9 and 10. In fact, the GLUT? sequence is 100% identical to that of GLUT2 at three 
locations. These regions do not coincide with the intron/exon boundaries ((Bell etal., 1990)) 
and so it is unlikely that GLUT? is a splice variant of GLUT2. One important difference in 
the sequences of GLUTs 2 and 7 is the presence of an additional six amino acids at the C- Iterminus of GLUT?. This sequence contains a consensus motif, (KKMKND) for the
. ■Iretention of transmembrane proteins in the endoplasmic reticulum (ER). GLUT? is a 528
■V
amino acid residue protein that, so far, has only been cloned from the rat (Waddell, 1992).
Western blotting experiments show that it is located in the microsomal fraction of the rat iliver, unlike GLUT2 which is located at the plasma membrane (Waddell et aL, 1991). In 
fact, GLUT? is localised to the endoplasmic reticulum hence the presence of the ER targeting 
motif.
In mammals, the regulation of blood glucose levels is achieved by balancing the rate
.0of glucose uptake by all tissues with the rate of release of glucose produced from 
gluconeogenesis and glycogenolysis in the liver. As already mentioned, GLUT2 plays an 
important role in mediating both efflux and influx of glucose across the hepatocyte plasma
membrane. The terminal step in glucose production by gluconeogenesis and glycogenolysis 
is the removal of the phosphate group from glucose-6 -phosphate. This reaction is catalysed 
by glucose-6 -phosphatase, a multi-enzyme complex located in the lumen of the endoplasmic 
reticulum. In order for glucose to be exported from the liver it must first cross the membrane 
of the endoplasmic reticulum before being transported across the hepatocyte plasma 
membrane by GLUT2. Thus, it has been proposed that GLUT? meditates the initial 
transport stage and therefore works in conjunction with GLUT2 to achieve hepatic release of 
glucose (Waddell, 1992).
However, given that there is a surprising lack of base drift in the third position of the 
codons over the GLUT2 and GLUT? sequences, the existence of GLUT? as a separate 
isoform awaits confirmation from other sources.
1.3  Homologous Transporters in Other Organisms.
For many years, little information was available regarding the primary structure of 
integral membrane proteins that transport small molecules such as sugars, ions and 
antibiotics across the cell membrane. These proteins are difficult to study because of their 
low abundance and hydrophobic nature. The advent of recombinant DNA technology 
enabled the cloning and sequencing of many genes encoding membrane transport proteins 
thus facilitating their study. From the DNA sequence, the order of amino acids can be 
deduced and sequence alignments have revealed that many membrane transporters comprise 
a highly homologous family extending from cyanobacteria, yeasts, algae and protozoa, 
plants, fungi and mammals including rat, mouse and man.
In 198?, the primary sequences of the arabinose/H+ and xylose/H+ transporters of 
E.coli were determined from their complementary cDNAs (Maiden et al., 198?). Sequence 
alignments revealed that, not only are these proteins homologous with each other, but they 
also share high homology with the human hepatoma and rat brain glucose transporters. All 
four proteins displayed sequence similarities with the E.coli citrate transporter. Conserved 
amino acid sequences identified by sequence alignment of homologous sugar transporters 
were also found to occur in the Tet A, B and C proteins which mediate tetracycline export in
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structure (Li & Tooth, 1987). In addition, it possesses many of the conserved motifs 
identified within this superfamily.
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- agram-negative bacteria, in addition to those of gram positive bacteria, Tet L and K. A 
rigorous analysis of such proteins was undertaken revealing that although transport proteins 
exhibit differences in substrate selectivity (e.g. antibiotics, antiseptics, carboxylates and 
sugars), direction of transport (influx versus efflux) and mechanism of transport (H+- 
dependent symports, antiports and uni ports, active and passive transporters), they are all 
derived from a common ancestor. Several highly conserved motifs have been identified and 
despite differences in sequence lengths of these transporters, all are predicted to have the 
same membrane topology, spanning the membrane twelve times with a large cytoplasmic 
loop linking helices 6  and 7 (reviewed in Henderson et ah, 1992). :?>
Four families of related transporter proteins have been identified within the larger 
"superfamily" of homologous proteins. The mammalian GLUT isoforms constitute part of 
the larger family. Other members of this group include AraE, the H+/L-arabinose symporter 
of E.coli ; Xyl E the H+/D-xylose symporter of E.coli and GalP, the galactose transporter
I
Îof E.coli. These share 23%, 27% and 25% sequence identity with GLUTl respectively.
■0 -GalP and AraE both bind cytochalasin B and GalP can bind forskolin with a similar affinity 
to that of GLUTl. Furthermore, proteolytic digestion of GalP photolabelled with 
cytochalasin B yields fragments of similar size to those obtained from digestion of labelled 
GLUTl. I
Interestingly, the mammalian Na+-linked glucose transporters and the bacterial ATP- 
and PEP-utilising active transporters are not included in the superfamily. It is uncertain if the 
lac permease of E.coli is a member as it displays little sequence identity to GLUTl. It is
however, thought to adopt a similar transmembrane topology, having twelve transmembrane 
a-helices which, in the case of the lac permease, are proposed to be arranged in a bilobular
I
1 .4  Structure of Mammalian Facilitative Glucose Transporters.
1 .4 .1 Introduction.
The last 10-15 years have seen technological advances in gene cloning and molecular 
biology that have facilitated the investigation of the relationship between glucose transporter 
structure and function. Of the mammalian family, GLUTl is the only isoform that is 
currently available in a purified and functional form and therefore is being studied 
extensively to elucidate the glucose transport mechanism. Its cloning and expression in 1985 
therefore represents a significant advance in this field (Mueckler et aL, 1985). In addition, 
the availability of the GLUTl cDNA led to the subsequent identification of the other 
isoforms through low stringency hybridisation techniques.
Today a whole range of techniques are being applied to the investigation of the 
GLUT isoforms, and these range from the use of spectroscopic techniques to analyse 
secondary structure to the use of antibodies, proteases, affinity labels and group-specific 
chemical reagents to elucidate the membrane topology. Sequence alignments have revealed 
the presence of conserved motifs that have been probed further by mutagenesis to map 
sequences involved in substrate binding and conformational changes.
1 . 4 .2  Sequence Alignments and General Topology.
The GLUTl cDNA was initially isolated from human HepG2 cells (Mueckler et aL,
1985). An open reading frame encoding a 492 amino acid residue polypeptide was identified 
and from this the amino acid sequence was deduced. Isolation of a cDNA clone from rat 
brain in 1986 revealed that the GLUTl protein sequence was highly conserved with 98% 
sequence identity between the two species (Bimbaum et aL, 1986). Such a high degree of 
sequence conservation implies that all regions of the GLUTl transporter are functionally 
important.
Based on the deduced primary sequence, a hydropathy analysis led to a speculative 
model for the topology of GLUTl in the membrane (Figure 1.2). Computer and graphical
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analyses of the protein sequence along with proteolytic studies of the native membrane- 
bound transporter support this model. A highly hydrophobic protein is predicted such that 
approximately 50% of the protein lies within the membrane bilayer. The transporter consists 
of twelve transmembrane segments each of about 21 amino acids predicted to form a- 
helices. These are linked by short hydrophilic extramembraneous regions of 7-14 residues 
that may form B-turns. Loops at the cytoplasmic surface are very short, typically eight 
residues long and this is a highly conserved feature throughout the wider transporter family. 
Severe constraints are placed on the possible tertiary structure as a consequence, suggesting 
a closely packed helical structure at the inner surface of the protein. The loops at the 
extracellular surface are generally longer and more varied in terms of length and sequence 
identity. Helical packing is likely to be less compact at this side of the protein.
Tryptic digestion of intact erythrocytes and sealed ghosts suggests the presence of an 
extremely hydrophilic loop of 65 residues on the cytoplasmic side that connects helices 6  and 
7, effectively dividing the transporter into N- and C-terminal domains. The 
extramembraneous N- and C-terminal segments are both hydrophilic and are also 
cytoplasmic, confirmed by the use of anti-peptide antibodies that react only when the inner 
surface of the transporter is accessible, for example in inverted vesicles (Davies et aL, 
1987;Haspel et aL, 1988). A large extracellular loop of 33 residues connects helices 1 and 2 
and contains a potential site for A-linked glycosylation at Asn45. Another potential 
glycosylation site is located within helix 11 (Asn^H) and is therefore unlikely to be
modified. This is consistent with proteolytic studies in which the transporter was cleaved at
cysteine residues to yield a large fragment of 3 IkDa corresponding to residues 133-428 and 
a short N-terminal fragment. The large fragment encompasses Asn^H but was not found to 
contain carbohydrate (Cairns etal., 1984), thus Asn‘^5 jg assigned as the glycosylation site. 
In addition, mRNA derived from the first N-terminal 40 amino acids can be translated in a 
reticulocyte cell-free system to produce a truncated protein that is inserted into the membrane 
of the endoplasmic reticulum and glycosylated at the same site as the full length protein.
Some of the transmembrane helices contain several serine, threonine, glutamine and 
asparagine residues. These polar residues are predicted to lie on the same face of an a-helix 
and therefore helices 3, 5 ,7 , 8  and 11 are suggested to be amphipathic. Hydroxyl and amide
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side chains of such residues in a transmembrane helix may line a channel or pore and partake 
in transient H-bond formation as the substrate translocates through the channel of the 
transporter across the membrane.
The other members of the mammalian facilitative transporters are of a similar size to 
GLUTl (-500 amino acids) and are predicted to share the same membrane topology 
including : twelve transmembrane cx-helices, a large extracellular loop connecting helices 1 
and 2 which contains a single site for iV-linked glycosylation, a large hydrophilic loop 
between helices 6  and 7, and cytoplasmically located N- and C-termini. Despite such 
similarity in both structure and function, there is still quite a high degree of sequence 
divergence within the family. There is 39-65% sequence identity and 50-76% sequence 
similarity between isofonns, 26% of the residues are absolutely conserved in all isoforms 
and a further 13% of the residues are conservative substitutions.
Sequence alignments have revealed that there are several conserved motifs present 
throughout the glucose transporters (Table 1.1). These include GRR(K) located between 
helices 1 and 2 in the N-terminus and, correspondingly, between helices 7 and 8 in the C- 
terminus; EXXXXXXR between helices 4 and 5 in the N-terminus and 10 and 11 in the C- 
terminal half; PESPR in the cytoplasmic loop connecting helices 6  and 7 paralleled by the 
PETKG motif in the C-terminal cytoplasmic loop. These motifs may have been conserved to 
maintain conformational stability and may be involved in the formation of salt bridges. 
Repetition of these sequences suggests that duplication of an ancestral gene encoding a six 
transmembrane helical protein may have given rise to the twelve transmembrane helical 
structure that is so highly conserved throughout the glucose transporter family (Baldwin & 
Henderson, 1989; Maiden et aL, 1987). The conformational constraints imposed by the 
short cytoplasmic loops make it unlikely that the protein is composed of a single group of 
twelve transmembrane a-helices. It is more likely that the protein adopts a bilobular structure 
involving six closely packed helices of the N- and C-terminal domains similar to that which 
is reported in low resolution electron microscopic images of the E.coli lactose permease (Li 
& Tooth, 1987). Recently, two three-dimensional structural models were proposed for the 
arrangement of helices in the protein tertiary structure (Zeng et aL, 1996). Both models are 
based on the prediction that an aqueous channel is formed from five amphipathic a-helices.
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The helices are arranged in bundles of four, and in both models the N-terminus contributes 
two helices that participate directly in channel formation (section 1.9). Other models have 
suggested alternative helical packing schemes (Baldwin, 1993), however the precise 
arrangement of the transmembrane segments of the transporter and the relative contributions 
made by the N- and C-termini are as yet unclear. Evidence from photolabelling studies and 
proteolytic digestion suggest that the glucose binding sites are located in the C-terminal 
domain of GLUTl and so transport occurs in this region. However the N-terminal domain 
may also play a role (section 1.7.4b).
1.4 .3  Spectroscopic Techniques.
The model for the topological arrangement of GLUTl and the other isoforms in the 
lipid bilayer was based mainly on theoretical structural analysis such as hydropathy plots. 
The protein is strongly hydrophobic and is predicted to span the membrane twelve times. 
Other analyses evaluate the probability of a-helices or 6 -sheet configurations. Confirmation 
of the predicted secondary structure has been obtained from various spectroscopic 
techniques. UV circular dichroism (CD) spectroscopy yields information regarding the 
extent of a-helical, 6 -sheet or random coil structures that are present in proteins. Spectra
have been obtained from proteins that contain either pure a-helices, 6 -sheet or random coil 
structures or known quantities of these various secondary structural motifs. These reierence 
spectra can then be used to estimate the percentage of each type of secondary structure in a 
new protein. GLUTl is estimated to contain 82% a-helix, 10% 6 -turn and 8 % random coil 
structure. No 6 -sheet structure was detected using this technique (Chin et aL, 1987).
Infrared (IR) spectroscopy has proven to be an important tool for elucidating protein 
secondary structure, particularly in the last 5-10 years. An empirical correlation exists
between the frequency of the amide I and II absorption bands and the secondary structural 
motifs present within a protein. The amide I and II absorptions are influenced by the strength 
of hydrogen bonds involving amide C=0 and N-H groups. As each secondary staictural 
motif (i.e. a-helix, 6-sheet, 6 -tum and random coil) has a characteristic hydrogen bonding 
pattern involving amide C=0 and N-H groups, they each give rise to distinct amide I and II
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absorptions. It is the separation of these absorption bands that allows the determination of 
protein secondary structure by IR spectroscopy. Fourier Transform methods of data 
acquisition (FTIR) enable the structural analysis of large proteins in aqueous media by 
deconvolution of spectra. Application of this technique to purified GLUTl, reconstituted 
into erythrocyte lipids in H2O, revealed that the protein adopts a mainly a-helical structure. 
Vibrational frequencies corresponding to 8 -strand and random coil structure were also 
detected from deconvoluted spectra (Alvarez et aL, 1987). However, the presence of 8 -turns 
is uncertain in this study due to difficulties in resolving the appropriate absorption bands in 
this region of the spectrum. Chin and co-workers in 1986 predicted the presence of a-helical 
structure in extramembraneous domains (Chin et aL, 1986). The first direct evidence for this 
came from FTIR analysis of GLUTl before and after proteolytic digestion (Cairns et aL, 
1987). Extramembraneous, cytoplasmic domains of the transporter removed by trypsin were 
found to contain a-helical structure. The observation that the transmembrane domain 
contains some 8 -structure (Alvarezes aL, 1987) was also corroborated in this study.
FTIR spectroscopy has also been employed to assess the orientation of the glucose 
transporter in the membrane bilayer. A spin drying technique has been used to obtain 
orientated multilamellar films of reconstituted GLUTl (Chin et aL, 1986). Linear dichroism 
of the IR spectra reveal that the a-helices are orientated perpendicular to the plane of the 
membrane with an average tilt angle of less than 38° from the membrane normal. This is 
comparable to the membrane orientation reported for rhodopsin and bacteriorhodopsin. The 
application of FTIR was then extended to assess the possibility that certain a-helices are 
arranged within the membrane to form a water-filled channel. Hydrogen-deuterium exchange 
of reconstituted GLUTl incubated in 2H2O resulted in band shifts in the amide II region of 
the IR spectrum. It was estimated that 70-80% of the amide hydrogens are accessible to 
solvent water. In addition, hydrogen-tritium exchange also corroborated these results. 25- 
30% of hydrogens exchange very rapidly and these are suggested to be in direct contact with 
solvent. Based on the fact that most of the protein mass is transmembrane, these results 
strongly suggest the presence of an aqueous channel. Furthermore, the presence of D- 
glucose and cytochalasin B drastically altered the kinetics of these rapidly exchangeable 
hydrogens indicating significant conformational changes in the protein (Jung et aL, 1986).
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FTIR spectroscopy has been applied to investigate other aspects of GLUT 1 structure , ,
■■ ,and function including substrate induced conformational changes. Intrinsic tryptophan
fluorescence has also been correlated with conformational changes resulting from ligand or £|
' ■ Isubstrate binding and has been used to resolve the dynamics of these events. A more detailed
review of these studies are given in the appropriate section. In conclusion, the application of ;1'chemical and physical techniques described give a consistent picture of a transmembrane
structure containing an aqueous pore through which substrate can pass. Large 
conformational changes occur such that the transporter reorientates the substrate binding site
•ifto the exo- and endofacial surfaces of the protein.
s1.5  Dynamics of Glucose Transport.
#1.5.1 Introduction "'I 
:Most kinetic, thermodynamic and ligand binding studies of glucose transport have
■Ïbeen carried out using erythrocytes. They are simple cells, available in large quantities and i
thus the erythrocyte transporter, GLUTl, is assumed as the prototypic model for such
..0studies. Based on the structural similarity between the GLUT isoforms, many of the 
properties determined for GLUT 1 will most likely apply to the other family members. %
However, the isofonns do exhibit differenœs in sugar specificity, kinetic parameters, ligand $
ibinding, targeting patterns, tissue expression and hormonal regulation which can be both f
acute and chronic.
1 . 5.2  Transport Studies
I .
1:
There are a variety of methodologies which have been used to measure glucose 
transport by GLUTl in erythrocytes. The most widely employed is the use of radiolabelled
Isugars which act as tracers for sugar movement. Other methods include chemical analyses of 
cellular sugar content, spectrophotometric monitoring of cell volume changes induced by
iglucose transport or coupling of transport to a secondary enzyme-linked assay to detect
Î
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changes in intracellular sugar levels. In addition, a variety of different assay conditions have tS:
been used to measure distinct parameters of the transport process and each are explained in 
turn below. The terminology is such that the cis -side of the membrane refers to the side 
from which transport occurs and the tram -side is the opposite side.
1.5.2b Zero-trans Exit.
1.5.2a Zero-trans Entry. ss
I
'This is the simplest study and involves the measurement of uptake of trace amounts 
of radiolabelled D-glucose into cells. Prior to assay, cells are stored in a glucose-free 
medium for a certain period of time to ensure that the cytosolic sugar concentration is as low 
as possible. External sugar concentrations are varied with each measurement. Initial
i
transport of glucose into the cell should be linear since the cytosolic sugar concentration is
:zero. Measurements are therefore recorded during this initial time period before reverse-flow '
of sugar occurs. The parameters which are determined are the affinity of the exofacial 
binding site for sugar (Km outside) and the maximum velocity of sugar entry under 
conditions of infinitely high sugar concentrations (Vmax entry).
Cells are pre-incubated with varying sugar concentrations plus tracer until 
equilibrium is reached. The external medium is rapidly replaced with one without sugar. 
Initial rates of sugar exit are determined by measurement of radioactivity levels in the 
external medium. Parameters determined from this type of assay are the affinity of the 
endofacial binding site for sugar (Km inside) and the Vmax for sugar efflux.
1.5.2c EquUibrium Exchange.
In this case intra- and extracellular sugar concentrations are identical and the 
unidirectional flow of radiolabelled sugar is measured in either direction. Values are obtained 
for the Km and Vmax for sugar exchange. This is the most common type of assay.
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1.5.2d Kinetic Properties of GLUTl.
Many transport assays using erythrocytes under various assay conditions have been 
performed by different groups. A summary of the kinetic parameters outlined above, 
determined for D-glucose transport at 0°C and at20-25®C, is reviewed by Carruthers (1990). 
All transport profiles show simple, hyperbolic Michael!s-Menton kinetics and several
jimportant features of the transport process in erythrocytes are noted from the presented data.
The kinetic parameters of glucose transport mediated by GLUTl are very temperature 
dependent with Km and Vmax values generally lower at subphysiological temperatures.
Also, very different values for these parameters are obtained depending on the assay 
conditions used. For example, at 0°C under z&xo-trcm entry conditions, the Km and Vmax 
values were approximately 0.15-0.2mM and 0.0035-0.0055mMs“l respectively whereas 
under zero-trans exit conditions these values are 1.64-3.4mM and 0.071-0.092mMs"i 
respectively. Thus, the kinetic values for zero-tram exit are 12-fold greater than those for 
zero-trans entry at O'^ C. This asymmetry of transport is somewhat reduced at 20-25°C to a 3- 
fold difference in kinetic parameters for entry and exit. One physiological significance of the 
observed GLUTl asymmetry would be to allow it to act effectively as a unidirectional 
transporter under conditions in which D-glucose concentrations on one side of the membrane 
are low and the demand on the other side is high, e.g. transport across the blood-brain 
barrier under hypoglycaemic conditions.
The kinetic parameters determined under equilibrium exchange conditions are 
substantially greater than those determined under zero-trans exit conditions. This observation 
can be explained in terms of a phenomenon known as tram -acceleration. This describes the
■teffect of the presence of sugar on one side of the membrane on the rate of unidirectional 
transport from the opposite side, for example, intracellular D-glucose stimulates D-glucose 
uptake and vice versa. This results in lower than expected initial transport rates under zero- 
tram conditions. Assuming that the rate limiting step for net transport is the reorientation of 
the unloaded carrier, under exchange conditions the transporter will bind a second sugar 
molecule before it reorientates, effectively bypassing this slow step. This is not the case 
under zero-tram conditions due to the initial absence of sugar on one side of the membrane.
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1.5 .3  Models for the Mechanism of D-Glucose Transport.
1.5.3a Introduction
Glucose transport is characterised by a number of properties: 1) transport of glucose 
occurs more rapidly than can be accounted for by simple diffusion across the lipid bilayer; 2) 
transport displays simple Michaelis-Menton saturation kinetics; 3) the rate of transport is 
proportional to the number of transporter proteins; 4) transport of sugars is stereospecific 
and there is competition between sugars for transport; 5) the transport capacity of cells can 
be regulated by endocrine and metabolic factors. Such properties liken the mechanism of 
glucose transport with those of enzyme-catalysed reactions.
1.5.3b The Single Site Alternating Conformer Model.
In 1952, Widdas proposed a simple, symmetric carrier model for glucose transport 
(Widdas, 1952) from which a kinetic model that can account both for transport asymmetry 
and for /raw.s'-acceleration arose. The model is known as the single site alternating 
conformation model (Figure 1.3).
The transporter is described as a simple asymmetric carrier that can alternate between 
two conformational states such that a single D-glucose binding site is sequentially and 
alternately exposed to either the cytoplasm (Tj) or the extracellular medium (To). So, at any 
point in time, a carrier can be available for either sugar efflux or influx, but not for both 
simultaneously. When sugar binds to one of these sites to form a canier-sugar complex (TiG 
orToG), a conformational change is induced such that the sugar is presented at the other side 
of the membrane. The re-orientation event may involve the substrate binding site or a larger 
portion of the transporter (Hodgson et al., 1992). Dissociation of the sugar occurs and the 
transporter is then available to bind a further sugar molecule for transport in the opposite 
direction, or it can isomerise back to its original state in the absence of sugar. Thus, re­
orientation of the carrier can occur in the presence or absence of D-glucose. The dissociation 
constants for sugar binding at the endofacial (Ksi) and exofacial (Kgo) sites are not
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necessarily equal, and the rate constants governing the re-orientation of the loaded carrier (k% 
and k _i) are greater than those relating to the movement of the unloaded carrier (k2 and k _%). 
Rates of association and dissociation of glucose from the transporter are also much greater 
than the rates of re-orientation and therefore the latter is the rate-limiting factor in the 
transport cycle (Figure 1.4). Indeed evidence has been obtained from an NMR study in 
support of this (Wang, 1986). Therefore under zero-trans conditions, unidirectional flux of 
D-glucose is retarded by the slow re-orientation rate of the unloaded carrier, a situation 
which does not prevail under equilibrium exchange conditions since D-glucose dissociation 
is rapidly followed by D-glucose association.
1.5.3c Measurement of Individual Kinetic Parameters Governing 
Transport.
Individual rate constants and activation energies that govern re-orientation of the 
loaded and unloaded carrier have been determined under zero-trans entry, exit and 
equilibrium exchange conditions for transport of radiolabelled D-glucose in erythrocytes by 
exploiting the temperature dependence of the transport process (Lowe & Walmsiey, 1986). 
Pre-steady state values for the rates of interconversion from Tj to To were determined 
spectroscopically by monitoring the intrinsic protein fluorescence in the presence and 
absence of D-glucose. Intrinsic fluorescence altered in a time dependent manner when 
purified GLUTl reconstituted in unsealed membranes was mixed with 4,6-O-ethylidene-D- 
glucose at 10°C. This is a non-transported glucose analogue that preferentially binds to the 
To conformation. Incubating the transporter at saturating concentrations of this analogue 
causes a rapid, first-order quenching of the intrinsic protein fluorescence as a result of the 
conversion of Ti to To . The transporter is then trapped in the TqEGIc complex. This 
methodology has enabled single half-turnover events to be measured. This approach was 
expanded to the determination of rate constants governing the conformational change in the 
opposite direction i.e. Tq to Ti, made possible with the use of n-propyl-B-D-glucopyranoside 
which binds preferentially to the Ti conformer (Barnett et al., 1975), complexing at least 
90% of the transporter in this conformation at equilibrium. Fluorescence was monitored in
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the presence and absence of D-glucose allowing determination of single "half turnovers" 
(Appleman & Lienhard, 1989).
- IThe values obtained for each individual rate constant under both steady-state and 
equilibrium exchange conditions are in good agreement and support the existence of the
Îalternating conformer model. Values are quoted in the legend to Figure 1.4 and to |
summarise, the relative rate constants are k2>k _2>ki>k
The dissociation constants for substrate at the exofacial and endofacial binding sites 
can be calculated from the rate constants for transporter re-orientation and the transport
0
kinetics. Values calculated for the exofacial binding site, Kgo, were found to remain constant
■Iat /-lOmM over a range of temperatures between 0°C to 37°C. Over the same temperature 
range, values for the endofacial binding site Ksi, increased from 13mM to 23mM. Thus, at
Ilow temperatures, the dissociation constants for the glucose-carrier complex on either side of 
the membrane are similar despite large differences between individual rate constants. This is 
in sharp contrast to the measured 10-fold lower affinity (Km) of the endofacial site at 0°C. It 
is likely that the large asymmetries in the zero-trans Michaelis constants observed at low
Itemperatures arise from the differences in individual rate constants for transporter re­
orientation and not from large changes in the affinity for glucose at the two sites. 
Consequently there is an asymmetric distribution of exo- and endofacial conformations of S
Iloaded and unloaded transporter at 0°C. In the absence of glucose, only 6 % and 7.5% of the 
unloaded and loaded transporter is in the exofacial conformation. This distribution changes
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in response to temperature such that at 37°C, 40% and 60% of the unloaded and loaded #
transporters are outwardly orientated (Walmsiey, 1987).
Thermodynamic analysis show that the temperature distribution may arise as a result #-
of endothermie enthalpy and positive entropy changes associated with re-orientation of the 
transporter from an endofacial to an exofacial conformation. It has been suggested that such 
changes emanate from the increased stability of the inward-facing conformation due to salt 
bridges present in the hydrophilic cytoplasmic domain of the transporter (Walmsiey, 1987).
Glucose binding to the transporter is probably dependent on the dissociation of water 
molecules from both the transporter and glucose molecule, followed by the subsequent 
formation of hydrogen bonds between glucose and the transporter at the binding site. This E|
fII■t
may provide a kinetic means by which glucose can accelerate the interconversion of the two 
conformational states.
1.5.3d Multiple Site Models.
The single site alternating conformer model accounts for the majority of kinetic data 
obtained from tiansport studies in erythrocytes. This includes discrepancies between kinetic 
parameters for net entry and exit and an exchange rate that is more rapid than net flux. 
However, there are some discrepancies between observed and predicted values derived from 
integrated rate equations for certain parameters and these have led to the proposal of 
alternative transport models. Carruthers has proposed several alternatives including the fixed 
site carrier models in which the carrier consists of two subunits that each act by alternating 
between two conformational states. The mechanism of transport is such that sugar binding at 
one site of a subunit induces its reorientation to the trans side of the membrane. This 
conformational change is coupled to the simultaneous re-orientation of the binding site of the 
second subunit in the opposite direction. The basic tenet of this model is similar to that of the 
altemating-conformer model but it also allows for the simultaneous existence of exofacial 
and endofacial binding sites that may act co-operatively when both occupied. A second fixed 
site model envisages the existan ce of a two-site aqueous channel. When both sugar binding
sites are occupied, a conformational change occurs that stabilises the channel in an opened
State that is sufficiently wide to allow the simultaneous translocation of two sugar molecules 
in opposite directions. Due to the complex nature of these fixed site models, they are less 
amenable to analysis by steady-state methods.
Experimental evidence has been obtained that supports the simultaneous presence of 
exo- and endofacial binding sites. Erythrocyte transporters have been shown to bind the 
endofacial ligand, cytochalasin B and also an exofacial ligand such as maltose, phloretin or 
4,6-O-ethylidene-D-glucose simultaneously (Helgerson & Carruthers, 1987). The effect of 
each of these ligands on the inhibition of D-glucose uptake by the other ligand suggests that
these simultaneously occupied sites exhibit negative co-operativity (Carruthers & Helgerson, 
1991). Also, glucose-induced fluorescence quenching has been shown to consist of two
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saturable components of low and high dissociation constants suggesting the presence of 
multiple substrate binding sites (Carruthers, 1986).
Perhaps the most direct evidence to support the single site alternating conformation 
model over the fixed site model came from the demonstration of a single half-tumover of the 
transporter. Erythrocyte transporters incubated with maltose, a non-transporter exofacial 
ligand, are effectively pulled into the outward facing conformation. Rapid dilution of maltose 
by the simultaneous addition of D-glucose allows a portion of the outwardly orientated 
transporters to bind D-glucose and undergo conformational changes, producing an initial 
burst of glucose uptake and a change in intrinsic fluorescence corresponding to formation of 
the inward-facing conformation (Lowe & Walmsiey, 1987). No such intrinsic fluorescence 
change would be predicted in a two site model since an outward-facing binding site is 
always exposed. Consequently, maltose would not have the effect of re-orientating the 
transporter.
1 .6  Conformational Changes.
1.6.1 Introduction.
Although the mechanism of transport mediated by GLUTl is still unclear and the 
distinct number of binding sites is still unresolved, there is little doubt that the transporter 
alternates between two different conformational states. The first piece of compelling 
evidence for this came from the demonstration that glucose derivatives with large bulky
substituents at the C-4 or C-6  position such as maltose or 4,6-O-ethylidene-D-glucose were
not transported but inhibited sugar transport when present only at the outside of the 
erythrocyte (Baker & Widdas, 1973, Barnett et aL, 1975). These ligands were therefore 
proposed to bind at the extracellular binding site, in contrast to endofacial ligands such as n- 
propyl-6 -D-glucopyranoside which has a large substituent at the C-1 position and inhibits 
transport only when present inside the cell. The orientation of the sugar is preserved at each 
side of the membrane such that binding at the exofacial site is via the C-1 position whereas 
binding at the endofacial site is via the C-4 and C-6 . Transport is therefore inhibited not by
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lack of sugar binding, but by steric prevention of the subsequent conformational changes 
that mediate substrate translocation.
1.6 .2  Detection of GLUTl Conformational Changes by Intrinsic 
Fluorescence.
Monitoring intrinsic protein fluorescence and measurement of the relative abilities of 
external hydrophilic molecules to quench protein fluorescence in the presence of various 
ligands has provided evidence for the occurrence of apparent conformational or positional 
changes during substrate translocation. GLUTl contains six tryptophan residues throughout 
its 492 amino acid sequence and the intrinsic fluorescence of the transporter due to these 
residues report on the overall tertiary protein structure and its relationship to the bilayer. 
Quenchers such as potassium iodide (KI) and acrylamide can be used to determine which 
tryptophan(s) are accessible to a hydrophilic environment. A maximum peak at 336nm in the 
fluorescence emission spectrum indicates the location of tryptophan in both polar and apolar 
environments. Fluorescence quenching by KI and acrylamide indicate that not all 
tryptophans are located within the hydrophobic interior of the protein or the lipid bilayer 
(Pawagi & Deber, 1990).
Both D-glucose and transport inhibitors such as maltose, 4,6-U-ethylidene-D- 
glucose, phloretin, cytochalasin B and forskolin quench the fluorescence, wuh this effect 
strongest at longer wavelengths, indicating the involvement of one or more tryptophans 
exposed to a polar environment, possibly at the substrate binding site(s) (Chin et al., 1992; 
Gorga & Lienhard, 1982). Individual replacement of Trp^U and Trp388 to leucine by site 
directed mutagenesis leads to decreased transport activity and perturbed cytochalasin B 
binding (Garcia et aL, 1992; Katagiri et aL, 1991). These residues are predicted to lie 
approximately opposite to one another within transmembrane segments 10 and 11. Trp^^ is 
located within an optimally dynamic segment which undergoes movement from an accessible 
aqueous environment to a less accessible environment as a result of ligand binding. As 
mutation of this residue results in markedly reduced cytochalasin B binding, it is proposed 
thatitTrp388 is involved in ligand binding at the endofacial site. Changes in the accessibility
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of certain groups as a result of ligand binding is also likely to be involved in the quenching 
mechanism. Indeed, it has been observed that the exofacial conformation of the unloaded 
carrier is 20% less fluorescent than the endofacial conformation (Appleman & Lienhard,
1989) as already described.
1.6 .3  Sensitivity of Transporter Conformations to Chemical Inactivation.
l-fluoro-2,4-dinitrobenzene (FDNB) is an amino-group modifying agent that can 
irreversibly inactivate GLUTl, with the endofacial and exofacial conformations exhibiting 
different reactivities toward this compound. Rates of inactivation increased in the presence of 
extracellular D-glucose but were reduced in the presence of intracellular glucose (Edwards, 
1973). Also, there is a direct correlation of protection with binding of non-transported 
ligands to the outside of the transporter and inactivation with binding at the inner side. For 
example, the presence of n-propyl-B-D-glucopyranoside accelerates GLUTl inactivation by 
FDNB. Protection from inactivation occurs in the presence of extracellular maltose, 4,6-O- 
ethylidene-D-glucose, phloretin (Baker & Widdas, 1973; Krupka, 1971) and 6-0 -alkyl-D- 
galactoses (Barnett e? «/., 1975). Although the precise mechanism of inactivation by FDNB 
is unknown, the results suggest that FDNB, which can rapidly penetrate membranes and is 
therefore present on both sides, acts only when the transporter is in the endofacial 
orientation. It may be that this reagent does not act directly at the binding site but modifies a 
reactive group that becomes exposed upon binding of endofacial ligands. The apparently 
anomalous observation that intracellular D-glucose protects against inactivation can be 
explained by an increased rate of re-orientation to the outward-facing conformation in the 
presence of glucose (Barnett et al., 1973; Edwards, 1973).
Another conformationally sensitive sulphydryl group has been identified as the sole 
exofacial cysteine residue located at residue 429 of GLUTL This group can be modified by 
impermeant sulphydryl group modifying reagents such as bis-(maleimidomethyl)-ether-L- 
P^S]cysteine, glutathione-maleimide and p-chloromercuri-benzenesulphonate (pCMBS), 
resulting in transporter inactivation (May et al., 1990; Wellner et al., 1992). Modification by 
these compounds is increased in the presence of ligands that interact at the exofacial binding
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site such as maltose and phloretin. In each case, cytochalasin B protects against modification 
by stabilising the inward-facing conformation. The Cys^^^ is probably located at a site that is 
structurally distinct from the substrate binding site since ligands that bind to the exofacial 
binding site actually increase the sensitivity of this residue to modification.
Cys429 is predicted to lie at the extracellular end of helix 12 in the C-teiminal half of 
the transporter. Evidence also exists to suggest that in addition to the C-terminal half, the N- 
terminal domain also takes part in conformational changes associated with substrate 
translocation across the bilayer. Inhibition of transport by N-ethylmaleimide correlates with
!modification of a sulphydryl group located in the N-terminus (May, 1989). Cytochalasin B 
binding protects the transporter from modification and this is likely to be due to steric 
hindrance.
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1 .6 .4  Susceptibility of GLUTl Conformational States to Proteolysis.
Data obtained from fluorescence spectroscopy and chemical modification studies 
most likely reflect the conformational states of the hydrophobic membrane spanning regions 
of the transporter. Studies assessing the susceptibility of the hydrophilic cytoplasmic 
domains to proteolysis reveal that these regions are also affected by conformational changes 
associated with substrate translocation. Trypsin and thermolysin cleave GLUTl at sites 
within the large, central hydrophilic loop and the C-terminal sequence yielding two large
■ ;fragments. The reversible binding of exofacial ligands such as maltose, phloretin and 4,6-0 
-ethylidene-D-glucose substantially reduce the rate of proteolytic cleavage (Gibbs et al.,
1988; King et al., 1991). Photoaffinity-labelling of GLUTl at the exofacial site by the bis- 
mannose derivative ATB-BMPA, provides almost complete protection from proteolysis 
(Clark & Holman, 1990). As the cleavage sites are cytoplasmic, such effects are not likely to 
be a result of steric hindrance between exofacial ligand binding and proteases. Exofacial 
ligands stabilise the outward facing conformation thereby providing indirect protection of the 
cytoplasmic domains from proteolysis by causing them to adopt an orientation that is less 
accessible to proteinase.
As would be expected, binding of reversible endofacial ligands such as n-propyl-B- 
D-glucopyranoside increase the rate of cleavage, presumably due to increased steady-state 
levels of the transporter in a proteolytically-sensitive orientation. A somewhat surprising 
observation, however, is that cytochalasin B binding has no effect on the rate of tryptic or 
thermolytic cleavage (Gibbs etaL, 1988; King et al., 1991). It is possible that cytochalasin 'I:
B stabilises a conformation that is distinct from those induced by binding of other ligands.
■'1Intracellular D-glucose increases the rate of proteolysis. This can be explained in terms of the 
asymmetric carrier model since kinetic theory predicts a modest increase in the steady-state jiproportion of outward-facing transporters in the presence of glucose (Lowe & Walmsiey,
1986). Increased sensitivity to proteolysis may also occur during the transport process itself.
The observation that trypsinised GLUTl is still capable of subsequently binding 
cytochalasin B, but has reduced affinities for the exofacial ligand, ATB-BMPA, suggests 
that the proteolysed transporter is locked in an inward-facing conformation (Cairns et al., |
1984; Clark & Holman, 1990; Karim et al, 1987). Similar characteristics are exhibited by a 
C-terminaily truncated mutant of GLUT 1 lacking 37 C-terminal amino acid residues (Oka,
1990). Conversely, a mutant truncated by removal of only 12 C-terminal residues does not
■display such characteristics. Thus, removal of residues 455-480 produces a transport- 
deficient protein that is locked in an inward-facing conformation.
Taken together, results obtained from the application of chemical and physical 
methodologies t<^ the study of glucose transport, particularly by GLUTl, have given a 
consistent picture of a transmembrane protein that mediates substrate translocation by 
alternating between two conformational states. The process is dynamic and involves
movement of at least some transmembrane helices and the cytoplasmic loops. A putative ; Î
:mode of operation of the GLUTl transporter has been proposed based on molecular
dynamics and molecular modelling studies (Hodgson et aL, 1992). Conformational changes
Ë:are proposed to occur in the region of transmembrane helix 10 enabling the transporter to sadopt two distinct glucose binding conformations. Modelling predicts that proline and
.glycine residues located within this helix may provide the flexibility required for such / 
positional changes to take place. The role of membrane-buried proline residues in the 
conformational changes required for substrate translocation is discussed in Chapters 3 and 4.
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1 .7  Location of the Substrate-Binding Site(s).
1 .7 .1  Introduction.
I
Identification of the substrate-binding site(s) of GLUTl has been greatly facilitated i
by the availability of specific inhibitors of transport that bind with greater affinity than D-
'■tglucose. Some of these inhibitors can be covalently attached to their binding sites on the 
protein by photoactivation using ultraviolet irradiation. Limited proteolysis of the 
photolabelled transporter using radiolabelled photoaffinity ligands should reveal the 
approximate position of the substrate binding site(s). Interpretation of such studies depends E
upon the assumption that the site of photoaffinity labelling does not sterically hinder glucose 
binding either directly or by inducing an altered conformational state. In addition, the site of I  
photolabelling and that of reversible inhibition of glucose transport are assumed to be the 
same.
vS
1 .7 .2  Affinity Labelling at the Endofacial D-Glucose Binding Site. 1,
Cytochalasin B is a naturally occurring fungal metabolite that acts as a high affinity 
inhibitor of sugar transport mediated by both mammalian and bacterial facilitated diffusion E
sugar transporters (Basketter & Widdas, 1978; Krupka & Deves, 1986). Cytochalasin B has 
been demonstrated to bind to various symporters of E.coli including the galactose/H'*' 
symporter, GalP and AraE, the arabinose/H+ symporter. The xylose/H+ symporter, XylE,
:does not bind cytochalasin B (Henderson et aL, 1992).
With regard to the mammalian GLUT isoforms, cytochalasin B was found to bind 
exclusively at the inner surface of GLUTl in a D-glucose inhibitable manner with a 
stoichiometry of one molecule per polypeptide chain (Baldwin & Lienhard, 1989) and a IQ |
of 120nM (Zoccoli et aL, 1978). The binding is quantitative and is therefore used as an 
assay for GLUTl activity in purified preparations. The inhibitor binds to GLUT2 (Axelrod 
& Pilch, 1983) and GLUT7 (Waddell et aL, 1991) with much lower affinities, (K^ o f-l^ M
Efor GLUT2) and does not appreciably bind to GLUTS (Burant et aL, 1992).
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A more precise location of the cytochalasin B binding site has emanated from the use 
of photolabelling in conjunction with proteolysis. Tryptic removal of hydrophilic, 
cytoplasmic domains of GLUTl leaves membrane embedded portions of the protein that 
retain the ability to bind cytochalasin B (Cairns et aL, 1984; Karim et aL, 1987). 
Photolabelling with pH]cytochalasin B after tryptic cleavage yields a C-terminal 18kDa 
fragment corresponding to amino acid residues 265-456. This region has been resolved 
further by extensive cleavage of photolabelled GLUTl with trypsin, thermolysin, 2-nitro-5- 
thiocyanobenzoic acid (2-NTCB) and A-bromosuccinimide (NBS). A 3kDa NBS cleavage 
fragment corresponding to amino acid residues 388-412 comprising the loop connecting 
transmembrane helices 10 and 11, and helix 11 itself was identified as the D-glucose 
inhibitable cytochalasin B binding site (Holman & Rees, 1987). The endofacial glucose 
binding site is therefore mapped to this region of GLUTl. Derivatives of cytochalasin B and 
forskolin are proposed to bind at this endofacial site since the oxygen atoms of these 
molecules are superimposable with those of D-glucose and therefore, are capable of forming 
equivalent hydrogen bonds with residues at the binding site. A recent observation that 
GLUTl is capable of simultaneously binding cytochalasin B and 4,6-O-ethylidene-D- 
glucose casts some doubt on the accuracy of the single-site alternating conformer model 
(Carruthers & Helgerson, 1991).
Forskolin is a diterpene toxin that competitively inhibits both 3 -0 -methyl-D-glucose 
transport and cytochalasin B binding (Sergeant & Kim, 1985; Shanahan et aL, 1987), It 
therefore binds to the endofacial side of the transporter in close proximity to the site of 
interaction with cytochalasin B and D-glucose. The 3-[^23j]iodo-4-azidophenethylamido-7-0 
-succinyldeacetyl (IAPS) derivative of forskolin is a high affinity photolabel of glucose 
transporters (Wadzinski et aL, 1987; Wadzinski etaL, 1988). In contrast to cytochalasin B, 
some disagreement exists as to the exact location of the forskolin and lAPS-forskolin
labelling site(s). Forskolin photolabelling has been located to the same 18kDa C-terminal 
tryptic fragment as cytochalasin B while lAPS-forskolin labelling has been mapped to amino 
acid residues 369-389 within helix 10 of GLUTl ((Wadzinski et aL, 1990) and helix 9 of 
GLUT4 (Hellwig & Brown, 1992). Since labelling is inhibited in the presence of 
cytochalasin B, this sequence may also comprise part of the endofacial D-glucose binding
site. Other derivatives include the iodinated 7-aminoalkylcarbamate form of forskolin that 
has a very high affinity (IC50 of 200nM) for the brain and erythrocyte isoforms (Morris et 
ah, 1991). GalP has also been reported to bind pH] I APS-forskolin with inhibition of sugar 
transport (Henderson et aL, 1992).
Recently, a transportable diazirine derivative of D-glucose, 3-deoxy-3,3-azi-D- 
glucopyranose (3-DAG) has been demonstrated to be rapidly transported by GLUTl into 
erythrocytes and resealed ghosts at a rate comparable to that of 3-O-methyl-D-glucose, in a
cytochalasin B inhibitable manner (Lachaal et aL, 1996). Upon UV irradiation, 3-DAG can 
be covalently incorporated into purified GLUTl, reconstituted into liposomes. Proteolysis of 
3-DAG-labelled GLUTl revealed that sequences within both the N- and C-terminal regions 
interacted with this substrate analogue and are therefore most likely to contribute to channel
,..k:formation. However, definitive assignment of 3-DAG labelling to individual transmembrane 
helices and amino acids was not possible in this study. Involvement of the N-terminal half in 
channel formation is consistent with the proposal that the glucose channel is formed at the 
interface between the N- and C-terminal domains involving five amphipathic helices of either 
3, 4, 7, 8  and 11 or 2, 5, 7, 8  and 11 (section 1.9). Identification of the individual 3-DAG- 
labelled amino acids would no doubt contribute to a more compelling map of the contact sites 
of D-glucose within the channel.
Other known photoaffinity labels of GLUTl include the naturally occurring steroid, 
androstenedionc which acts as a potent competitive inhibitor of 3-O-methyl-D-glucose 
uptake. Cytochalasin B binding is also inhibited and photo-incorporation has been mapped
,to the 18kDa tryptic fragment of erythrocyte ghosts ((May, 1988).
1 .7 .3  Affinity Labelling at the Exofacial D-Glucose Binding Site.
Several attempts have been made to synthesise an impermeant, exofacial 
photoaffinity label to facilitate mapping of the exofacial D-glucose binding site. A series of 
bis-hexoses have been designed by Holman and colleagues, based on the rationale that these 
would bind to the exofacial D-glucose binding site (Clark & Holman, 1990; Holman & 
Karim, 1988; Holman et aL, 1986). Identification of an impermeant bis-mannose core as a
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photolabile substituent has made possible the synthesis of a number of photoactivatable
■ #compounds that have an affinity for GLUTl. These include the bis-hexoses 2-A-(4-)-l,3- 
bis(D-mannos-4-yloxy)propyl-2-amine (A SA -B M PA ), and 2-A-[4-azi-2,2,2- itrifluoroethyl)benzoyl]-l,3-bis(D-mannos-4-yloxy)-2-propylamine (ATB-BMPA). Each
Écompound was found to bind exofacially to GLUTl and was displaced by D-glucose, 4,6-0
. E-ethylidene-D-glucose and cytochalasin B binding. Similar to cytochalasin B labelling, E:
photolabelling of GLUTl with these compounds followed by tryptic cleavage of the native 
membrane-bound transporter yields a labelled ISkDa fragment. ASA-BMPA labelling has 
been localised to a region between amino acid residues 347-388, probably at the extracellular
end of helix 9 (Holman & Rees, 1987). ATB-BMPA, which exhibits better selectivity, is 
suggested to label at a site located within helix 8, between residues 301 and 330 (Baldwin,
1993; Saravolac & Holman, 1997). ATB-BMPA-labelled fragments were identified in this 
study by their pattern of recognition by site-directed anti-peptide antibodies.
Thus, transmembrane helices 8 and 9 may contribute to the exofacial substrate 
binding site whereas the endofacial site is composed of helices 10 and 11. This implies some 
structural separation of the endo- and exofacial binding sites. 'I
1 .7 .4  Role of the N- and C-Terminal Domains in Formation of the
.-ÏÏExo- and Endofacial Substrate Binding Sites.
Various studies in which GLUTl has been photolabelled by cytochalasin B, bis- Imannose derivatives and forskolin derivatives (as outlined above), and proteolysis, suggest
.1that the six transmembrane a-helices of the C-terminal domain contain both the endo- and 
exofacial D-glucose binding sites. Ligand binding sites are also located within this region. 
Site-directed mutagenesis has identified several key amino acid residues that are involved in 
the binding sites and, interestingly, all but one of these residues are located in the C-terminal 
domain of the transporter (i.e. from the start of helix 7 to the end of the cytoplasmic C- E 
terminal tail). There are three predicted amphipathic helices within this domain, helices 7, 8
and 11, that are particularly rich in conserved polar residues that could participate in transient I:hydrogen-bond formation with D-glucose during translocation through an aqueous channel
,
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lined by these helices. Such residues have also been targeted for mutagenesis, and roles for 
these helices in the transport mechanism and formation of the substrate binding sites have 
been implicated. Similar studies have also implicated helices 9 and 10 as important regions. 
Data supporting a function for the N-terminal domain presents a much less clear
■ |
picture. Lack of information regarding this region of the transporter prompted a study in
which the individual stability of the N- and C-terminal domains of GLUTl were investigated
(Cope et aL, 1994). Truncated GLUTl constructs encoding either the N-terminal or C-
terminal domains were heterologously expressed in Sf9 cells. Surprisingly, when expressed
separately, both constructs were targeted with high efficiency to the plasma membrane but
neither were capable of binding the site specific ligands ATB-BMPA or cytochalasin B.
Simultaneous expression of both constructs, however, resulted in restoration of the ligand-
binding capacity of the C-terminal domain. Thus, both domains are sufficiently stable to be
targeted conectly to the plasma membrane and to recognise the other domain. It is possible
that the N-terminal domain permits the C-terminus to bind ligands by providing a packing
surface against which the C-terminal helices can arrange themselves for correct and stable
exposure of the ligand binding sites. It is unlikely that the N-terminus provides amino acid 
.side chains that participate directly in ligand binding since the N-terminal half is not labelled
by active site ligands.
1.7.4a Contribution of the C-Terminus to Substrate Binding.
Residues thought to participate in hydrogen bond formation with sugars can be 
divided into those important for binding inside-specific ligands, and those that are important 
for outside specific ligands. It is possible using mutagenesis to target such residues resulting 
in disruption of either binding site without affecting the other. The first demonstration, using 
site-directed mutagenesis, that helix 7 constitutes part of the exofacial ligand binding site was 
carried out in 1992. Replacement of Gln^^^-Leu in helix 7 perturbs exofacial binding of 
ATB-BMPA without any detectable disruption of cytochalasin B binding (Hashiramoto et 
aL, 1992). In contrast, the mutation Tyr293-He resulted in a transporter that had
-
approximately a 300-fold reduction in affinity for cytochalasin B at the endofacial site whilst
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its ability to bind D-glucose and ATB-BMPA was unaffected (Mori et al., 1994). Thus, the 
Gln282_Leu and Tyr^^-Ile mutants are conformationally locked in an inward or outward- 
facing state respectively. Both studies provide additional evidence supporting the structural 
separation of the exo- and endofacial binding sites. It was concluded that Gln^82 and Tyr^^S 
are both essential for hydrogen bonding to D-glucose and are involved in closing the 
exofacial binding site during substrate translocation. Since Gln^82 is predicted to lie in the 
centre of helix 7, it is suggested that this helix moves up in the membrane to accept exofacial 
ligands (Figure 1.6). This may involve some unfolding of the helical structure at the 
endofacial end (Hashiramoto et aL, 1992). Proteolytic studies also support this upward 
helical movement.
C-terminal deletion analysis of rabbit GLUTl, (Oka et aL, 1990), has provided 
compelling evidence that the cytoplasmic C-terminal domain is required for formation of the 
exofacial binding site (Figure 1.6). Truncation of 37 of the 42 intracellular C-terminal amino 
acid residues results in a conf ormationally locked protein that is transport deficient and 
unable to bind exofacial ligands. However, the protein retains the ability to bind endofacial 
ligands. In addition, a mutant lacking twelve amino acids from the C-terminus retains wild- 
type expression levels and transport activity (Lin et aL, 1992). Similar studies have been 
undertaken with human GLUTl, yielding a similar pattern of inhibition. Deletion of C- 
terminal 40, but not 21 amino acids, virtually abolishes transport activity (Due et aL, 1995).
In order to determine the point at which conformational locking is localised, 
sequential truncations of the GLUTl C-terminal tail were performed. Removal of up to 24 
amino acids was without significant effect on transport activity or endo- and exofacial ligand 
binding. Deletion of 25-27 amino acids resulted in loss of transport activity associated with 
reduced ATB-BMPA labelling but normal levels of cytochalasin B labelling (Muraoka et aL, 
1995). It was demonstrated that Gly466 and Phe'^7 are not specifically required at position 
26 and 27 (from the C-terminal end), respectively, since point mutations at these sites do not 
affect the proteins ability to transport 2-deoxy-D-glucose. Therefore the minimum structure 
at the C-terminus that allows correct formation of the exofacial binding site requires all but 
the last 24 amino acids. The significance of the C-terminus regarding transport activity was 
further demonstrated by revealing that C-terminal deletions alter the turnover number for 3-
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O-methyl-D-glucose transport mediated by both murine GLUTl and GLUT4 (Dauterive et 
al, 1996).
1.7.4b Contribution of the N-Terminus to Substrate Binding.
The only residue located outwith the C-terminal domain that seems to affect ligand- 
binding is Glnl^l (Figure 1.6). Mutagenic studies in which this residue was replaced with 
leucine or asparagine resulted in a 50-fold and 10-fold reduction in transport activity 
respectively (Mueckler gr aA, 1994a). This was attributed to a 7.5-fold reduction in the 
catalytic turnover number and not due to reduced affinity for substrate since the Km for zero- 
trans influx of 2-deoxy-D-glucose was unaffected by substitution of Gln^^^ with aspartate. 
The ability of this mutant to bind the exofacial ligand 4,6-O-ethylidene-D-glucose was also 
reduced. The data, combined with the high degree of conservation of this residue within the 
twelve helix membrane spanning hexose transporters, is consistent with Gln^^l constituting 
part of the exofacial binding site. In addition, this residue is likely to be involved in events 
subsequent to substrate binding, such as conformational changes since mutation affected the 
turnover number of the transporter (Figure 1.6)
Mutation of Tyr^^ in GLUT4 to phenylalanine resulted in a 70% reduction in 
transport activity (Wandel et aL, 1994) when expressed in COS-7 and LTK cells. This 
residue is located within helix 4 and is highly conserved among all GLUT isoforms. It was 
concluded that the hydroxyl group of this residue could provide a hydrogen bond for the 
formation of the pore-forming complex of helices. Alternatively, it could represent a contact 
site for the substrate during translocation. Helix 4 contains the highly conserved motif 
VPMYI'^^XGEX (where X represents V or I) of which only TyrU3 of GLUT4 has 
been investigated. This helix has been included as a possible channel-forming helix in the 
speculative models proposed (Zeng a/., 1996) and discussed in section 1.9, however, the 
precise role of residues within helix 4 of the N-terminal domain remains unclear.
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1.8 Mutagenesis.
The common features revealed by alignment and analysis of the amino acid 
sequences of the mammalian glucose transporters and the wider superfamily of sugar 
transporters have been outlined previously in section 1.4.2. There are a number of highly 
conserved regions, ranging from single residues to various sequence motifs (Table 1.1). It 
was also mentioned in section 1.4.2 that the repetition of such sequences in the N- and C- 
terminal domains may represent the occurrence of an ancient gene duplication event. Such 
high conservation of these motifs suggest that they may be involved in transporter function, 
thus making them obvious targets for mutagenesis. A number of strategies have been 
employed ranging from substitution of individual residues to replacement or removal of 
entire domains and construction of chimeric transporters. Such efforts to elucidate the 
relationship between transporter structure and function has produced a whole range of 
phenotypic effects which will be discussed in the relevant chapters of this thesis.
1.9 Tertiary Structure of GLUTl.
-
.As described, there is much evidence in support of the occurrence of large |
conformational changes in transporter structure as a consequence of ligand binding and 
transport catalysU. Such structural alterations are too large to be accounted for by the 
localised movement of amino acid side chains. Various molecular modelling and molecular
dynamics techniques have been applied to assess the conformational flexibility of GLUTl
'S(Hodgson et aL, 1992). Such theoretical studies have highlighted transmembrane helix 10 as 
containing a Pro-Gly rich, flexible region which may act as a pivotal point around which 
helices can pack to alternately expose the endofacial and exofacial binding sites (Gould &
Holman, 1993).
It has been suggested that the cytoplasmic region at the base of helix 12 packs
.""'Eagainst the bottom of helix 10. This blocks the cytochalasin B binding site and exposes the
Elexofacial binding site comprising helices 7, 8 and 9. Conversely in the endofacial ; |
conformation, the cytoplasmic tail at the base of helix 12 is predicted to move away from the
■'Vi
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base of helix 10, thus enabling cytochalasin B to bind to this conformation. This model is 
consistent with conclusions drawn from the C-terminally truncated GLUTl study in which 
the mutant was found to be locked in an endofacial conformation (Oka et aL, 1990). It 
would also explain why the length of the cytoplasmic tail appears to be critical for correct 
foiTnation of the exofacial binding site. In the truncated mutant, the tail is not long enough to 
pack against the endofacial binding site, which consequently remains exposed.
In the absence of any three-dimensional crystallographic structural data, the 
arrangement of the transmembrane a-helices in GLUTl remains to be elucidated. Several 
hypothetical models have been predicted but, unfortunately, none are entirely consistent with 
the mutagenic, structural and kinetic data. The most recent attempts have made use of 
computer modelling and recent advances in protein structure prediction algorithms to 
generate low-resolution structural models of the transmembrane domains of GLUTl. Two 
models have been proposed which seem to fit many of the biochemical and biophysical 
observations made with this protein. Several criteria are considered including the physical 
dimensions and water-accessibility of the channel, lengths of loops connecting helices, 
macrodipole orientation in a four-helix bundle motif and the helical packing energy. Five 
transmembrane helices are predicted to line a channel and the remaining helices pack around 
them (Figure 1.7). The channel is lined either by helices 3, 4, 7, 8 and 11 (model 1) or 
helices 2, 5, 7, 8 and 11 (model 2). It is interesting to note that helices 7, 8 and 11, which 
are predicted to be highly amphipathic, are predicted to line the channel in both models. The 
other two helices are provided by the N-terminal domain. In addition, in both models, the 
helices that are frequently labelled, helices 8-10, are proposed to lie adjacent to one another. 
Although these models are consistent with much of the mutagenic data, they are purely 
speculative in the absence of any crystal structures. They do, however, provide a template 
for the design of further biochemical and biophysical studies to probe the structure and 
function of these proteins.
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1.10  Oligomerisation of GLUTl.
GLUTl protein recovered from erythrocytes by cholate solubilisation of membranes "I
and purified by size exclusion chromatography and sucrose gradient ultracentrifugation can 
be reconstituted in proteoliposomes. The resulting protein complex displays transport 
activity and D-glucose inhibitable cytochalasin B binding (Herbert & Carruthers, 1991).
Analysis of the particle size of these complexes by target size analysis of radiation- 
inactivation of GLUTl, indicate that, under different reducing conditions, the transporter can 
exist as dimeric or tetrameric assemblies of a 55kDa monomer. Hydrodynamic studies of I
cholate solubilised GLUTl, the use of conformationally specific antibodies and chemical
Ë.cross-linking of membrane resident GLUTl suggest that the native transporter exists as a if
tetramer (Herbert & Carruthers, 1992). In this state, the GLUTl complex can bind one
molecule of cytochalasin B per two molecules of GLUTl and presents at least two binding
;!'-isites to D-glucose. Upon reduction to the dimeric form, cytochalasin B binds with a
stoichiometry of 1 molecule per GLUTl molecule and a single population of glucose binding 
sites are presented.
A model has been proposed for the interaction of monomeric subunits in the dimeric
■i;and tetrameric forms (Figure 1.8). In the dimer, the monomers can isomerise between the 
exofacial and endofacial conformations independently of each other. Cytochalasin B binds to 
the endofacial conformation and gives rise to the observation that cytochalasin B binds to 
GLUTl with a stoichiometry of 1:1 in this state. In the tetramer, conformationally active 
parts of each monomer are constrained by the interaction of the subunits. This results in 
coupling of the isomérisation events between the exofacial and endofacial conformations in 
the two dimers that constitute the tetramer. Therefore, each dimer presents an exofacial and 
endofacial binding site simultaneously with an antiparallel arrangement, i.e. isomérisation of 
one subunit from an exofacial to endofacial conformation induces reorientation of the 
adjacent subunit in the opposite direction.
Carruthers suggested that the major physiological form of GLUTl in erythrocytes is 
the tetramer, and that this isoform is 2- to 8-fold catalytically more active than the dimer.
This model is consistent with most of the kinetic data on substrate binding (Herbert &
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Carruthers, 1992). A physiological advantage of this system is that the rate-limiting step in 
the transporter turnover cycle, i.e. reorientation of the unloaded carrier, is accelerated due to 
the coupled isomérisation events between the subunits. The differences observed between 
the kinetics of purified and reconstituted GLUTl and the native GLUTl in intact 
erythrocytes can also be rationalised by this model. The catalytic turnover (kcat) of the 
reconstituted protein is 20-fold lower than that of the native transporter in erythrocytes 
(Connolly et aL, 1985; Herbert & Carruthers, 1992; Wheeler and Hinkle, 1981)
The presence of a single intramolecular disulphide bridge between Cys '^f'  ^ and 
Cys421 has been proposed to stabilise the tetramer (Zottola aL, 1995). This observation is 
somewhat questionable due to the finding that a GLUTl Cys-less mutant displays wild type 
kinetics and is capable of accelerated exchange (Due et aL, 1995a). Thus, the role of a 
putative disulphide bond in facilitating accelerated exchange is unclear.
Several studies have been undertaken to address the question as to whether the other 
GLUT isoforms are capable of forming oligomeric structures. Such studies have made use 
of mutagenic techniques and heterologous expression systems. For example, the possibility 
of interactions between GLUTl and GLUT4 was investigated by engineering two 
GLUT 1 /GLUT4 chimeric proteins which were expressed in CHO cells. The chimeras 
consisted of N-terminal GLUTl sequence with the C-terminal 29 or 294 amino acids . 
replaced with those of GLUT4. Both mutants co-immunoprecipitated with native GLUTl 
using an anti-GL^Jl'4 C-terminal peptide antibody. The N-terminal 199 residues of CLUTl 
were concluded to contain the sequence governing subunit interactions. No co- 
immunoprecipitation of native GLUTl and GLUT4 was detected in 3T3-L1 cells using the 
same antibody, suggesting that GLUTl can form homodimers but not heterodimers in vivo 
(Pessino etaL, 1991).
GLUT2 and GLUT3 can be heterologously expressed in Xenopus oocytes where 
they exhibit distinct kinetic profiles (Burant & Bell, 1992; Colville et aL, 1993b). 
Simultaneous expression of the two isoforms in oocytes results in a kinetic pattern that can
be separated into two components attributable to each isoform. Thus, in this system at least,
,GLUT2 and GLUT3 do not interact to form heterodimers. Further evidence supporting the 
occurrence of monomeric GLUT3 comes from a study in which wild-type GLUT3 was
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heterologously co-expressed with a transport-deficient GLUT3 mutant. The observed 
kinetics were indistinguishable from those exhibited by wild-type GLUT3, even when a 3- 
fold excess of the mutated mRNA was injected (Burant & Bell, 1992).
1.11 Aims of this Study.
The basis of this study, initially, is to investigate the role of proline residues in 
GLUT3 transporter function. All members of the mammalian GLUT isoforms contain 
several highly conserved proline residues, and many of these are located within putative 
transmembrane segments of the protein. Transmembrane proline residues are of particular 
interest because they are proposed to have a characteristic structural and/or dynamic role in 
the function of various membrane transport proteins. Isomérisation of the peptide bonds 
formed by this unique imino acid has been suggested to endow regions of proteins with 
conformational flexibility which may be crucial for transporter function. Since this 
isomérisation event is unique to Xaa-Pro peptide bonds, then replacement of the proline
:
residue of interest should, in effect, remove the flexibility around this peptide bond. Proline 
residues of interest will be replaced by alanine by site directed mutagenesis utilising
mutagenic oligonucleotides and recombinant PCR methodology. Transmembrane proline
residues of helix 10 will be targeted for mutagenesis in addition to other proline residues that 
are located close to the endofacial side of the membrane within highly conserved motifs. 
Heterologous expression in the Xenopus laevis oocyte system will enable kinetic 
characterisation of the transporters. Two such studies investigating the role of 
transmembrane proline residues of GLUTl have recently been reported. However, an 
extensive kinetic characterisation of the Pro-Ala mutants generated in these studies was not 
carried out and it is therefore possible that subtle structural effects caused by the mutations 
have been overlooked. GLUT3 Pro-Ala mutants generated in this study will be investigated 
with the use of site-specific ligands to highlight effects mediated at the exofacial and 
endofacial substrate binding sites.
In an effort to further characterise the kinetics of the GLUT3 Pro-Ala mutants, a 
protocol will be designed for the isolation of plasma membranes from Xenopus oocytes.
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This will enable quantitation of the transporter proteins expressed at the plasma membrane,
'i:.:thus enabling turnover numbers to be calculated. This is an important and useful parameter 
to measure when characterising mutant transporter proteins, since the effect of the mutation ;
can be manifested in aspects of the transport cycle other than the substrate binding events.
■;ÿ;
The isolation of pure plasma membrane fractions in this laboratory (and others), has 
previously proved to be problematic, mainly due to the nature of the oocyte which contains a 
high amount of glutinous yolk proteins. Subcellular fractionation of oocytes expressing v:
GLUT3, in combination with quantitative immunoblotting against membrane fractions 
expressing known amounts of GLUT3, will be used in an attempt to quantify the 
heterologously expressed glucose transporters at the plasma membrane.
IGLUT2 and GLUT3 have previously been demonstrated to exhibit differential 
substrate specificities and isoform specific kinetics. In an effort to address the structural 
basis of substrate selectivity, a series of GLUT2/GLUT3 chimeric transporters have 
previously been constructed in this lab (Dr.M.Arbuckle, Glasgow University). The partial
■Ekinetic characterisation of the GLUT3-series of chimeric transporters expressed in oocytes
has already been reported (S.Kane, Ph.D. Thesis, 1997, Glasgow University). However, |
expression of the entire GLUT2 series was not achieved due to expression problems
■encountered for two of the chimeras in this series. In an effort to address this problem, the
1relevant chimeras will be regenerated, sequenced and subcloned into vectors suitable for
'
expression in oocytes.
The use of an alternative expression system for a more detailed analysis of the
various mutants will be investigated. The establishment of stable cell lines expressing 
GLUT2, GLUT3 and the GLUT3 chimeras will be undertaken. Simple and reproducible 
protocols for subcellular fractionation of CHO-cells are available, thus enabling quantitation ' i
of transporters expressed at the plasma membrane and therefore measurement of turnover |
numbers. This system is also more convenient for photolabelling of transporters with 
cytochalasin B and ATB-BMPA. Thus, establishment of stable cell lines expressing wild 
type and mutant transporter proteins will provide a useful system in which to extend the 
studies that are not possible utilising the oocyte system.
ES
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Figure 1.1
Interaction of p-D-glucose at the Exofacial Binding Site of GLUTl.
This diagram shows the hydrogen bonding interactions formed between b-D- 
glucose and the exofacial binding site of GLUTl, and is based on a model proposed by 
Barnett et al. Hydrogen bonds form between the transporter and the sugar hydroxyls of 
carbons C-1, C-3 and C-4. The ring oxygen of the sugar is also involved. Possible 
hydrophobic interactions between the transporter and the sugar at the C-6 position have 
also been suggested (Barnett et al., 1973). Hydrogen bonds are represented by dotted 
lines, and the C-6 hydrophobic interactions are illustrated as a dashed area.
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Figure 1.1
Interaction of D-Glucose at the Exofacial Binding Site of GLUTl.
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Figure 1.2
Topological Model of the Mammalian Facilitative Glucose Transporters.
This model is based on the results of hydropathy analysis of GLUTl (Mueckler 
et ai, 1985), and has been confirmed by glycosylation scanning mutagenesis. Since the 
hydropathy plots of GLUTl and GLUTs 2 ,3 ,4 , and 5 are virtually superimposable, it 
is assumed that the model is applicable to all the isoforms in the glucose transporter 
family. The diagram shows the twelve predicted transmembrane helices as boxes, 
numbered 1-12. The amino- and carboxy-termini (labelled NH2  and COOH 
respectively) are located on the cytoplasmic side of the membrane. The N- and C- 
tenninal "halves" of the structure are separated by the large central cytoplasmic loop 
between helices 6 and 7. The large loop connecting helices 1 and 2 is exofacial and 
contains a site for ^-linked glycosylation. This site is labelled "CHO" in the diagram. 
Invariant residues are shown by their single letter abbreviations.
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Figure 1.2
Topological Model of the Mammalian Facilitative Glucose Transporters.
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Figure 1.3
Single-Site Alternating Conformation Model for GLUTl-Mediated D-Glucose 
Influx.
The diagram is a schematic representation describing the conformational 
changes associated with transport of D-glucose mediated by GLUTl and the other 
isoforms. Glucose binds at an exofacial site on the transporter which induces a 
conformational change such that D-glucose is presented at the endofacial side of the 
transporter. Dissociation of glucose from the endofacial binding site is followed by the 
substrate-independent re-orientation of the carrier such that the binding site is once 
again exposed to the exofacial side of the transporter.
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Figure 1.3
Single-Site Alternating Conformation Model for G L U T l-Mediated D 
Glucose Influx.
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Figure 1.4
King-Altman Representation of the Glucose Transport Cycle.
This figure shows a King-Altman diagram of the alternating conformation 
model of GLUTl. Tq represents the transporter in the outward-facing conformation, in 
the absence of substrate. TqS represents the transporter in the outward-facing 
conformation, in the presence of substrate. Tj, and TiS represent the transporter in the 
inward-facing conformation, in the absence and the presence of substrate, respectively. 
Kso and Ksi represent the dissociation constants of substrate (i.e. D-glucose), at the 
exofacial and endofacial binding sites, respectively. The rate constant for the re­
orientation of the unloaded transporter from the outward-facing conformation to the 
inward-facing conformation is denoted as k i. Re-orientation of the empty carrier from 
the inward-facing conformation to the outward-facing conformation is denoted as k_%. 
The rate constants for the movement of loaded transporter from the outward-facing 
conformation to the inward-facing conformation and back again, are denoted as k%, and 
k-2, respectively. The values of these constants, measured for GLUTl atO^'C are shown 
below (Lowe & Walmsley, 1986).
Rate Constant Value at 0°C (s“l)
ki 12.1 ±0.98
k_i 0.726 ± 0.498
k2 11131498
k-2 90 1 3.47
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Figure 1.4
King-Altmaii Representation of the Glucose Transport Cycle.
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Figure 1.5
Structures of Cytochalasin B and ATB-BMPA.
The structures of the site-specific inhibitors cytochalasin B and ATB-BMPA are 
shown. These compounds interact competitively with glucose at the endofacial and 
exofacial binding sites, respectively. They are reported to bind to the transporter 
specifically at these sites and, upon exposure to ultra-violet illumination, can be 
covalently attached.
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Figure 1.5
Structures of Cytochalasin B and ATB-BMPA.
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Figure 1.6
Diagram Showing Regions of Importance in the Transporter Structure.
This diagram shows regions of the transporter which have been reported to be 
involved in formation of the exofacial and endofacial binding sites, as demonstrated by 
studies using conformational-specific ligands ATB-BMPA, forskolin, and cytochalasin 
B. Also shown are regions important in the ability of the transporter to undergo 
conformational changes.
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Figure 1.6
Diagram Showing Regions of Importance in the Transporter Structure.
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Figure 1.7
Speculative Model for the Arrangement of Transmembrane a-Helices in GLUTl.
This is a diagrammatic representation of the exoplasmic view of two proposed 
models for the tertiary structure of GLUTl in the membrane. Both models fit many of 
the biophysical and biochemical data available for this protein. Model 2 incorporates a 
stmctural role for the large central cytoplasmic loop which serves to locate helix 7 near 
to helices 1 and 2 on the far side of the protein relative to helix 6. It also has a bilobular 
symmetry, as reflected in the hydropathy profile, and is consistent with that proposed 
for the lac permease of E.coli, The models emphasise the physical dimensions and 
water accessibility of the channel, loop lengths between transmembrane helices, 
macrodipole orientation in the 4-helix bundle motifs, and helical packing energy. Both 
models predict that the channel is lined by five helices (shown in red), either helices 3, 
4, 7, 8 and 11 in model 1 or 2, 5, 11, 8 and 7 in model 2. The remaining helices 
surround the channel forming helices and provide a packing surface for their 
arrangement. Each model is composed of three 4-helix bundles (shown in green) which 
assemble together to form the aqueous channel for glucose passage. The bundle 
foimation is different in the 2 models- in model 1 adjacent helices in sequence form the 
bundles whereas in the second model, helices far apart in sequence form bundles, with 
helix 5 and helix 11 occurring in two bundles.
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Figure 1.7
Speculative Model for the Arrangement of Transmembrane a-H elices in 
GLUTl .
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Figure 1.8
Diagram Showing the Proposed Model for GLUTl Oligomerisation.
This diagram shows a representation of the two oligomeric structures that 
GLUTl can exist in, as described in the model proposed by Carruthers. GLUTl can 
exist as a dimer or a tetramer. Each of the two molecules of GLUTl that exist in the 
dimer can isomerise independently of the other. Hence in this situation, both 
transporters can be outward-facing or inward-facing at the same time. Alternatively, 
one may be outward-facing whilst the other is inward-facing. In the tetrameric form 
however, the subunits are conformationally linked. The tetramer is effectively 
composed of two dimers of GLUTl, but the subunits of these dimers are coupled so 
that isomérisation of one subunit results in the isomérisation of the adjacent subunit. 
Therefore, in the tetramer, two of the GLUTl subunits will be outward-facing, and two 
will be inward-facing. Glucose binding to any of these subunits will induce 
conformational changes in that subunit, and also in the adjacent subunits. The result of 
this is that every re-orientation of a GLUTl subunit from the outward-facing 
conformation to the inward-facing conformation is accompanied by the linked 
movement of another subunit into the outward-facing conformation. The diagram 
indicates that from the evidence put forward by Carruthers, tetrameric GLUTl can be 
converted to dimeric GLUTl under reducing conditions.
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Figure 1.8
Diagram Showing the Proposed Model for GLUTl Oligomerisation.
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Table 1.1
Conserved Motifs Present in the Mammalian Facilitative Glucose. 
Transporters.
Motif Location Function
GRRK Intracellular loops connecting 
TM2-3andTM7-8
Conformational stability
EXXXXXXR Intracellular loops connecting 
TM4-5andTM10~ll
Conformational stability and 
salt bridging between helices
PESPR Intracellular loop at the 
baseof TM6
Conformational stability
QQXSGXNXXY TM7 Exofacial substrate binding and 
closure of exofacial binding 
site
VPETKG C-terminal cytoplasmic loop Conformational stability
GPGPIP TMIO Conformational flexibility
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CHAPTER 2
Materials and Methods
64
1 ” Molecular Biology and Use of Xenopus laevis Oocytes.
2 .1  Materials.
Adult female Xenopus laevis were obtained from either Blades Biologicals, 
Edenbridge, Kent, UK, or directly from South Africa, (African Xenopus Facility, PO Box 
118, Noordhoek, Republic of South Africa). "Frog Brittle" was also obtained from Blades 
Biologicals.
Tricaine Methane Sulphonate, MS222 was supplied by Thompson & Joseph Ltd., 
Norwich, UK.
Chromic sterile catgut® was supplied by Ethicon Ltd., London, UK.
2-deoxy-D-glucose, (3-D-fructose, maltose, phloretin, kanamycin, ampicillin, 
tetracycline, dithiothreitol, collagenase, cytochalasin B, were supplied by Sigma Chemical 
Company, Poole, Dorset, UK.
Ammonium formate, and chloroform (Analytical Reagent) were supplied by BDH, 
Poole, UK.
Bacto®-tryptone, Bacto®-agar and Bacto®-yeast extract were supplied by Difco, East 
Molesey, Surrey, UK.
Tris was supplied by Boehringer Mannheim Gmbh., Lewes, East Sussex, UK.
Agarose (electrophoresis grade), DNA ligase and 5x ligase buffer were supplied by 
Gibco BRL, Paisley, UK.
Lambda ladder (B5?E II digested) and ribonuclease A were supplied by New England 
Biolabs, Hitchen, Herts, UK.
Sequencing grade urea. Tris, EOT A, de-ionised formamide, and TEMED were 
obtained from International Biotechnologies Inc. Ltd. (IBI), Cambridge, UK.
National Diagnostics Sequagel-6™ 6% sequencing gel solution and SequageP" 
Complete Buffer Reagent were obtained from BS&S, Edinburgh, UK.
Ultima-floAF scintillant was obtained from Canberra Packard Ltd., Pangbourne, 
Berks., UK.
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Taq DyeDeoxy™ Terminator Cycle Sequencing kits and sequencing-grade 
phenol/chloroform/HaO (68:18:14) was obtained from Applied Biosystems Inc. (ABI), 
Warrington, Cheshire, UK.
Plasmid Maxi Preparation Kits were supplied by QIAGEN, UK.
Elutip-D DNA purification columns (Schleicher & Schuell) were obtained from 
Anderman Ltd, London, UK.
Permacel™ tape was obtained from Genetic Research Instruments, Dunmow, Essex,
UK.
Alconox™ detergent was supplied by Aldrich Chemical Company Ltd., Gillingham, 
Dorset, UK.
'Native' PJu DNA polymerase and 'Native' PJii polymerase lOx buffer were obtained 
from Stratagene, Cambridge, UK.
Vent DNA Polymerase was supplied by New England Biolabs Inc., Beverly, M.A.
All restriction enzymes and corresponding lOx buffers, Taq DNA polymerase with 
supplied lOx buffer and MgCU, calf intestinal alkaline phosphatase and lOx buffer, 
polynucleotide kinase and polynucleotide kinase lOx buffer, rNTPs, dNTPs, nuclease-free 
H2O, 5x transcription buffer, dithiothreitol (DTT), RNasin, RNA ladder (360-9,490 bases) 
and SP6 RNA polymerase were supplied by Promega, Southampton, UK.
[2,6-^H]2-deoxy-D-glucose, [U-l^CJD-fructose and [U-^H]D-galactose were 
supplied by DuEont NEN, Stevenage, Herts, UK.
Dialysis tubing (Visking size 1-8/32") was supplied by Medicell International Ltd, 
London, UK.
Sterile Acrodisc® 0.2 jwm filters were supplied by Gel man Sciences Ltd., 
Northampton, UK.
Sodium diguanosine triphosphate, GpppG (5' Cap) was supplied by Pharmacia, 
Milton Keynes, UK.
All oligonucleotides (Tables 3.3 and 3.4) were synthesised by Dr. V. Math, 
Department of Biochemistry, University of Glasgow.
NHS-LC-biotin and sulfo-NHS-biotin were supplied by Pierce and Warriner (U.K.) 
Limited, Chester.
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2 .2  Recombinant Polymerase Chain Reaction.
2.2.1a Synthesis of Oligonucleotides.
Oligonucleotides (15'mers) with identical sequence to GLUTS in the region of the 
proline reisdue of interest were synthesised (Dr. V. Math, Department of Biochemistry, 
University of Glasgow). The oligonucleotides were designed such that the base triplet 
encoding the proline contained a single base change such that alanine was incorporated in its 
place (Table 3.3). This base change was located towards the centre of the oligonucleotide.
Pairs of oligonucleotides were constructed encoding the same codon change: one sequence 
representing the sense strand and another the complementary strand. These oligonucleotides 
will subsequently be referred to as internal mutagenic primers. In addition, an 
oligonucleotide (37'mer) was constructed which had positive polarity and a sequence 
complementary to the 5' untranslated region of GLUT3. An antisense oligonucleotide 
complementary to the 3* untranslated end of GLUT3 was synthesised (Figures 3.4-3.5).
Both of these oligonucleotides, referred to as external primers G3-start and G3-end 
respectively, incorporated a Sal I restriction site at there 5' end for cloning purposes (Table ). 
3.3).
2.2.1b Precipitation of Oligonucleotides.
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I «Oligonucleotides (stored in 0.88d aqueous NH^OH) were prepared for use in PCR 
reactions by ethanol precipitation. 360jwl of the oligonucleotide was added to an Eppendorf 
tube containing AOpl 3M sodium acetate, pH5.5 and 1.2mls ice cold absolute ethanol. The 
solutions were mixed thoroughly before incubation at -20°C for at least 1 hour. The DNA 
was pelleted by centrifugation at 16,000 x gav in a microfuge for 30 mins. The pellet was 
washed with 70% ethanol, dried in air for 5 mins and resuspended in 100-250/^1 sterile 
H2O, depending on the yield.
2.2.2a Reaction Conditions.
. '
12.2.1c Quantitation of Oligonucleotides.
The OD26onm was determined for each oligonucleotide. From this value the 
concentration of the solution can be calculated, since an OD26onin of 1 is equal to 
33.3mg/ml. Measurement of the OD28onm value allows an estimation of the purity of the 
solution from the OD26o/<^28onm ratio (the closer the ratio is to 2, the more pure the |
solution is). I
2.2.2 Primary Polymerase Chain Reactions Using Taq DNA Polymerase.
1.6/^g "internal" primer
1.6/<g "external" primer
lOOng template pSPGT3 dsDNA
'■1/d dNTPs (20mM dATP, 20mM dCTP, 20mM dGTP, 20mM
dTTP)
lOjA lOx Taq DNA polymerase buffer (Mg^+-free)
6/d 25mM MgCl2
2,5 units Taq DNA polymerase
sterile water to a final volume of 100/<1
Two identical primary PCR reactions were carried out using either the internal primer
Îcorresponding to the antisense strand in conjunction with G3-start, or the internal primer |
corresponding to the sense strand in conjunction with G3-end. Reactions were carried out in
0.5ml microfuge tubes and components were added in the above order, adding Taq DNA 
polymerase last. Upon completion of the thermal cycling program (see below), 20pi\ of 5x 
DNA gel loading buffer was added to each reaction and mixed, before loading the entire
reaction volume onto a 1.6% agarose gel. Following electrophoresis (section 2.2.6a), cDNA 
bands were identified by size and excised from the gel, electro-eluted (section 2.2.6b),
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purified (section 2.2,6d) and precipitated (section 2.3.3). DNA solutions obtained from 3 
reactions were combined and passed through the same Elutip-d column (section 2.2.6d) and 
the final DNA pellet was resuspended in a volume of 60/d of sterile H2O. 3/d of this was 
analysed by 1% agarose gel electrophoresis to assess the yield of the primary PCR product.
2.2.2b Thermal Cycling.
Tubes were placed in a Techne PHC-3 Thermal Cycler with a heated lid. The 
machine was programmed as follows:-
Initial Melt 95°C 3 min
Cycling- (30 cycles total, with a ramp rate of 1°C/sec) 
Separation 95°C 1 min
Primer Annealing X°C 30 secs
Extension 72°C 2 min
Final Extension 72°C
Soak 4°C
2 min 
Hold
"X" = 0-5°C below the melting temperature of the oligonucleotide having the lower 
melting temperature.
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2.2.3a Reaction Conditions.
2 . 2 . 3  Secondary Polymerase Chain Reactions Using Taq DNA
D  IPolymerase.
2l.6jdg G3~start (external primer)
l.ôjAg G3 -end (external primer)
lOOng template (5' primary product)
1 OOng template (3 ' primary product)
1]a\ dNTPs (20mM dATP, 20mM dCTP, 20mM dGTP, 20mM
dTTP)
10/d lOx Taq DNA polymerase buffer (Mg2+-free)
6/d 25mM MgCl2
,::S
2.5 units Taq DNA polymerase
sterile water to a final volume of 100/d
"t
Secondary PCR reactions were carried out using a similar procedure as described for
fthe primary reactions, except that the two primary products both act as templates in a single 3 
secondary PCR reaction. G3-start and G3-end are the primers used to amplify the full-length 
secondary product. During the first few cycles of the chain reaction, the two primary 
products denature and re-anneal at their comiriplementary sequences, i.e. the 3' end of the 5' s
primary product (encoding the N-terminal portion of GLUT3) anneals to the 5' end of the 3'
primary product (encoding the 3' portion of GLUT3) (Figure 3.5). Following 3' extension 
from the annealing site, using the other strand as a template for this extension, the strands I
denature and associate with the external primers for amplification of the full-length product.
The thermal cycling parameters were modified to include a lower annealing temperature for 
the first 3 reaction cycles. Six identical reactions were carried out for each mutant to obtain 
enough secondary product to carry out the subsequent cloning procedures. i
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Upon completion of the thermal cycling program, the reaction products were treated 
in exactly the same way as described for the primary fragments, except that the final purified 
product was resuspended in a total volume of 20jaI.
2.2.2b Thermal Cycling.
Tubes were placed in a Techne PHC-3 Thermal Cycler with a heated lid. The 
machine was programmed as follows:-
Initial Melt 95°C 3 min
Cycling- (3 cycles total, with a ramp rate of 1°C/sec) 
Separation 95°C 1 min
Primer Annealing 3TC 30 secs
Extension 72°C 2 min
Cycling- (27 cycles total, with a ramp rate of l°C/sec) 
Separation 95°C 1 min
Primer Annealing X°C 30 secs
Extension 72°C 2 min
Final Extension 72°C
Soak 4°C
5 min 
Hold
"X" = 0-5°C below the melting temperature of the oligonucleotide having the lower 
melting temperature.
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2 .2 .4  Primary Polymerase Chain Reactions Using Pfu DNA Polymerase.
2.2.4a Reaction Conditions.
l.6pig "internal" primer
l.Gpig "external" primer
lOng template pSPGT3 dsDNA
lpt1 dNTPs (20mM dATP, 20mM dCTP, 20mM dGTP, 20mM dTTP)
1 Ojwl 1 Ox Pfu DNA polymerase reaction buffer
2.5 units Pfu DNA polymerase
sterile water to a final volume of 100/d
Oligonucleotide primers used were identical to those described for use with Taq 
DNA polymerase. Reaction components were added to sterile 0.5ml microfuge tubes in the 
above order, adding the polymerase after the initial 10 min separation step (see below). This 
is referred to as "Hot Start PCR". Tubes were vortexed briefly to mix their contents and 
placed in a Techne PHC-3 Thermal Cycler with a heated lid. On completion of the thermal 
cycling programme (section 2.2.4b), 20/d of 5x DNA gel loading buffer was added to each 
reaction. The entire reaction volume was loaded onto a 1.6% agarose gel (section 2.2.6a). 
Following electrophoresis, cDNA bands were visualised under ultra-violet illumination, 
appropriate bands located and excised from the gel, electro-eluted (section 2.2.6b) and 
purified by passing through an Elutip-d column (section 2.2.6d) followed by ethanol 
precipitation (section 2.3.3). DNA solutions obtained from 3-6 reactions were combined and 
passed through the same Elutip-d column, and the final DNA pellet was resuspended in a 
volume of 60/d of sterile H2O. 3/<l of the final primary PCR product was further analysed 
by 1% agarose gel electrophoresis to assess the recovery of the purified product.
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2.2.4b Thermal Cycling.
Tubes were placed in a Techne PHC-3 Thermal Cycler with a heated lid. The 
machine was programmed as follows:-
Initial Melt 95°C lOmin
Addition o f Pfu DNA polymerase
Cycling- (3 cycles total, with a ramp rate of 1°C/sec) 
Separation 95°C 1 min
Reannealing 40°C 5 min
Extension 72°C 5 min
Cycling- (27 cycles total, with a ramp rate of 1°C/sec) 
Separation 95°C 1 min
Reannealing X°C 2 min
Extension 72°C 5 min
Final extension 72°C
Soak 4°C
10 min 
Hold
"X" -  0~5°C below the melting temperature of the oligonucleotide having the lower 
melting temperature.
The main difference between the protocols used for Taq DNA polymerase and Pfu 
DNA polymerase is the stage at which the enzyme is added to the reaction mixture. With the 
later protocol, the enzyme is added after the intial melt and this is referred to as "Hot Start 
PCR" (section 3.4,3d).
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2 . 2 .5  Secondary Polymerase Chain Reactions Using Pfu DNA
Polymerase.
2.2.5a Reaction Conditions.
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1.6/f g G3-start (external primer)
1.6/^g G3-end (external primer)
1}Â template (5' primary product)
1 jmI template (3 ' primary product)
IjKl clNTPs(20mMdATP,20mMdCTP,20mMdGTP. 20mM
dTTP)
10/^ 1 lOx Pfu DNA polymerase reaction buffer ^
2.5 units Pfu DNA polymerase
sterile water to a final volume of 100^1
Secondary reactions were carried out as described for the primary reactions with the 
exception that the two primary PGR products, one 5’ and one 3' product, were used as 
templates in the secondary reaction.The templates encode the N- and C-terminal portions of 
GLUT3 respectively and they are single-stranded, complementary and overlapping (Figure 
3.5). Prior to addition of the two templates to the reaction mix, their relative concentrations 
were assessed by 1% agarose gel electrophoresis. The more concentrated template, usually 
the smaller fragment, was diluted to an approximately equal concentration as the other 
template such that approximately equimolar ratios were added in the secondary PGR 
reaction. This was found to be important in determining the overall yield of the secondary @
PGR reaction.
2.2.5b Thermal Cycling.
A.' 1
Theraml cycling parameters for the secondary PGR reaction were identical to those i 
used for the primary PGR reactions.
2 . 2 .6  Purification of PCR Fragments. 
2.2.6a Seperation of PCR Fragments by Agarose Gel Electrophoresis.
20/fl of 5x DNA gel loading buffer was added to the PCR reaction mixture and 
mixed on completion of the cycling procedure. The entire reaction volume was loaded onto a
1.6 % agarose gel alongside a lambda ladder marker (section 2.3.2). A current of 100mA 
was applied until the dye front had migrated a suitable distance to obtain sufficient resolution 
of PCR fragments to enable excision from the gel with minimal contamination of non­
specific products (Figure 3.6).
2.2.6b Elution of DNA Fragments from Agarose Gel Slices by 
Electrophoresis.
DNA fragments to be isolated were identified by size on the agarose gel under ultra­
violet illumination. A gel slice containing the DNA band was excised from the gel and 
transfered to a piece of dialysis tubing, prepared as decribed in section 2.2.6c, sealed at one
lOmM EDTA was added and the tubing was incubated in the boiling solution for lOmins.
end using a clip. 1ml of Ix TAE buffer was added to the tubing which was then sealed at the 
other end. The tubing was transfered to an electrophoresis tank containing 1 litre of Ix TAE 
buffer (Table 2.1). A weight (e.g. a gel comb) was applied to ensure that the gel slices were 
completely submerged in the buffer. 150V was applied for 2 hours. The direction of the 
current flow was reversed for approximately 30 secs before transfering the DNA soluion to a 
sterile eppendorf tube. At this point, the DNA soluion was either stored frozen at -20°C or
■S.
was passed through an Elutip-d column to further purify the DNA (section 2.2.6d).
2.2.6c Preparation of Dialysis Tubing for Electroelution.
Approximately lOg of dialysis tubing (Visking, size 2 Inf Dia 18/32") was cut into 
pieces of 3-4cm in length and transfered to a 500ml glass beaker. 500ml of 2% NaHCOg^
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After washing with distilled water, the tubing was stored in 50% ethanol, 50% water 
containing ImM EDTA at 4°C. Prior to use the tubing was boiled in distilled water for 10 
mins.
2.2.6d Purification of DNA Using Elutip-D Affinity Columns.
The DNA to be purified was extracted from the gel into Ix TAE buffer as described 
in section 2.2.6b. An Elutip-d affinity column was firstly prepared by gently forcing l-2ml 
of high salt solution (Table 2.1) into the column. This serves to pre-wash the column 
matrix. A second syringe (5, 10 or 20ml depending on the sample size) was loaded with 5ml 
of low salt solution (Table 2.1) and this was passed through the column to ensure that all the 
high salt solution had been removed from the matrix before application of the DNA sample. 
The same syringe was loaded with the DNA sample and this, together with a OApim
cellulose acetate Elutip prefilter was attached to the column. Use of the filter ensures the
removal of any particulates from the sample. All of the sample was forced through the filter 
and column at a flow rate of l-2ml/min to ensure complete adsorption of the DNA to the 
column matrix. The same syringe was loaded with 2-3ml of low salt solution which was 
passed through the column, washing any remaining DNA sample from the filter and syringe 
into the column. 0.4ml of high salt solution was then passed through the column without the 
filter attached to elute the DNA from the matrix. The eluate was collected m a 1.5ml 
Eppendorf tube, and the DNA further concentrated by alcohol precipitation, as described in 
section 2.3.3.
2 .3  General Techniques Used for Manipulation of cDNA.
2 .3 .1  Plasmid Constructs.
Human glucose transporter cDNAs encoding GLUTs 2 and 3 have been cloned into 
pSP64T as described previously (Krieg & Melton, 1984) to fonn pHTL217 and pSPGT3, 
respectively (Figures 2.1 and 3.4). These constructs contain the protein coding region of the
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cDNAs and various amounts of the 5'- and 3'- untranslated regions. The cDNA sequences
are flanked by 89bp of 5'- and 141 bp of 3'- untranslated regions of the 6-globin gene of 
Xenopus laevis (Kayano et al., 1990). The plasmids contain an SP6 RNA Polymerase 
promoter located 5' to the transporter sequence and a gene conferring ampicillin resistance.
i
2 . 3 .2  Agarose Gel Electrophoresis.
Various agarose concentrations, gel volumes and combs were used for the seperation 
of DNA fragments. The number of samples and the degree of separation required between 
DNA fragments determined the gel volume. The choice of comb was governed by the 
sample volume. Differing degrees of band separation was achieved by varying the agarose 
concentration. High molecular weight species are separated better at low agarose 
concentrations whereas lower molecular weight bands are resolved better at higher 
concentrations. 1.0% and 1.6% (w/v) are typical agarose concentrations used.
Example: For a 100ml 1.0% agarose gel, Ig of agarose was dissolved in 100ml 4Idistilled water by heating in a microwave until boiling point was reached. On cooling, 2ml
450x TAE buffer (Table 2.1) was added and the solution was mixed before pouring on to an |
appropriate gel base sealed with tape. A comb was inserted and the gel was left to set at 
room temperature for approximately 15 mins. The tape was removed from the gel base 
before transferring the gel and gel base to the electrophoresis tank containing 1 litre of Ix
TAE buffer, sufficient to completely cover the gel and fill the sample wells on removal of the 
comb. The samples to be loaded were prepared by addition of approximately 1/4 volume of
5x DNA loading buffer (Table 2,1). This serves to ensure that the samples sink to the 
bottom of the wells as loading buffer is more dense than the electrophoresis buffer due to the 
presence of glycerol. Samples were mixed and loaded directly into the wells by pipetting. 
lOpl of loading buffer containing 25jWg/ml BstF Il-cut lambda DNA ladder was loaded into a 
well adjacent to the samples. 50pl of lOmg/ml ethidium bromide was added to the 
electrophoresis buffer and the electrodes were connected such that the negative electrode was |
connected to the well-end of the gel. Samples were electrophoresed at 50-100mA using an
LKB 2197 power supply until the dye front had migrated to the appropriate distance, usually 
approximately two thirds the length of the gel. DNA was visualised under ultra-violet light 
using an ultra-violet transilluminator. Correctly sized DNA species were identified by their 
migration relative to the Lambda ladder markers. A gel photograph was taken using a 
Mitsubishi video copy processor.
2 . 3 . 3  Alcohol Precipitation of DNA
0.2 volumes of 100% ethanol, stored at 4 '^C, was added to the DNA sample in a 
1.5ml Eppendorf tube. After vortexing, the solution was incubated at -20®C for at least 1 
hour, or at -80°C for 30 mins. DNA was pelleted by centrifuging at 16,000 x gav for 30 
mins. The supernatant was removed and the pellet washed with 300-500jWl of 70% ethanol, 
centrifuging at 16,000 x gav for 15 mins to re-pellet the DNA. The supernant was removed 
and the pellet allowed to dry in air for 10 mins before resuspending in an appropriate volume 
of sterile water.
2 . 3 . 4  Restriction Digestion of DNA.
:Restriction digestion of cDNA and plasmid DNA was performed by the addition of
therestriction enzyme(s) to the DNA in an appropriate buffer containing the optimum salt 
concentration and pH for the individual enzyme. When DNA was to be cleaved with two 
enzymes, the digests were carried out simultaneously if both enzymes had the same buffer 
requirements. Alternatively, the DNA was first digested with the enzyme requiring the buffer 
of lowest ionic strength and/or temperature, and then the appropriate amount of sodium 
chloride and the second enzyme added. A typical reaction contained 0.5-10/<g of DNA in a 
reaction volume of lOpil per Ipg of DNA. 1 volume of the appropriate lOx buffer was added 
to 9 volumes of the reaction volume before addition of the restriction enzyme. This was 
mixed and incubated for 3 hours at 37°C (unless otherwise stated, depending on the 
particular enzyme). Reactions were terminated by addition of 1/4 volume of 5x DNA loading 
buffer and the reaction volume loaded onto an agarose gel for analysis by electrophoresis.
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2 . 3 .7  Preparation of Competent £ .co/ï (JM109) Cells.
lOptl of a frozen stock of JM109 cells were used to streak an LB plate. After 
incubation at 37°C for 12-16 hours, a single colony was used to innoculate 3ml of sterile LB 
medium which was incubated for 12-16 hours at 37°C with shaking, SOOpl of this starter 
culture was transfered to a 1 litre flask containing 50mls of sterile LB. The cells were grown
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Any bands of interest were excised from the gel and the DNA purified and concentrated as 
described (sections 2.2.6a-d).
2 . 3 . 5  Dephosphorylation of Double Stranded DNA using Calf Intestinal 
Phosphatase (CIP).
GIF catalyzes the removal of 5' phosphate groups from DNA fragments to prevent 
religation. Plasmid DNA was cleaved with the appropriate restriction enzyme(s) for 3 hours 
and then treated with RNase A for 15 mins at 37°C. The reaction volume was made up to 
lOOpl by addition of dephosphorylation buffer (provided with the enzyme), 10 units of CIP 
and the appropriate volume of sterile water. Reactions were carried out at 37°C for 2 hours. 
DNA was isolated from the enymes by passing through an Elutip-d column and alcohol 
precipitation as described (sections 2.2.6b-d).
2 . 3 .6  Ligation of Double-Stranded cDNA.
cDNA fragments were ligated into pSPGTS backbone vector that had been restricted 
to remove a BstX l-EcoR V fragment of the wild type GLUT3 cDNA sequence (sections 
2.3.4). In order to increase the efficiency of ligation, an insert:vector molar ratio of 
approximately 13:1 was used. cDNA fragments and lOOng of vector DNA (10:1) were 
incubated overnight at 16°C in the presence of 3 units of T4 DNA ligase in ligation buffer. 
Ligation reactions were stored at -20°C. A 5-10/d aliquot was used to transfonn competent 
E.coU cells as descibed (sections 2.3.7-2.3.9).
at37°C with shaking for 2 hours before being harvested by centrifugation at 6000 x gav at 
4°C for 5 mins in a Beckman CPR benchtop centrifuge. The supernatant was discarded and 
the cell pellet resuspended in 20mls of ice-cold lOOmM CaCl2 solution. The suspension was 
incubated on ice for 20 mins before harvesting the cells as previously described. The cell 
pellet was resuspended in 4mls of ice-cold lOOmM CaCh solution and incubated at 4°C for 
at least 1 hour. (NB/ Cells remained competent at 4°C for up to 24 hours).
2 . 3 .8  Transformation of Competent E.coU (JM109) Cells.
IQOjû of competent cells (section 2.3,7) were transferred to a pre-chilled 13.5ml 
Falcon tube to which 5-lOjwl of the ligation mix is added. The tubes are incubated on ice for 
40 mins to allow uptake of the DNA by the competent cells. Transformation is terminated by 
heat-shocking the cells at 42°C for 45 secs, followed by incubation on ice for 5 mins. 0.8mls 
of sterile LB is then added and the cells incubated at 37°C with shaking for 1 hour. After 
centrifugation at 6000 x gav for 5 mins at 4°C, 0.9mls of the supernatant was discarded and 
the cells were resuspended in the remaining 100/d which was plated out immediately onto 
LB agar plates containg 50^g/ml ampicillin. The plates were inverted and incubated at 37°C 
for 12-16 hours.
2 . 3 .9  Transformation of Ultraeompetent E.coU (JM109) Ceils.
Ultracompetent cells were purchased from Promega and stored at -70°C. Cells were 
thawed by incubating in an ice-bath for 5 mins and mixed by flicking the tube. A 100/d 
aliquot (per transformation) was transferred to a pre-chilled 13.5ml Falcon tube. 5-lOjû of 
the ligation mixture was added to the cells which were mixed gently and immediately 
incubated on ice for 10 mins. The transformation was terminated by heat-shocking the cells 
at 42°C for 45 secs, and incubating on ice for 2 mins. 900/d of SOC medium (Table 2.1) 
was added and the cells were grown for 1 hour at 37°C with shaking at 225rpm. lOOpil of 
the transformation mixture was plated onto LB plates containing SQpg/ml ampicillin. The 
remaining 900j4\ was centrifuged at 6000 x gav for 10 mins to pellet the cells. SOOpl of the
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medium was removed and the cells resuspended in the remaining IQOyX which was also 
plated as described. The plates were incubated at room temperature for 15 mins to dry before 
inverted and incubated at 37°C for 12-16 hours.
2.3.10 Preparation of Small Quantities of Plasmid DNA
Colonies were picked from LB agar-ampicillin plates (50/<g/ml) and used to 
innoculate 1.5mls of sterile LB. Cells were incubated at37°C for 12-16 hours with shaking, 
centrifuged at 4°C for 5 mins at 6000 x gav, and gently resuspended in 100/^ 1 glucose buffer 
(Table 2.1). The cell suspension was incubated on ice for 5 mins, 200^1 0.2M NaOH, 1% 
SDS added, and the cells returned to 4°C for 10 mins. 300/<l 3M potassium/5M acetate was 
added. After a 5 min incubation at 4°C, the cells were centrifuged at 16,000 x gav in a 
microfuge. 600^1 of the supernatant was transfered to a sterile Eppendorf tube, 4/fl RNase A 
(lOmg/ml stock) was added and the tubes were incubated at 37°C for 30 mins. The DNA 
was extracted once with phenol:chloroform (1:1) and twice more with chloroform. 0.1 
volumes of 3M NaOAc and 2 volumes of absolute ethanol (4°C) was added, the solutions 
mixed thoroughly and incubated at -20°C overnight (or at -70°C for 30 mins). After 
centrifugation at 16,000 x gav in a microfuge for 30 mins, followed by a 70% ethanol rinse, 
the DNA pellet was air-dried and resuspended in a volume of 6 0 ] a \  of sterile H2O. A 5 p \  
aliqout was analysed by 1% agarose gel electrophoresis (section 2.3.2) along with a suitable 
undigested plasmid as a size standard.
2.3.11 Restriction Digestion Analysis of Small-Scale Plasmid cDNA 
Preparations.
For initial identification of Pro-A la mutant pSPGT3 constructs, a small scale 
preperation of plasmid DNA was carried out as described above. Typically, 5jA of the DNA 
sample (depending on the yield, as assessed by agarose gel electrophoresis) was analysed by 
restriction digestion to identify clones that contained BstXI-EcoRV insert. Digestions 
were carried out as described in section 2.3.4 in a reaction volume of 25/<l, and the reaction
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terminated by addition of 5pi\ of 5x DNA gel loading buffer. The resulting digestion pattern 
was analysed by 1% agarose gel electrophoresis. Positive clones were identified by the 
presence of a band of 4825bps, corresponding to the backbone pSPGT3 vector, and a 
second band of 871bps, corresponding to the BstXl-EcoRV insert (Figure 2.2). Large scale 
plasmid preparations (sections 2.3.12 and 2.3.13) of any positive clones were carried out 
such that sufficient quantities of plasmid DNA were obtained for full sequencing of the 
constructs (section 2.4).
2.3.12 Large Scale Preparation of Plasmid DNA using QIAGEN QIAprep 
Plasmid Maxi Preparation Kits.
This method of plasmid preparation is based on the modified alkaline lysis procedure 
and on the adsorption of DNA onto an anion-exchange resin in the presence of low salt. The 
kits contain various buffer solutions and columns and the protocols are designed for 
purification of up to 500/<g of plasmid DNA from an appropriate volume of an overnight 
culture of E.coU cells in LB medium.
Components (supplied with kits):-
Buffer ?1 (Resuspension Buffer):
Buffer P2 (Lysis Buffer): 
Buffer P3 (Neutralization Buffer): 
Buffer QBT (Emiilibration Buffer): 
Buffer QC (Wash Buffer) : 
Buffer OF (Elution Buffer);
50mM Tris-HCl, pH8.0; 
lOmMEDTA;
lOOpg/ml RNase A, stored at 4°C. 
200mMNaOH; 1% SDS.
3.0M KOAc, pH5.5; stored at 4°C. 
750mM NaCl; 50mM MOPS, pH7.0; 
15% ethanol; 0.15% Triton X-100. 
l.OM NaCl; 50mM MOPS, pH7.0; 
15% ethanol.
1.25M NaCl; 50mM Tis-HCl, pH8.5; 
15 % ethanol.
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TE; lOmM Tris-HCl, pHS.O; ImM EDTA.
STE: lOOmM NaCl; lOmMTris-HCl,pH8.0;
ImM EDTA.
Plasmid Maxi Preparation Protocol
A colony of cells containing the plasmid to be purified was used to innoculate 3ml of 
sterile LB containing the appropriate antibiotic(s). This was incubated with shaking at 37°C 
for 12-16 hours. From this starter culture 0.5ml was transferred to 300ml of sterile LB plus 
antibiotic(s) which was then incubated shaking at 37°C for a further 12-16 hours. Cells were 
harvested by centrifugation at 4,000 x gav for 10 mins at 4°C, and the bacterial pellet 
resuspended in 10ml of Buffer PI. The pellet was resuspended completely such that no cell 
clumps remained. 10ml of Buffer P2 was added and the solution mixed gently by inverting 
the tube 4-6 times. After incubating at room temperature for 5 mins, 10ml of chilled Buffer 
P3 was added, the tubes were mixed gently and incubated on ice for 20 mins. After 
centrifugation at 20,000 x gav for 30 mins at 4°C in a Beckman JA-20.1 rotor, the 
supernatant was promptly transferred to clean tubes and recentrifuged for a further 15 mins.
The supernatant was removed promptly and transferred to a QIAGEN-tip 500 equilibrated 
with 10ml of Buffer QBT. The QIAGEN-tip was then washed with 2 x 30ml of Buffer QC. 
Plasmid DNA was eluted by application of 15ml of Buffer QF to the tip, which was allowed 
to empty by gravity. DNA was precipitated with 0.7 volumes of room - temperature
.isopropanol followed by immediate centrifugation at 15,000 x gav for 30 mins at 4°C. The 
supernatant was carefully removed and the DNA pellet washed with 5ml of 70% ethanol, 
recentrifuged, air-dried for 5 mins at room-temperature and redissolved in a suitable volume 
of sterile H2O. A sample of the plasmid solution was analysed by agarose gel 
electrophoresis (section 2.3.2).
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2.3.13 Large Scale Preparation of Plasmid cDNA.
Solutions:-
Buffer 1;
Buffer 2*:
Buffer 3:
PEG:
Other Soutiens:
50mM glucose
lOmMEDTA
25mM Tris, pH8.0
1% SDS
0.2M NaOH
60 ml 5M KOAc
11.5 ml acetic acid
28.5ml st.H20
20% PEG (Mol.wt 6000)
2.5M NaCl
TE Buffer
5M Lithium Chloride 
SMNaOAc
* Solution 2 was made up fresh on the day of use.
All procedures, following initial cell harvesting were carried out on ice.
Protocol:-
A colony of cells containing the plasmid to be purified was used to innoculate 3ml of 
sterile LB containing the appropriate antibiotic(s). This was incubated shaking at 37° C for 
12-16 hours. From this starter culture 0.5ml was transferred to 500ml of sterile LB plus 
antibiotic(s) which was then incubated shaking at 37°C for a further 12-16 hours. Cells were 
harvested by centrifugation at 4°C for 10 mins at 4,000 x gav in a Beckman centrifuge. The 
resulting supernatant was carefully decanted from the pellet which was resuspended 
completely in 25 ml of Buffer 1. 25 ml of Buffer 2 was slowly added whilst swirling the 
solution on ice. To this, 25 ml of Buffer 3 was added followed by thorough mixing.
iI
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Centrifugation at 4°C for 10 mins at 4,000 x gav resulted in a clear supernatant which was 
transferred to clean 250ml Beckman centrifuge tubes by filtering through a double thickness 
of fine muslin. 100ml of isopropanol (room temerature) was added and mixed thoroughly 
before incubating at -20°C for 15 mins. The DNA was precipitated by centrifugation at 4°C 
for 10 mins at 4,000 x gav, and the resulting supernatant discarded. The pellet obtained from 
the entire 500ml culture was resuspended in 7.5ml TE buffer and transferred to 50ml 
Beckman centrifuge tubes to which 10ml of 5M lithium chloride solution was added. After 
incubating on ice for 2-5 mins, the solution was centrifuged at 4°C for 10 mins at 4,000 x 
gav in a JA-20 rotor. The resulting supernant was retained and transfered to a clean tube. 2 
volumes of ice-cold absolute ethanol was added, the DNA solution was incubated at -20°C 
for 20 mins, and precipitated by centrifugation as described for 20 mins. The resulting pellet 
was rinsed with 70% ethanol and air-dried before resuspension in 0.5ml TE buffer. RNAse 
A was added to40^g/ml and the tubes incubated at 37°C for 15 mins. 0.5 volumes of PEG 
solution was added, followed by an incubation period of 15 mins on ice. After 
centrifugation, the resulting pellet was resuspended in 0.6 ml TE buffer and the DNA 
extracted once with phenol:chloroform and twice more with chloroform. 0.1 volumes of 3M 
NaOAc and 2 volumes of ice-cold absolute ethanol was added to the final extract, the 
solutions mixed thoroughly and incubated at -20°C overnight. After centrifugation at 16,000 
X gav iit a microfuge for 30 mins, followed by a 70% ethanol rinse, the DNA pellet was air- 
dried and resuspended in a volume of 100-200/d of sterile H2O, depending on the size of the 
pellet. The purity and yield of the plasmid was determined as described in section 2.3.14.
2.3.14 Calculation of Plasmid DNA Concentration and Purity.
Absorbance at 260nm of 1.0 = 50jwg / ml dsDNA.
Absorbance at 260nm of "a" = "a" x 50jWg / ml dsDNA.
Absorbance at 260nm = "b"
Absorbance at 280nm
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DNA has a lower protein concentration and a higher purity when the value of "b" is 
nearer to 2.0.
2 .4  Taq DyeDeoxy™ Terminator Cycle Sequencing Protocol.
This protocol was used with the Applied Biosystems Taq DyeDeoxy™ 
Terminator Cycle Sequencing Kit, in conjunction with the Applied Biosystems Model 
373A Automated Sequencer.
2.4.1a Kit Reagents.
XQO JÂ G DyeDeoxy™ Tenninator
100 /d A DyeDeoxy™ Terminator
100 JÂ T DyeDeoxy™ T erminator
100 jA C DyeDeoxy ™ T erminator
100 dNTP mix- (750 piM dGTP, 150 pU  dATP, 150 pM  dTTP,
50 pM  dCTP)
400 units AmpliTaq® DNA Polymerase, 8 units//<l
400 pil 5x Terminator Ammonium Cycle Sequencing (TACS) Buffer-
(400 mM Tris-HCl, 10 mM MgCl2, 100 mM (NH4 )2 S0 4  pH 9.0)
6 pig pGEM®-3Zf(+) double-stranded DNA Control Template, 0.2 pig/pil
50 pil -21M13 Forward Primer, 0.8 pmoles//d
2.4.1b Other Reagents.
Distilled water
De-ionised formamide
Phenol/H20/Chloroform (68:18:14, v/v/v)
Alconox™ detergent 
Ethanol
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Gel Reagents- Sequagel~6^“ 6% Sequencing Gel Solution
Sequagel^^ Complete Buffer Reagent 
10% Ammonium persulphate solution 
TEMED
2 . 4 . 2  Preparation of Templates and Sequencing Reactions.
pSPGT3 dsDNA was prepared from colonies as described previously (section 
2.3.12). The quantities of template and sequencing oligonucleotide primer used per 
reaction were 2 ptg dsDNA template and 35 ng of primer. The primers used are listed in 
Table 3.4. The combined volume of template and primer did not exceed 10.5 since
9.5 of reaction premix was added to bring the final volume to 20 pi. The total volume 
was adjusted to 20 jwl by the addition of sterile water. A reaction premix sufficient for 20
■* 
1;
reactions consisted of:-
Reagents;-
5x TACS Buffer so  pil
dNTP mix 20 p \
DyeDeoxy A Terminator 20 pil
DyeDeoxy™ T Terminator 20 pil
DyeDeoxy™ G Terminator 20 pA
DyeDeoxy™ C Terminator 20 p i
AmpliTaq® DNA Polymerase 10 p i
The reagents were mixed in a 0.5 ml microfuge tube
Reaction Premix 9.5 p \
Template DNA (0.4mg/ml) 5.0 p i
Primer (7ng//<l) 5.0 p i
dH20 0.5 pil
Final volume 20 p i
- . —  - .. / .  ... '-V.- _■ .
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2 .4 .3  Thermal Cycling.
Initial Melt 96°C 3 min
plates were balanced on a rest so that the open top was raised and the angle between the 
plane of the plates and that of the desktop surface was 30-45°.
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The tubes were placed in a Techne PHC-3 Thermal Cycler with a heated lid. The Ifollowing parameters were programmed into the machine: -
1
Cycling- (30 cycles total, with a ramp rate of l°C/sec) #
Separation 96°C 30 sec 1
Reannealing 50°C 15 sec s1
Extension 60°C 4 min
Soak 4°C Hold 1-3:
Acrylamide Gel Preparation.
IThe gel required a minimum period of 2 hours for polymerisation before pre- 
running so the gel was prepared whilst the reactions underwent thermal cycling.
2.4.4a Preparing the Gel Plates.
The plates, spacers and comb were washed with Alconox^'^ and dH20. Only the I
plates were then wiped with absolute ethanol. The plates were aligned with the spacers
between them along the outside of the longer edges and clamped into position.
Permacel™ tape was applied along the short bottom edges of the plates and the lower 4
ends of both longer edges so that the comers were covered and a seal was formed. The
2.4.4b Casting the Gel.
60ml of Sequagel-6™ 6% Sequencing Gel Solution was mixed with 15ml of 
Sequagel™ Complete Buffer Reagent and 0.6ml of 10% ammonium persulphate solution 
was added while stirring. 60/d of TEMED was added, the solutions were mixed and the 
gel was immediately poured between the glass plates up to the top edge of the notched 
plate with the aid of a 60ml syringe. All air bubbles were removed with the aid of a 
Promega "Bubble Hook". The plates were lowered so that they were lying flat on the 
bench and the gel casting comb was carefully inserted, the comb was secured by 
clamping the top of the gel with two binder clamps and the well was topped up with gel 
solution. The gel was then incubated at room temperature until complete polymerisation 
was achieved.
2 . 4 .5  Setting Up for a Sequencing Run.
All the clamps and tape were removed from the gel plates and the casting comb 
carefully taken out. Excess acrylamide was cleaned off the plates which were then 
washed with Alconox™, distilled water and ethanol making sure that the plates were 
especially clean in the region where the laser read (about a third of the way from the 
bottom of the plates). A 24-well-shark's tooth comb was carefully placed on the gel 
surface so that it indented the gel but did not puncture it. The 373A DNA Sequencer and 
the Macintosh Ilci computer were switched on. The gel was placed onto the lower buffer 
chamber and the beam-stop rack locked. The gel plates were scanned for the presence of 
dirt particles by initiating a pre-run scanning program. If the baselines were flat, then 
there was judged to be no dirt on the plates- if they were not then the plates were cleaned 
again. 1.5 litres of Ix TBE buffer (Table 2.1) was prepared and about half added to the 
upper buffer chamber and the remainder poured into the bottom chamber. The wells 
were rinsed with a syringe fitted with a 18-gauge needle containing Ix TBE buffer. The 
gel was left to pre-run for approximately 30-40 mins, during which time the gel was 
equilibrated at 40°C.
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2 . 4 . 6  Sample Extraction and Precipitation.
After the cycling (section 2.4.3) was complete, SOpl of sterile water was added 
to each reaction mixture. 100/d of phenol/water/chloroform (68:18:14, v/v/v) was added 
to each tube and vortexed for at least 1 min, and then centrifuged for 2  min in a 
microfuge. The upper aqueous phase was retained, discarding the lower organic phase. 
This process was repeated. The extracted aqueous phase was transferred to a fresh 
microfuge tube and precipitated by the addition of 15/d of 2 M sodium acetate and 300/d 
of absolute ethanol (stored at -20°C). Tubes were vortexed to mix the contents and then 
placed at -20°C for 30 min to ensure complete precipitation. The tubes were centrifuged 
in a microfuge for 15 min to pellet the cDNA, the pellets washed in 70% ethanol, and 
dried in air for 5-10 mins.
2 . 4 .7  Preparing and Loading Samples.
4pl of de-ionised formamide/10 mM EDTA was added to each of the samples 
and mixed well. Samples were then heated at 90°C for 2 min, and placed onto ice 
immediately. The wells of the gel (section 2.4.5) were flushed out with Ix TBE and 4/d 
of each odd-numbered sample added to its corresponding well in the gel. The sequencing 
program was initiated and left for 10 mins to allow these samples to enter the gel. The 
program was then interrupted and the wells of the gel rinsed again before loading the 
remaining samples into their corresponding wells. The sequencer was restarted and the 
collect program initiated.
2 . 4 .8  Analysis of Samples.
The samples were electrophoresed at a constant temperature of 40°C for 12 
hours, passing through the "read window" area of the gel where laser light was 
periodically passed along this area of the gel. The resulting fluorescence emitted by the 
DyeDeoxy™ Terminator dyes over a period of time were measured by the 373A
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sequencer and incorporated by the ABI Data Collection Program on the Macintosh Ilci 
computer. After the data was collected, it was analysed by the ABI Data Analysis 
Program. Sequences were determined by use of this program. When different sequences 
were generated by the use of various sequencing primers (Table 3.4) with the same 
template cDNA, these were compared using the GeneJocky II (Biosoft) program.
2 .5  In vitro synthesis of mRNAs from Plasmid cDNA.
All work with mRNA was conducted wearing gloves with sterile solutions and 
equipment, since ribonucleases which can degrade mRNA can be found on the skin and 
elsewhere. All reagents were thawed on ice. A nucleotide stock (2.5mM rATP, 2.5mM 
rCTP, 2.5mM rUTP and O.SmM rGTP) was made up from lOOmM stock solutions of each 
ribonucleotide. The diguanosine triphosphate (S' cap analogue) was prepared at lOmM in 
RNase-free water. Reagents were added to a sterile Eppendorf tube in the following order:-
15p\ ribonuclease-free H20 
40/d 5x transcription buffer 
20/d lOOmM dithiothreitol (DTT)
40/d nucleotide mix (see above)
10/fl GpppG (S' Cap) (25 units/100 /d)
10/d linearised plasmid cDNA (--1 pglml ;)
2.5p\ SP6  polymerase (25 units)
This gave a total volume of 200/d. The tube was placed in a 37°C water bath for 
1 hour, after which a further 0.5/d of SP6  polymerase was added, mixed and incubated 
at 37°C for 30 min. At this point the reaction was centrifuged in a microfuge to collect the 
condensate and then 1 volume of phenol/chloroform [1:1 (v/v)] added. This was 
vortexed for 1 min and centrifuged in a microfuge for a further 1 min. The upper 
aqueous phase, which contained both mRNA and cDNA, was carefully collected into a 
clean tube. 100/d  of chloroform was added to the solution, before vortexing,
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centrifuging, and again collecting the aqueous phase. This procedure was repeated, 
before finally adding 0.3 volumes of 5 M potassium acetate and 2.5 volumes of ice-cold 
absolute ethanol to precipitate the nucleic acid. The reaction was mixed and incubated at 
-20°C for approximately 1 hour, then centrifuged in a microfuge for 30 min. The pellet 
was washed with 0.5ml 70% ethanol and centrifuged as above. All traces of ethanol 
were removed from the pellet by drying under vacuum. The pellet was resuspended in 
40/d of ribonuclease-free H2 O. 3/d of this was mixed with 3p\ of 5x DNA gel loading 
buffer (Table 2.1) and loaded into a 1% agarose gel immersed in Ix TAE running buffer 
(Table 2.1) to assess the integrity of the mRNA. 5/d of 100 //g/ml Bst EII-cut lambda 
ladder DNA was loaded into an adjacent well and the current adjusted to 50 mA so that 
negatively charged ribonucleic acids migrated toward the positive electrode. 
Electrophoresis was carried out until the dye-front was half to two thirds across the gel, 
then 20/d of 10 mg/ml ethidium bromide added per litre of running buffer. The bands 
were visualised by viewing the gel under ultra-violet light, and the size of any mRNA 
bands checked by its relative migration to the lambda ladder. A typical photograph of 
mRNA on a 1% agarose gel can be seen in Figure 2.3. mRNA used for injection 
appeared on a gel as a distinct band with no evidence of smearing.
2 .6  Use of Xenopus laevis Oocytes for Heterologous Expression of 
GLUT Constructs.
2 .6 .1  Housing of Xenopus laevis.
Adult female Xenopus laevis (average length of 15cm) were kept in an aquarium 
maintained at a constant water temperature of 16-18°C on a 12 hour day/night cycle. 2-4 
animals were housed per tank containing bin of distilled water located in a quiet 
environment. The animals were fed on a weekly basis on a diet of raw chopped sheep heart 
or "frog brittle" obtained from Blades Biologicals. The water was changed the day after 
feeding to remove undigested or decomposed food. Each animal was maintained in such an 
environment for at least one month prior to operating to allow for acclimatisation.
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2 . 6 . 2  Chemical Anaesthesia.
The animal to be operated on was placed in a tank containing 500ml of distilled water 
and 0.75g Tricane Methane Sulphonate (MS222) supplemented with 25ml 0.5M sodium 
bicarbonate. MS222 has a low pH and is thus an irritant to amphibian skin. The use of the 
bicarbonate raises the pH to neutrality making it acceptable or the animal Anaesthesia is rapid 
resulting in a state of unconciousness within about 5-10 mins such that when the animal is 
placed on its back, it is completely immobile.
2 . 6 . 3  Surgery.
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This proceedure requires both Home Office Project and Individual Animal Handling 
Licenses. The anaesthetised animal is placed on her back and a small incision made (~lcm) 
in the lower third of the abdominal wall followed by a further incision in the inner body 
cavity. Oocyte lobes are removed using fine watchmakers forceps and fine scissors and are 
transfered to a universal tube containing Barths solution. A single stitch in the abdominal 
wall is made using chronic sterile catgut, followed by 2 stitches in the dermis. The animal
was then rinsed with distilled water and placed in a recovery tank containing 2-3 mm of
. . . .  distilled water until consciousness was completely regained. Animals were returned to their
housing tanks within 2 hours of surgery and kept for at least 3 months before a second
operation performed.
2 .6 .4  Oocyte Isolation and Injection.
Oocyte lobes were removed from the adult female Xenopus laevis as described. 
Before beginning individual isolation, the oocytes were inspected closely under a 
microscope. Only healthy oocytes at the correct stage of development, stage IV or V, are 
suitable for injection. These are characterised by several important criteria such as a distinct 
boundary between the animal (dark brown) and vegetal (pale green/yellow) poles. They are 
the largest oocytes and should exhibit a unifoim pigmentation of the dark pole, i.e. no spots :|
or mottling. Oocytes that do not meet these criteria were not suitable for injection and were 
therefore discarded.
Individual oocytes are attached via a translucent vein and connective tissue to the 
central artery. They can be stripped from the central artery using fine watchmaker's forceps. 
This delicate procedure is carried out in a petri dish containing Barths solution and with the 
aid of a binocular dissecting microscope. Isolated oocytes were then transferred to a 50ml 
Sterelin vial containing Barths for storage. Damaged oocytes were periodically removed 
from the petri -dish and the Barths solution was changed regularly to remove endogenous 
oocyte proteases released throughout the isolation procedure. The number of oocytes 
isolated was generally 2-3 times the number required for microinjection so as to take into 
account the percentage of cells expected to die during the 4S hour incubation prior to assay.
The injection apparatus consisted of a 0-10/d micro-injector (Drummond Scientific 
Co.), 6  inch capillary tubes, a micro-manipulator (Narshige, Japan), a PUL-1 needle puller 
(World Precision Instruments), a Nikon SMZ-2B binocular microscope (10x23 eyepieces) 
and swan-necked fibre-optic lamp unit, a petri-dish fitted with a Spectramesh grid (Fischer), 
paraffin oil and a syringe. Gloves were worn throughout the injection procedure to prevent 
contamination of mRNA with ribonuclease present on the fingertips. A capillary tube was 
secured in the needle pulling unit, which uses a combination of heat and a pulling motion to 
produce needles with a bore size of about 2pm. The tip of the needle was then broken off 
with forceps and filled with paraffin oil with the aid of a syringe and a 25 gauge needle. The 
barrel of a 0~10p\ micropipette (set at 1.5/d) was carefully inserted into the end of the oil- 
filled needle, avoiding air bubbles. The micropipette was then secured in the 
micromanipulator. The mRNA to be injected was pulsed briefly (20 secs) in a microfuge, to 
pellet any debris, and about Spl of the supernatant was transferred to a sterile microfuge tube 
lid under the microscope. The micropipette was lowered such that the tip of the needle was 
submerged in the mRNA droplet, and the mRNA was drawn slowly up into the needle. 
Oocytes, submerged in Barths in a petri dish, were aligned on a SpectraMesh grid. The 
needle was introduced into the vegetal pole of the oocyte by applying a gentle downward 
force using the micromanipulator. 50nl of mRNA was expelled into the oocyte cytoplasm, 
and the needle was slowly removed. Oocytes were stored in Barths medium at 18-20° C for
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48 hours, transferring to fresh Barths medium every 12 hours. Oocytes were then ready for 
assay.
2 .7  Sugar Transport in Xenopus Oocytes.
2 .7 .1  Transport Assay Conditions.
Groups of 7 oocytes were incubated in 0.45ml Barths medium (Table 2.2) in 13.5ml 
centrifuge tubes at room temperature. Transport (z&ro-trans entry) was initiated by the 
addition of 50/d of [2,6-3H]2-deoxy-D-glucose or [U-^HjD-fructose to give a specified final 
sugar concentration with an activity of -'IjwCi / ml. After a designated time period, usually 30 
mins or 60 mins for 2-deoxy-D-glucose and D-fructose transport respectively, the media 
was aspirated from the oocytes and the transport quenched by three washes with ice-cold Ix 
PBS (Table 2.2) containing O.lmM phloretin (a potent transport inhibitor). Oocytes were 
individually dispensed into scintillation vials using a P200 Gilson pipette and tip with the 
end cut off. 1ml 1% SDS was added to the oocytes which were incubated overnight, before 
addition of 4ml scintillation fluid and subsequent measurement of radioactive uptake by a 
scintillation counter. For each group of injected oocytes assayed, non-injacted oocytes were 
assayed in parallel under identical conditions to determine the endogenous transport levels 
under the specified assay conditions. Subtraction of these rates from those obtained from 
injected oocytes yields the specific rates mediated by the heterologously expressed 
transporter.
Transport rates measured over a range of external sugar concentrations enabled 
Line weaver-Burk plots to be constructed by a double reciprocal plot of the measured rates 
(y-axis) vs the concentration of external sugar (x-axis). Km values were calculated from 
such plots.
To investigate the inhibitory effects of maltose and cytochalasin B on 2-deoxy-D- 
glucose transport by GLUT3 and mutant GLUT3 transporters, oocytes were incubated in the 
presence of these inhibitors prior to initiation of radiolabelled sugar uptake. Oocytes were 
incubated in 0.45ml of 50mM maltose in Barths medium at room temperature for 15 mins
95
- - ,'< ■ - ' - - '  ’  - ' ":|||
prior to assay. Use of cytochalasin B however, required pre-treatment of the oocytes with 
collagenase solution (section 2.7.2). Collagenase treated oocytes were then incubated in
0.45ml 2pM  cytochalasin B for 15 mins prior to assay. Again, transport rates were 1
'0measured over a range of external sugar concentrations and construction of Lineweaver- |
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Burk plots enabled calculation of Ki values. Non-injected oocytes were assayed in parallel 
under identical conditions as described above.
2 .7 .2  Collagenase Treatment of Oocytes.
Both injected and non-injected oocytes to be assayed in the presence of cytochalasin IB were pre-treated with collagenase solution to facilitate removal of the follicular cell layer of %
Athe oocyte. A 2mg/ml solution of collagenase (Sigma, Type II) was prepared in Barths 4
medium. Oocytes were incubated in lOmls of collagenase solution in a petri dish for 30 mins 
at room temperature with gentle agitation. Collagenase was then removed by washing 3-4 
times with 15ml Barths medium. Oocytes were then incubated in the presence of 2pM 
cytochalasin B prior to assay as described in section 2.7.1.
'.f.
-
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Table 2.1
Solutions and Buffers Used for DNA Manipulation.
Solution Constituents
50x T ris-acetate (TAE) buffer 242g Tris base; 57.1ml glacial acetic acid, 
100ml 0.5M EDTA, pH 8.0
High salt solution IM NaCl; 20mM Tris, pH 7.4; 
ImM EDTA
Low salt solution 0.2M NaCl; 20mM Tris-HCl, pH 7.4; 
ImM EDTA
lOx Tris-borate (TBE) buffer 108g Tris base; 55g Boric acid; 
40ml 0.5M EDTA, pH 8.0
TE buffer (pH 8.0) lOmM Tris-HCl, pH 8.0, ImM EDTA, 
pH 8.0
5x DNA gel-loading buffer 0.25% (w/v) bromophenol blue; 
30% (w/v) glycerol in water
SOC medium - per lOOmls 2g Tryptone (Bactotryptone); 0.5g Yeast 
extract; 1ml IM NaCl; 0.25ml IMKCl; 1ml 
2M Mg2+stock; 1ml 2M glucose
Glucose buffer 50mM glucose; lOmM EDTA ; 25mM Tris- 
HCl, pH8.0
Luria-Bertani medium (LB) - per litre lOg Tryptone (Bactotryptone) ; 
5g Y east extract; lOg NaCl
LB plates - per litre lOg Tryptone (Bactotryptone);
5g Yeast extract; lOg NaCl, 15g Agar
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Table 2.2 
Table of Buffers.
Buffer Constituents
Barths buffer 88mM NaCl; ImMKCl; 2.4mM 
NaHCOs; 0.82mM MgS0 4 ; 0.41mM 
CaCh; 0.33mM Ca(N0 3 )2 ;
5mM HEPES-NaOH, pH 7.6.
lOx Phosphate Buffered Saline 
(PBS)
1.37M NaCl; 26.8mM KCl; 
43mMNa2HP0 4 ; 14.7mM KH2PO4, 
pH 7.4
Krebs ringer phosphate buffer 
(KRP)
1.28M NaCl; 47mM KCl; 50mM Na2HP0 4 ; 
12.5mM MgS0 4 ; 12.5mM CaCl2; final 
pH7.4at37°C
2x HEPES Buffered Saline 
(HBS)
50mM Hepes, pH7.1; 280mM NaCl; 
1.5mM Na2HP0 4 ;
Homogenisation buffer 
(HB)
0.25M sucrose; lOmM HEPES, pH7.4; 
ImM EGTA; 2mM MgCh
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Figure 2.1
Diagram of a GLUT cDNA Cloned into the pSP64T Vector.
The GLUT2 cDNA was ligated to Bgl II DNA linkers and cloned into the 
untranslated regions of the Xenopus 6-globin gene, which had previously been cloned 
into the multiple cloning site of pSP64 (Krieg and Melton, 1984). The GLUTS cDNA 
was cloned into the pSP64T construct as a Bgl lUBam HI fragment into the 
untranslated regions of the Xenopus 6 -globin gene. The 5' untranslated region (UTR) is 
89 bp long and the S' untranslated region is 141 bp long. The GLUT cDNA and its 
flanking sequences are located S' of the SP6  polymerase promoter.
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Figure 2.1
Diagram of a GLUT cDNA Cloned into the pSP64T Vector.
5' Xenopus UTR 
(89bps)SP6Promoter
GLUT cDNA  
sequencepGLUT
Amp resistance
3' Xenopus UTR 
(141bps)Xbal
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Figure 2.2
1% Agarose Gel Showing the Restriction Digestion Analysis of GLUT3 Pro-Ala 
Mutant cDNAs.
Small scale plasmid preparations were isolated from transformed E.coli cells 
and were subjected to restriction digestion analysis. Restriction of plasmids containing 
GLUTS Pro-Ala mutants with BstX I and EcoR V yields a large fragment of 4825 bps 
corresponding to the backbone vector and a smaller fragment of 871 bps corresponding 
to the BstX VEcoR V fragment of GLUTS that contains the point mutation.
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Figure 2.3
1 % Agarose Gel of In Vitro Synthesised mRNA.
3/<l samples of in vitro synthesised mRNA (from a total of 40/d) were subjected 
to 1% agarose gel electrophoresis and stained with ethidium bromide. DNA markers are 
loaded in Lane 1 (not applicable to RNA sizes), Lanes 2 and 3 contain GLUT2 and 
GLUTS mRNA, and Lanes 4-7 contain mRNA synthesised from P ro ^^ , Pro^^l, 
Ppq383 and Pro^^l linear DNA templates.
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Figure 2.3
1% Agarose Gel of In Vitro Synthesised mRNA.
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Linear DNA 
template
mRNA
104
2 .8  Subcellular Fractionation of Xenopus laevis Oocytes.
2 . 8 .1  Oocyte Isolation and Injection.
Oocytes were isolated from adult female Xenopus laevis as described in section
2.6.4 GLUTS mRNA was synthesised as described in section 2.5 from pSPGTS linearised 
with Xba I. Oocytes were subsequently injected with 50nl mRNA and incubated for 48 
hours at 18-20®C in Barths medium before they were fractionated or assayed for transport 
activity.
2 . 8 . 2  Transport Assays.
Prior to subcellular fractionation of oocytes to obtain a plasma membrane fraction, 
oocytes were first checked for expression levels of GLUTS by measurement of the rates of 
[2,6-SH]2-deoxy-D-glucose transport into oocytes. Oocytes that express GLUTS at the 
plasma membrane exhibited elevated rates of transport over non-injected control oocytes. 10 
GLUTS injected oocytes or 5 non-injected oocytes were incubated in 0.45ml Barths medium 
in a lS.5ml Falcon tube at room temperature. Transport was initiated by the addition of 50/rl 
Barths medium containing [2,6 -^H]2-deoxy-D-glucose with an activity of IpCHml and a 
final sugar concentration of 0.1 mM. After a SO min incubation period, transport was 
terminated as described in section 2.7, and the amount of radioactive tracer accummulated in 
individual oocytes measured by scintillation counting. Oocytes exhibiting transport rates of 
S-5pmoles/min/oocyte were suitable for subcellular fractionation.
2 . 8 .3  Subcellular Fractionation of Oocytes - Method 1.
This method for the preparation of plasma membranes from oocytes was based on 
the method described by Wall and Patel in 1989.
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2.8.3a Reagents.
Barths medium |
NHS-LC-biotin dissolved in a minimum volume of DMSO i
20mg/ml L-lysine solution made up in Barths medium 
Homogenisation buffer containing the following protease inhibitors:-
100//M diisopropylfluorophosphate i
l^g/mlaprotinin
2/<MpepstatinA
2.8.3b Biotinylation of Intact Oocytes.
100 GLUTS injected oocytes were transferred to a glass tube containing Smls Barths t
medium and were incubated on ice for 15 mins. lOmgs NHS-LC-biotin was dissolved in the 
minimum volume of DMSO, 1ml Barths medium was added and this solution was mixed 
with the oocytes. After incubating on ice for 15 mins with gentle shaking, the biotin solution 
was removed by aspiration, the oocytes were washed with 3x Sml Barths medium, to ensure 
removal of excess biotin, and 1ml of a 20mg/ml L-lysine solution in Barths was added. The 
oocytes were incubated on ice for a further 15 mins with gentle mixing. The L-lysine was 
removed by aspiration and the oocytes washed with 3x 3ml Barths medium before addition
of 1ml homogenisation buffer (HB Buffer) containing protease inhibitors.
2.8.3c Fractionation of Oocytes
The biotinylated oocytes were transfered to a 1ml Dounce homogeniser and were
V-carefully disrupted with 6-7 strokes using a loose-fitting pestle. This process produced large 
plasma membrane sheets (PM) with adherent pigment granules and other organelles which 
were allowed to settle to the bottom of the vessel by gravity over a period of 5-10 mins. The 
supernatant fraction was removed from the pellet and retained as the initial supernatant 
fraction (Sinitial. consisting mainly of yolk protein). The pellet containing the PM sheets was
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gently resuspended in 6mls HB+protease inhibitors (Table 2.2) using a glass pasteur 
pipette. Note, from here on the same pipette was used throughout the procedure ; to 
minimise loss of PM fragments. Again the PM sheets were allowed to settle by gravity to the 
bottom of the vessel and the resulting supernatant removed and retained as the wash fraction 
(Swash)- The resuspension, gentle disruption and settling proceedure was repeated a further
4-5 times until a clear PM fraction was obtained, each time removing the supernatant and 
pooling with the previously removed wash. The final PM fraction contained large 
translucent plasma membrane sheets that were clearly visible by eye. The final PM fraction 
along with the Sinitial Swash fractions were subjected to centrifugation at 66,700 x gav at 
4®C for 1 hour in a Beckman Ultrcentrifuge, and the resulting pellets resuspended in a 
suitable volume of Ix PBS (depending on the pellet size) and snap frozen in liquid nitrogen 
for storage at -70^C.
2.8.3d Lowry Protein Determination Microassay.
Solution 1 - (a)
Solution 2 
Solution 3
(b)
500mg CuS0 4 .5 H2 0  
Ig potassium tartrate 
250ml H20 
50g Na2C03 
250ml H20
Slowly add solution (b) to solution (a).
10% (w/v) SDS
0.8N sodium hydroxide
Reagent 1: Mix 25ml of solutions 1,2 and 3 with 25ml H2O
Reagent 2; Mix 25ml Folin-Ciocateau with 100ml H2O
(stored at 4°C in a brown bottle)
Précipitants: 0.15% (w/v) deoxycholate (DOC)
72% (w/v) trichloroacetic acid (TCA) 
Standards: 0, 4, 8 , 12, 16, 20p% BSA
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The sample volume was adjusted to 0.5ml with H2O. 100/^ 1 0.15% (w/v) DOC was 
added, the solutions mixed and incubated at room temperature for lOmins. lOOpil (w/v) TCA 
was added and the solutions were mixed and centrifuged at 16,0(X) x gav for 10 mins. The 
supernatant was discarded and the volume of the pellet was resuspended in 0 .2 mls H2O by 
vortexing. 200pl of reagent A was added, mixed and incubated at room temperature for 10 
mins before addition of lOOptl of reagent B, mixing immediately. After an incubationof 30 
mins at room temperature, the A?snnm was measured, using Ix PBS as the blanking 
solution. A standard curve was constructed from the BSA absorbances from which the 
protein concentration of each sample was determined.
2.8.3e Detection and Quantitation of Plasma Membranes Using 
12^1-Streptavidin.
Samples were diluted to a suitable and equal concentration in Ix PBS. 10-20jwl 
aliquots were spotted onto nitrocellulose membrane squares and allowed to dry before 
addition of the next aliquot. Typically, a volume of 50jwl was spotted in total. The squares 
were left to completely dry before being transfered to a petri dish containing 15mls of 3% 
(w/v) BSA in Ix PBS. The membrane squares were incubated in this blocking solution for a 
period of 2 hours at room temperature with gentle agitation. Excess BSA was removed from 
the membranes by rinsing with Ix PBS. 125i-Streptavidin (0.5mCi/mlf*10^ cpm) was added 
to 10 mis Ix PBS and the membranes were incubated in this solution for 3 hours with gentle 
agitation. The membranes were washed thoroughly with Ix PBS, placed between 2 pieces 
of wet phosphocellulose sheets and dried for 30 mins using a hair dryer. The 
phosphocellulose sandwich was placed in a developing cassette and stored at -20°C for a 
suitable time period before developing using a Kodak X-OMAT processor Model ME3,
2 . 8 . 4  Subcellular Fractionation of Oocytes - Method 2.
This method was based on that described previously with modifications to improve 
the yield of PM fraction obtained during the homogenisation procedure. A water soluble
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form of Biotin was used to avoid the use of DMSO. In addition to the dot blot analysis of the 
oocyte fractions, GLUTS was detected by immunoprécipitation (section 2.17).
2.8.4a Reagents.
Barths medium
sulfo-NHS-biotin dissolved in Barths medium 
20mg/ml L-lysine solution made up in Barths medium 
Homogenisation buffer containing the following protease inhibitors;- 
lOOjwM diisopropylfluorophosphate 
l/fg/ml aprotinin 
2jMM pepstatin A
2.8.4b Biotinylation of Intact Oocytes.
The biotinylation procedure was exactly as described in section 3.8.3b, except that a 
lOmg/ml solution of sulfo-NHS-biotin was made up in Barths and then added to the 
oocytes. The labelling and quenching procedures were identical in all other aspects.
2.8.4c Fractionation of Oocytes.
Oocytes were disrupted by gentle pipetting using a P200 Gilson pipette with the tip 
cut to approximately the diameter of an oocyte (-l-2mm). The glass tube containing the 
homogenate was placed on ice and the PM sheets were allowed to settle to the bottom of the
I
tube by gravity. After approximately 10 mins, the majority of the supernatant, containing 
predominantly yolk protein, was removed from the pellet and transferred to an Eppendorf
tube. The tube was centrifuged at 1000 x gav for 5 mins to remove contaminating yolk 
granules, and the supernatant transferred to another tube. The disruption and centrifugation 
steps were repeated, typically 6 -8  times depending on the oocytes, until all contaminating
yolk and pigment granules had been removed from the supernatant. Y oik pellets obtained at
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each centrifugation step were resuspended in 50pl Ix PBS and combined to form the yolk 
fraction (Y). The resulting supernatant was transferred to a Ti-50 centrifuge tube and was 
centrifuged at 204,000 x gav at4°C for 1 hour in a Benchtop Beckman Ultracentrifuge. The 
resulting supernatant was removed (and retained) from the plasma membrane pellet which 
was resuspended in 200/d of Ix PBS (S^ash fraction). Thus, a total of 3 final fractions were 
obtained by this procedure referred to as the Y (yolk), PM (plasma membrane) and S 
(supernatant) fractions. These were then snap frozen in liquid nitrogen and stored at -70°C 
until further analysis.
2.8.4d Protein Concentration Determination Using the Quantigoid Assay.
I
This is a faster, alternative method to the Lowry assay described in section 2.8.3d, 
and allows detection of as little as 5ng of protein. BSA standards were prepared in the range 
of 0-200ng BSA/10^1. Various dilutions of the protein samples to be measured were made.
SOOpil of the Quantigoid reagent was added to disposable 1ml micro-assay cuvettes and these 
were equilibrated to room temperature. lOpiX of each protein sample or standard samples 
were added to the appropriate cuvettes which were mixed immediately. After a 40-60 min
I
incubation at 37°C, the OD595um was measured for each sample, using lOpl of water in 
SOOptl of Quantigoid as the blanking reagent.
2.8.4e Detection of GLUT3 Transporters by Immunoprécipitation.
Oocyte fractions were separated by SDS/polyacrylamide gel electrophoresis (section 
2.17.1). The gels were removed from the plates and were assembled in a Bio-Rad mini 
trans-blot electrophoretic transfer cell. The proteins were transferred to nitrocellulose 
membrane by application of a constant current of 275mA for 3 hours at room temperature 
(section 2.17.2). Non-specific binding sites on the nitrocellulose membrane were blocked 
(section 2.17.3) and the membranes were probed with a rabbit polyclonal antiserum (1 in 
250 dilution) raised against a synthetic peptide corresponding to the C-terminal 14 amino
1 1 0
acids of human GLUT3. l^I-labelled goat anti-rabbit IgG (l/<Ci/20ml) was used for 
detection by autoradiography (section 2.17.4)
2 . 8 .5  Assessment of the Relative Enrichment of Oocyte Fractions.
2.8.5a Reagents.
Buffer A:
Reaction Mix:
Précipitants:
150mMKCl 
20mM Hepes, pH 7.2 
2mMMgCl2 
(stored at4®C)
50-100/<l of sample to be assayed 
0.3% (v/v) TX-lOO
5mM 2'3'"AMP (lOx stock stored at -20° C) 
0.2mM 5'-AMP (lOx stock stored at -20°C) 
I jaC i pH]5'-AMP
0.25M Zn(S0 4 )2  (stored at room temperature) 
0.125MBaCl2
2.8.5b 5'Nucleotidase Assays.
To an Eppendorf tube 100^1 each of TX-lOO, 2'3'-AMP, 5'-AMP; 2p\ of pH]5'- 
AMP and 648//1 of Buffer A was added. The solutions were mixed and incubated at 37°C for 
5 mins to equilibrate before addition of 50]A of the protein sample at T=0. Immediately, 2 x 
5}A aliquots were removed from each tube and transfered to separate tubes containing 50;^ 1 
of 0.25M Zn(S0 4 )2. Further aliquots in duplicate were removed from the reaction tubes at 
15, 30, 60, 90 and 120 mins. At the end of the incubation period, lOOpl of 0.125M BaCl2 
solution was added to the tube containing the 5pi\ aliquots and the Zn(8 0 4 )2- The solutions 
were mixed and incubated on ice for 10 mins, centrifuged for 10 mins in a microfuge, and 
200/fl of the resulting supernatant was transfered to a scintillation vial. 4mls scintillation
I
.1I
1
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fluid was added to each vial and the amount of radioactivity measured by scintillation | f
counting. The 5'nucleotidase activity associated with each oocyte fraction was calculated and 
plotted as a function of time. Comparison of the gradients of the resulting lines gives an
2 - Cell Culture.
2.9 Cell Culture Materials.
1 1 2
estimate of the fold enrichment of enzyme activity associated with each fraction relative to 
another.
In addition, 10 non-injected oocytes were extensively homogenised in 0.7 ml PBS 
using a 0.1ml Dounce homogeniser to obtain a total protein sample.
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Nutrient Mixture F-12 (HAM) with L-Glutamine, Non-essential amino acids and 
Foetal Calf Serum were supplied by Gibco Life Technologies LTD, Paisley, Scotland.
Trypsin-EDTA and Pienicillini/streptomycin were supplied by Sigma Chemical 
Company, Poole, Dorset, UK.
Calcium phosphate transfection kit was supplied by Invitrogen, The Netherlands
CalPhos Maximizer was supplied by Clontech Laboratories, USA. ïI
Geneticin (G418-sulphate) was supplied by Calbiochem-Novabiochem LTD, 
Nottingham (U.K.).
Ciproxin was obtained from the Western Infirmary, Glasgow, U.K.
Cell culture plasticware was purchased from NUNC and Falcon (Beckton Dickson) 
unless otherwise stated.
2 .10  Growth and Storage Media.
2.10.1 Chinese Hamster Ovary (CHO-) Cell Growth Media.
Ham's F12 media was supplemented with 10% (v/v) Foetal Calf Semm, 200 lU 
penicillin, non-essential amino acids and 200/<g streptomycin / 500ml.
 : 1.:.:,  r    f'hi:
2.10.2 Freeze media.
Ham's F12 media supplemented with 10% (v/v) Foetal Calf Serum, 200 lU 
penicillin, non-essential amino acids and 200/<g streptomycin/500ml, 10% (v/v) sterile 
glycerol and equilibrated at 37°C.
2.11 Long Term Storage of Ceils.
2.11.1 Preparation of Cells for Frozen Stocks.
CHO cells were grown in supplemented Ham's F12 medium in 25ml flasks until 
95% confluent. Growth media was aspirated from the cells which were then trypsinised 
(section 2.12) and transferred to a 13.5ml falcon tube containing l-2mls of quenching media 
(section 2.10.1), Cells obtained from 1-2 flasks were pooled at this stage. Centrifugation at 
1,000 rpm for 2  mins at room temperature resulted in a cell pellet which, after removal of the 
supernatant, was resupended in 2.5mls of filtered cell freeze-down media (section 2.10.2). 
Aliquots were transfered to cryo-tubes, incubated at -80° C for 12-16 hours and then 
transfered to liquid nitrogen for long term storage.
2.11.2 Resurrection of Frozen Cell Stocks from Liquid Nitrogen.
A vial containing the frozen cell stock was removed from the liquid nitrogen and 
rapidly thawed by incubating in a 37°C water bath. An aliquot from the vial was then
transferred to a 75ml flask containing 14ml of normal growth media supplemented with
Ciproxin (5ml/500ml media). Cells were incubated at37°C in a 10% CO2 incubator.
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2 .12  Trypsinisation of Cells.
Media was aspirated from the cells which were then rinsed with 1ml of trypsin- 
EDTA. This was quickly removed from the cells and a further 2-4mls trypsin-EDTA added. 
After incubation at 37°C for 2-5 mins in a 10% C02 incubator the cells began to lift from the 
surface of the plate/flask The reaction was terminated by addition of lOmls of growth 
medium and the cell suspension washed over the growth surface of the plate/flask using a 
pipette to aid resuspension. Growth media was added to obtain the required dilution factor 
and the cells were transferred to fresh flasks/plates.
2.13 Transfection of CHO-Cells Using Calcium Phosphate.
2.13.1 Preparation of Cells for Transfection.
CHO cells were plated at a density of ICri/cm  ^ (approximately 7 x 10  ^cells/10cm 
plate) in Ham's F I2 media supplemented with 10% (v/v) fetal calf serum. The cells were 
cultured overnight at 37°C in 10% CO2. 3-4 hrs prior to transfection fresh media was added 
to the dishes.
2.13.2 Transfection and Selection Protocol.
5-20/fg of DNA was added to a sterile 13.5ml falcon tube. To this, 36pi of 2M 
CaCl2 was added and the final volume made up to 300//1 with sterile H2O. This solution 
was slowly added dropwise using a pasteur pipette to another tube containing S O O ja I  2 x 
Hepes Buffered Saline (HBS- Table 2,2) whilst bubbling air through the solution using 
another pipette. This process was performed over 1-2 mins. After incubation at room 
temperature for 30 mins, a fine precipitate forms which is then added dropwise to cells in 
10cm plates. Cells are maintained at 37°C in a 10% CO2 incubator for 6-12 hours before 
removal of the precipitate by washing the cells twice with Ix PBS. Media is aspirated from 
the plates and 3ml of a fresh solution of Ix PBS/10% (v/v) DMSO was added. Cells were
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then incubated at room temperature for 2.5 mins before removal of the DMSO solution and 
replacement with fresh growth media. The cells were incubated under normal growth 
conditions for a further 24-48 hours. At this point, the selection reagent, G418 at 600><g/ml 
was added to the media which was subsequently changed every 2  days to remove cell debris 
and to allow resistant cells to grow. This process was carried out for 7-14 days post 
transfection until colonies appeared under the microscope. Individual colonies were isolated 
and cultured for further analysis.
2.13.3 Isolation and Propagation of Individual Clones.
Media was aspirated from the cells. A sterile cloning ring was then placed over an 
individual colony of cells and secured to the plate using sterile vaseline. 200/d of trypsin- 
EDTA solution was added and after 2-3 mins the cells began to lift from the plate aided by 
gentle titration using a P200 Gilson pipette. The cells were then transferred to a 6 cm plate 
containing 5mls normal growth media supplemented with G418 (ISOpi/ml). Cells were 
propagated under these conditions, with frequent media changes until confluent. At this 
point cells could be split and grown for transport assays or frozen down in liquid nitrogen 
for long term storage (Section 2 .11).
2.14 Identification of GLUT-Transfected Clones.
2.14.1 Preparation of CHO-Cells for Western Blotting.
Cells were grown on 6cm plates until nearly confluent. They were then washed with 
3x 5ml of Ix PBS and 1ml of SDS sample buffer was added (Table 2.3). Cells were scraped 
from the plate, resupended in the sample buffer and transferred to an Eppendorf tube. 
Disruption of the cells was achieved by passing them through a 1ml syringe fitted with a 25 
gauge needle several times. The samples were then incubated in a boiling water bath for 2-3 
mins before either storage at -20°C or analysis by SDS-PAGE (section 2.17.1) and Western 
blotting (section 2.17.2).
%
"I-
•■ll'I
i
115
2.15 Measurement of [^H]2-Deoxy-D-Glucose Uptake by CHO-Cells.
2.15.1 Reagents.
Ix KRP Solution (stored at 4°C).
Ix KRP containing BSA at Img/ml.
10/fM cytochalasin B in Ix KRP solution.
1% (w/v) TX-lOO.
Ix PBS Solution (stored at4°C).
Sugar stocks made up in Ix KRP containing BSA at 1 mg/ml.
2.15.2 Preparation of Cells for Transport Assays.
CHO-cells were grown as described and were split into 6 -well plates. Growth media 
was aspirated form cells that were 70-80% confluent, and replaced by serum-free Ham’s 
F12 media containing non-essential amino acids. After an incubation period of 2 hours at 
37°C in a CO2 incubator, the cells were ready for analysis of transport activity.
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2.15.3 Transport Assays.
Cells were rinsed with 3x 3ml KRP (Table 2.2) at 37°C. 95Qpi{ of KRP/BSA 
solution was added to each well. For measurement of basal transport levels, 950pt\ of 
KRP/BSA containing lOptM cytochalasin B was added. The cells were incubated at 37°C on 
a hot plate for 15 mins. Transport was initiated by the addition of a 50pil aliquot containing a 
final concentration of 0. ImM 2-deoxy-D-glucose and 0.25//Ci pH]2-deoxy-D-glucose to 
each well. Transport activity was terminated after an incubation period of 3 or 10 mins at 
37°C by flipping the contents out of the wells and immersing the plates in 2 litres of ice-cold
Ix PBS solution. Excess PBS was removed from the cells by inverting the plates and 1ml of
.1% Triton X-100 was added to each well. Plates were left at room temperature overnight on 
a rotating plateform before the solubilised cells were transfered to scintillation vials,
:
f
scintillation fluid was added and the amount of radioactivity measured by scintillation 
counting.
3 - Western Blotting and Immunodetection of Proteins.
2.16  Materials.
ECL Western blotting detection reagents supplied by Amersham Life Science, U.K. 
Broad range molecular weight markers were supplied by BioRad Labs, BioRad 
House, Herts, U.K.
Acrylamide and bisacrylamide were supplied by BDH, Merck Ltd, Hunter Boulevard, 
Magna Park, Leics, U.K.
Aprotinin, diisopropylfluorophosphate, pepstatin A and Kodak film were supplied 
by Sigma Chemical Company, Poole, Dorset, UK.
Nitrocellulose (Schleicher & Schuell) was supplied by Anderman Ltd, London, UK. 
Goat anti-rabbit IgG was supplied by Amersham
Anti-GLUT2 and anti-GLUT3 antibodies were generated by Dr. Gwyn Gould and 
the animal house technical staff and purified by Dr. Jacqueline Rice, Department of 
Biochemistry, IBLS, University of Glasgow, U.K.
GLUT3 rat brain and GLUT2 rat liver standards were provided by Ian Campbell, 
Glasgow University, U.K.
2.17 Immunodetection of GLUT2 and GLUTS Proteins.
2.17.1 SDS/Folyacryiamide Gel Electrophoresis (SDS /PAGE).
SDS polyacrylamide gels were prepared using either Bio-Rad mini-Protean II or 
Hoefer large gel units. Typically a 10% (w/v) resolving gel was used consisting of 0.383M 
Tris-HCl, pH8 .8 ; 10% acrylamide/bisacrylamide and 0.1% SDS; polymerised with 0.1% 
(w/v) ammonium persulphate and 0.001% (v/v) TEMED. Stacking gels were typically 2 and
117
3cm for mini- and large gels respectively and consisted of 0.135M Tris-HCl, pH8 .8 ; 5% 
acrylamide/bisacrylamide; 0.1% SDS polymerised with 0.1% (w/v) ammonium persulphate 
and 0.001% (v/v) TEMED.
Protein samples to be analysed were solubilised in Ix sample buffer (Table 2.3) 
containing Ijwg/ml aprotinin, 100/<M diisopropylfluorophosphate and 2pM  pepstatin A, and 
stored at -20° C until required.
The gel apparatus was assembled and the gels immersed in Ix electrode buffer (Table 
2.3). Prestained broad range molecular weight markers (Bio-Rad, ranging between 202- 
6.9kDa) were loaded followed by the protein samples. Mini-gels were electrophoresed at 
150V until the tracking dye front reached the bottom of the gel and good separation of the 
prestained molecular weight markers was obtained. Large gels were run at 40V overnight.
2.17.2 Western Blotting of Proteins.
Proteins were seperated by SDS-PAGE as previously described'section 2.17.1). The 
gels were removed from the plates and rinsed with Ix transfer buffer (Table 2.3). Each gel 
was placed onto a blotting cassette on top of a piece of Whatman 3mm blotting paper soaked 
in transfer buffer. Nitrocellulose membrane {OASpiM pore size, Schleicher and Schuell) was 
cut to the same size as the gel, pre-soaked in transfer buffer and placed on top of the gel. 
Pre-soaked blotting paper was placed on top of the nitrocellulose and all air bubbles were 
removed from the "sandwich". The cassette was secured and placed into the blotting tank 
containing transfer buffer. Transfer was performed using a Bio-Rad mini trans-blot 
electrophoretic transfer cell at a constant current of 275mA for 3 hours at room temperature. 
Large gels were transferred to nitrocellulose in much the same way using larger cell units 
and at 40mA overnight. On removal of the nitrocellulose membrane from the blotting 
apparatus the efficiency of transfer was qualitatively determined by the presence and intensity 
of the pre-stained molecular weight markers.
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2.17.3 Blocking of Nitrocellulose Membranes and Probing with 
Anti-GLUT2 and Anti-GLUT3 Antibodies.
Non-specific binding sites on the nitrocellulose membranes were blocked by shaking 
for 1-3 hours in 1st wash buffer (Table 2.3) containing 5% (w/v) non-fat milk (Marvel, 
Premier Brands U.K.). The nitrocellulose was then rinsed with 1st wash buffer to remove 
excess blocking solution and transferred to 1st wash buffer containing 1% (w/v) BSA and 
primary antibody at the appropriate dilution, typically 1:100 to 1:250 dilution. The 
membrane was incubated with primary antibody overnight in a sealed bag with shaking at 
room temperature before being washed extensively with 1st wash buffer over a period of 1 
hour, changing the buffer every 10 mins.
GLUT2 and GLUT3 antibodies were generated by immunising a rabbit with 
synthetic peptides corresponding to the C-terminal 14 amino acids of human GLUT2 and 
GLUT3 isoforms.
2.17.4 Immunodetection of Proteins by Autoradiography.
Membranes probed with antisera to GLUT2 or GLUT3 were incubated in 1% 
Marvel/1st wash buffer containing l//Ci/20ml -labelled goat anti-rabbit IgG. After 
incubation at room temperature for 3 hours, the membranes were washed four ames at 10 
min intervals with 2nd wash buffer, draining off the final wash. The membranes were then 
dried overnight between two sheets of Bio-Rad cellophane, assembled in a developing 
cassette and exposed to Kodak X-OMAT S 100 film for 12-24 hours at -80°C. The film was 
developed using an X-OMAT processor.
2.17.5 Detection of Immunoprecipitated Proteins using Enhanced 
Chemiluminescence (ECL).
Washed membranes prepared asdescribedabove were transferred to a clean container 
and excess buffer drained from them. An equal volume of detection solutions 1 and 2
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(obtained fom Amersham Life Sciences) were mixed to produce a final volume sufficient to 
cover the membrane (0.125ml/cm^). Membranes were immersed in the detection solution 
mixture for Imin before decanting the solutions o ff. The membranes were wrapped in cling­
film and exposed using Kodak X-OMAT S 100 film for varying time periods depending on 
the relevant band intensities and the background signal. Films were developed using an X- 
OMAT processor.
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Table 2.3
SDS-PAGE and Western Blotting Buffers.
Solution Constituents
Ix Electrode buffer 120mM Tris-HCl, pH83; 40mMglycine; 
0.1% (v/v) SDS
Ix Sample buffer 93mM Tris-HCl, pH6.B; 2% (w/v) SDS; 
10% (v/v) glycerol; 1 OmM Na2 EDT A ; 
0.002% (w/v) bromophenol blue
Transfer buffer 25mM sodium phosphate buffer, pH6.5
1st Wash buffer Ix PBS, pH7.4; 0.1% (V/V) Triton X-100; 
ImM EDTA
2nd Wash buffer 9g NaCl per 250mls 1st Wash buffer
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CHAPTER 3
Construction and Sequencing of Pro-Ala 
Mutants of the Brain-Type Glucose 
Transporter-GLUT3,
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3 .1  Aims
1. To construct a series of eight mutated GLUTS cDNAs using recombinant PGR 
technology. These mutants will contain single base changes such that the proline residue of 
interest is replaced by alanine. Proline residues targeted for mutation are highly conserved in 
GLUTs 1-5 and are located within or near the start/end of a putative transmembrane helix.
2 . Mutated cDNAs will be subcloned into the vector pSPGTS to form a series of 
constructs that can be used as templates for in vitro synthesis of mRNA for subsequent 
heterologous expression in Xenopus laevis oocytes.
3 . pSPGTS cDNA clones will be screened by automated DNA sequencing to confirm 
the presence of the desired mutation. Positive constructs will then be fully sequenced on 
both strands to ensure that no sequence errors were incorporated during the PGR reactions 
and subcloning procedures.
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3 .2  Structure-Function Studies of GLUT Isoforms using Mutagenic
Techniques.
3 . 2 ,1  Introduction.
Recent advances in recombinant molecular biological techniques and the availability 
of cloned cDNAs for each of the glucose transporters have facilitated the study of the 
importance of individual amino acid residues in the mechanisms of substrate binding and 
translocation across the plasma membrane. Indeed, the replacement of individual amino acid 
residues in protein sequences is now a widely used technique for the dissection of reaction 
mechanisms at the molecular level. Investigation of the glucose transporters by site-directed 
mutagenesis is still at an early stage, with analysis of less than 5% of the 492 residues of 
GLUTl reported in the literature. As a first step in the molecular dissection of the GLUTl 
transporter, site-directed mutagenesis coupled with the use of heterologous expression 
systems provide the basis for the construction of a detailed mutational map and thus, an 
investigation of transporter structure and function. A residue of interest can be replaced by 
another residue to determine its functional importance. Loss of transport activity or a 
perturbation of ligand binding suggests that a particular residue is somehow involved in 
sugar transport. Residues that are targeted for mutational studies are usually highly 
conserved or are invariant among all of the transporter isoforms. The majority of such 
studies have been carried out on the GLUTl isoform. However, recently, investigation of 
such residues have been extended to the other GLUT isoforms in an effort to address the 
generality of the proposed structure-function model and, to identify factors that govern 
isoform specific characteristics. The three main mutagenic strategies that have been 
employed are the generation of point mutations, deletion mutants and the construction of 
chimeric transporters, which have large sequences of one transporter replaced by the 
equivalent sequence of another.
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3 . 2 . 2  Substitution of Conserved Polar Residues.
Hydropathy analysis of the deduced amino acid sequence of GLUTl ((Mueckler,
1985)) predicts that transmembrane segments 3, 5, 7, 8 and 11 may form amphipathic a- 
helices. These contain several serine, threonine, glutamine and asparagine residues which 
have been predicted, using molecular modelling studies, to lie on the same face of the a- |
helices, directed toward the centre of the protein. It is possible that these helices bundle 
together to form a membrane channel through which the substrate can pass. Hydroxyl and 
amide groups of polar amino acids lining the channel are capable of forming specific 
interactions with D-glucose via hydrogen bonding during its translocation across the 
membrane.
Studies involving the use of photoactivatable transport inhibitors have provided some 
clues as to the location of the substrate binding sites. The bis-mannose derivative, ATB- 
BMPA, has been shown to specifically interact at the exofacial binding site of the transporter |
(section 1.7.3), which has been mapped to a region within helices 7 and 8 (Davies et aL,
1991). Helix 7 contains the highly conserved motif QQXSGXNXXXYY, which is present 
in all of the mammalian transporters and also is highly conserved in the wider super family 
of glucose transporters. Helix 8 also contains a number of conserved polar residues. The 
first demonstration using mutagenic techniques that helix 7 constituted part of the exofacial 
ligand-binding si^e came from a study in which three conserved residues Gln^^^ and Asn^^ 
of helix 7, and Asn^U of helix 8, were mutated to leucine, isoleucine and isoleucine 
respectively (Hashiramoto et aL, 1992). When expressed in CHO-Kl cells all mutants were 
detected by Western blotting at comparable levels to wild type GLUTl. Retention of high 
levels of 2-deoxy-D-glucose transport activity by all three mutants implies no absolute 
requirement of these residues for transport activity. The structural separation of the exo- and 
endofacial binding sites in these mutants was investigated using the site specific ligands 
ATB-BMPA and cytochalasin B. All mutants retained comparable levels of cytochalasin B 
labelling at the endofacial site and the Asn^SSHe and Asn^Ujie mutants retained high levels 
of ATB-BMPA labelling at the exofacial site. However Gln^^^, located in helix 7, is 
implicated in fonning the outside specific ligand-binding site due to a striking 95% reduction
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in the level of ATB-BMPA labelling of this mutant, and a 10-fold increase in the Ki 
determined for 4,6-0 -ethylidene-D-glucose inhibited 2-deoxy-D-glucose transport.
As Gln282 is predicted to be located in the centre of helix 7, it was postulated by 
Hashiramoto and co-workers that this helix moves up in the membrane to accept exofacial 
ligands, possibly involving some unfolding near the top of the helix. Indeed, protection 
against proteolysis by ATB-BMPA supports the occurrence of a large conformational change 
resulting in the upward movement of helix 7 rendering the bottom of the helix inaccessible to 
proteases (Hashiramoto et aL, 1992).
In a second study by Mueckler co-workers in 1994, the role of five highly conserved 
transmembrane polar residues Asnl^^» Gln^^l, Gln^^O Tyr292 and Tyr^^ were investigated 
by mutagenesis. The aim was to assess the importance of these residues in substrate binding 
by replacing them with hydrophobic amino acids lacking hydroxyl or amide side chains and, 
in the case of Asn^OO and Gin more conservative substitutions were also made i.e. to 
uncharged polar residues. Both Gln^^l mutants exhibited reduced 2-deoxy-D-glucose 
transport activity in oocytes due to reduced intrinsic activity of the protein and not as a 
consequence of reduced affinity for substrate, since no elevation in Km was observed. As 
reorientation of the unloaded transporter is assumed to be the rate limiting step (Lowe & 
Walmsley, 1986), then mutation of Gln^^l is likely to affect this step which involves a 
substrate independent conformational change. In contrast, the mutation of Gln^^^ is 
postulated to affect the substrate binding event only (Hashiramoto et aL, 1992), since a 
reduction in exofacial ligand binding was observed despite very little effect on transport 
activities. Both studies by Mueckler and Hashiramoto are consistent with the hypothesis that 
helices 5 and 7 are amphipathic and contribute to the formation of the aqueous pore. These 
helices contain side groups that can participate in transient hydrogen bond formation with the 
substrate during translocation.
Due to it s high degree of conservation throughout the wider superfamily of glucose 
transporters, the sequence Q^82q x s GXN288x x FYY293^  towards the endofacial end of 
helix 7 has been the target of much mutagenic interest in the context of its role in the 
transport mechanism. Site-directed mutagenic studies on residues Gln^^^ and Asn^^S have 
already been discussed above. Mutation of tyrosine residues at positions 292 and 293 to
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either isoleucine or phenylalanine was the object of a further study by Mori and co-workers 
in 1994. Of the four mutants, decreased 2-deoxy-D-glucose transport activity was observed 
only with the Tyr293 to isoleucine mutation. Ligand binding studies revealed that this loss of 
transport was associated with complete abolition of cytochalasin B labelling at the endofacial 
site. The conserved FYY sequence is predicted to form part of a hydrophobic patch on the 
transporter, located close to the C-6 position of the sugar as it locates at the exofacial site. 
This hypothesis is based on D-glucose analogue studies (Barnett et aL, 1975; Barnett et aL, 
1973). Thus, the sequence Q282QLSGnqAVFYY293 helix 7 of GLUTl is hypothesised 
to have a dual role in both hydrogen bonding to D-glucose and closing of the exofacial 
binding site during translocation. The Gln^^^Leu mutation is consistent with this 
interpretation since ATB-BMPA binding is abolished. In contrast, mutation of Tyr^^Sjig 
results in decreased transport activity associated with complete loss of cytochalasin B 
binding at the endofacial site and retention of ATB-BMPA labelling. The transporter is 
therefore stabilised in an outward facing conformation as a result of a single point mutation 
within helix 7 that perturbs the conformational changes necessary for closing of the exofacial 
site. This is a somewhat striking observation when compared to the conclusions drawn from 
a study in which 37 of the 42 C-terminal amino acids of GLUTl were deleted (Oka et aL,
1990). Although expressed at the plasma membrane of CHO cells, the truncated GLUTl 
was functionally inactive, probably due to an inability to alternate between conformational 
states. As cytochalasin B labelling was retained with a corresponding abolition of high 
affinity ATB-BMPA labelling, it was concluded that this mutant was locked in an endofacial 
conformation. It was postulated that the C-terminal domain is not involved in 
substrate/ligand binding to the endofacial site per se, but is involved in the formation of the 
outward facing binding site.
There are four other conserved tyrosine residues within the GLUT isoforms located 
at positions 28, 143, 308 and 432 in GLUTl. These, along with Tyr^92 ^nd Tyr^93 were 
mutated to Phe in the rat GLUT4 isoform (Wandel et aL, 1994). Glucose transport activity 
was reduced in Tyr^^^Phe and Tyr^^Phe but was unaffected in the other mutants. 
Cytochalasin B binding was reduced in mutants Tyr^^^Phe, Tyr292phe and Tyr^93phg
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Tyrosines at positions 143 and 293 seem to be functionally important and Tyr^92 may 
represent an additional contact site for cytochalasin B.
Transmembrane helix 11 contains a highly conserved polar amino acid located at 
position 415. Mutation of this asparagine to aspartic acid, i.e. replacement of a positive 
charge with a negative charge, causes a 5-fold decrease in the turnover number and a 1.5- 
fold increase in Km (Ishihara et al., 1991). Cytochalasin B & 4,6-O-ethylidene-D-glucose 
data suggest modulation at the inner but not the outer binding site, Asn^l^ is likely to reside 
close to the inner binding site and the presence of an ionic charge in this domain may have 
decreased the turnover number of the protein by affecting the rate of conformational changes 
between the inward and outward facing transporter.
3 . 2 .3  Substitution of Conserved Tryptophan Residues.
In 1981, a model was proposed, based on kinetic studies, in which the transporter 
undergoes conformational changes allowing the protein to alternate between two 
conformational states (Baldwin et at., 1981). Since then, much evidence has been 
accumulated to support the conclusion that a change in protein secondary structure occurs as 
a consequence of D-glucose binding (Chin et aL, 1987; Chin et aL, 1986). D-glucose 
binding increases the a-helical content and, on this basis, domain transfer of an aqueous- 
accessible segment into the membrane was proposed (Pawagi & Deber, 1987).
Tryptophan residues can be used to monitor the intrinsic fluorescence of proteins and 
this is a useful technique to obtain information regarding substrate binding and 
conformational changes in the absence of an overall tertiary structure. In addition, 
information regarding the relationship of the integral membrane protein with the cellular lipid 
bilayer can be obtained. Protein intrinsic fluorescence can be monitored in the presence of 
small hydrophilic quencher molecules such as acrylamide and potassium iodide. If a 
tryptophan residue is directly involved in substrate binding or, if it is located in a dynamic 
segment that undergoes a domain shift during ligand-binding/translocation, then alterations 
will occur in its emission wavelength or its susceptibility to quenching.
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Such techniques were used to investigate conformational/positional changes 
occurring in GLUTl in the presence and absence of D-glucose and in the presence of the 
inhibitors cytochalasin B and maltose (Pawagi & Deber, 1990). GLUTl contains six highly 
conserved tryptophans, the majority of which are predicted to be located in inaccessible 
hydrophobic regions of the membrane. Results obtained in the presence of inhibitors are 
interpreted in terms of ligand activated movement of a protein segment containing a 
tryptophan from an initially aqueous located region into or toward the membrane. This 
relocation event opens the channel whereas maltose and cytochalasin B block this 
conformational change and thus inhibit D-glucose transport. Conformational and hydropathy 
analyses have suggested that the region encompassing Trp^^ is a dynamic segment that 
could undergo ligand activated movement into the membrane and hence open a putative 
channel within the protein.
Upon exposure to ultra-violet irradiation, GLUTl can be covalently labelled with 
cytochalasin B at a region close to the endofacial glucose binding site. Labelling is D-glucose 
inhibitable. The wavelength required for photolabelling and the cleavage of photolabelled 
transporter with various proteases (Cairns etal., 1987; Holman & Rees, 1987) suggest that 
the cytochalasin B labelling site may involve Trp^D and/or Trp^^^ of GLUTl. Due to the 
high conservation of Trp4l2 in the other isoforms, this residue was implicated in glucose 
binding and/or other aspects of the transport mechanism. Mutation of this residue in rabbit 
GLUTl to leucine (Katagiri et aL, 1991) reduced 2-deoxy-D-glucose transport to 15-30% of 
wild type levels of activity when expressed in CHO cells. A marked decrease in 2-deoxy-D- 
glucose transport was also observed when the corresponding tryptophan residue in GLUT3, 
Trp410 was replaced by leucine (Burant & Bell, 1992b). Further analysis of 2-deoxy-D- 
glucose transport kinetics revealed that this dramatic decrease in transport activity was 
associated with a 2.5-fold increase in Km and a 3-fold decrease in turnover number. In 
addition, cytochalasin B labelling was not abolished but decreased by 40% and cytochalasin 
B binding was also decreased. Side-specific glucose analogues used in conjunction with 
cytochalasin B binding show that this mutation does not affect the exofacial binding site, but 
alters the conformation at the endofacial site such that cytochalasin B binding and its 
inhibition by n -propyl-/ -D-glucopyranoside were both affected. Thus it seems that Trp^l2
129
is not the sole cytochalasin B labelling site but is located close to the inner binding site. 
Protease digestion studies of cytochalasin B-labelled GLUTl indicate that the photolabelling 
site is located between residues 388-412 (Holman & Rees, 1987) and so Trp412 may be one 
of many labelling sites in this region.
This led to a study by Garcia and co-workers in 1992 to assess the possible role of 
all six tryptophan residues in transporter activity. When replaced by either glycine or leucine, 
only mutations atTrp^^ (in helix 10) and Trp^l2 (in helix 11) affected 2-deoxy-D-glucose 
or 3-0 -methyl-D-glucose transport activity when expressed in oocytes, CHO cells or COS- 
7 cells (Garcia et a t, 1992; Katagiri et aL, 1993; Shurman et aL, 1993)). Decreased 
transport activity in the case of Trp^D mutants was associated with a dramatic reduction in 
the intrinsic activity of the mutant proteins. Whilst only a moderate reduction in intrinsic 
activity was detected for the Trp^^ mutants, decreased transport activity can be accounted 
for by reduced level of protein detected in oocytes and decreased targeting to the plasma 
membrane. Double mutation of both Trp388 and Trp^D in GLUTl results in total abolition 
of cytochalasin B labelling and reduced cytochalasin B binding or 2-deoxy-D-glucose 
transport. Thus, it was proposed that either tryptophan residue could be labelled by 
photoactivation (Inukai et aL, 1995).
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3 . 2 .4  Substitution of Proline Residues.
There are a number of highly conserved sequences among the GLUT isoforms that 
are rich in proline residues. Indeed, this observation can be extended to the wider family of 
membrane transporters. It is rather surprising that these residues exist in the membrane 
spanning domains since proline is known as a classic breaker of a-helical structure. Such 
considerations have prompted several groups to investigate the role of these residues in 
transporter function, particularly with regard to the confonnational changes involved in 
substrate translocation. Such studies will be discussed in detail in section 3.3 and Chapter 4 
of this thesis.
I
3 .2 .5  Mutation of Cysteine Residues of GLUTl.
Despite no absolute conservation amongst the mammalian GLUT isoforms, cysteine 
residues have been targeted for mutagenesis to examine their role in transport activity, 
protein conformational stability and oligomerisation. GLUTl contains 6 cysteine residues 
and the individual replacement of these residues have no reported consequences on 
transporter function (Wellner, 1994). Double, triple and cysteine-less mutants retain wild 
type GLUTl transport kinetics (Due et aL, 1995a; Wellner, 1995). Mutants lacking cysteine 
residues in either the N- or C-terminal domains and the cysteine-less mutant all exhibit 
asymmetric transport. In addition, Km and Vmax parameters for equilibrium exchange of 3- 
O-methyl-D-glucose were greater than those for z&vo-trans uptake, as is the case for the wild 
type transporter. With regard to cytochalasin B binding, mutation of cysteines in the N- and 
C-terminal domains results in increased affinity. The cysteine-less mutant exhibits an affinity 
for cytochalasin B that is at least 5-fold greater than the wild type (Wellner, 1994).
Mutagenic studies have confirmed the locations of Cys^^V and Cys429 at the 
endofacial loop between transmembrane helices 6 and 7, and at the exofacial loop between 
transmembrane helices 11 and 12, respectively. Constructs in which these residues were 
individually replaced lost sensitivity to /?-chloromecuribenzenesulphonate (pCMBS) when 
either injected intracellularly or applied externally to oocytes ((Wellner, 1994).
The observation that the cysteine-less mutant retains wild type transport kinetics 
questions the proposal made by Carruthers and co-workers in 1995 that a single 
intramolecular disulphide bridge between Cys^47 and Cys'f^l stabilises transporter 
oligomeric structure and accelerates transport function (section 1.10). The expression system 
used in this study (CHO-cells) however, is different from that used by Wellner and co­
workers and this may affect the oligomeric states of the transporters. The fully functional 
cysteine-less mutant should also prove useful in further studies investigating the 
transmembrane topology and function of GLUTl. For example, it can be used as a template 
to substitute cysteines back into the transporter at serine residues likely to be exposed at 
extraniembraneous regions or, at locations close to the channel or substrate binding site(s). 
This, in combination with cell-impermeant sulfhydryl reagents, should identify regions
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necessary for transporter function. The mutant should also provide a useful template for the 
introduction of fluorescent groups in selected regions of the transporter allowing observation 
of transporter function via fluorimetric methods. That is, of course, providing that the 
transporter remains fully functional.
3 .2 .6  Point Mutations in the N-Terminus.
The effects of substitution of an N-terminal amino acid on both ligand binding and 
transport activity was discussed in section 1,7.4b. The only other residue (in addition to 
Gin in helix 5), located within the N-terminus that has been reported to affect transport 
activity is Vall65 in GLUTl or VaB97 in GLUT2. Mutation of the afor-mentioned valines in 
both isoforms to isoleucine resulted in a severe reduction in transport activity (Mueckler et 
aL, 1994). Such an effect is most surprising, considering that the mutation represents 
replacement of one hydrophobic transmembrane residue for another, differing in structure by 
only one methyl-group. The Vall97ne substitution of GLUT2 has been discovered in a 
single allele of a patient with non-insulin-dependent diabetes. Interestingly, the reverse 
mutation of this residue, i.e. Ile-Val, resulted in a complete restoration of functional activity 
when expressed in oocytes (Mueckler ef a/., 1994b). Substitution of isoleucine for valine is #
one of the more common conservative substitutions observed at equivalent positions in 
homologous proteins (Schultz & Schimier, 1979). A further point of interest is that VaU^^ 
in GLUTl is predicted to lie approximately one helical turn in distance from Glu^^ l^ which 
has been demonstrated to affect exofacial ligand binding (Mueckler e? aL, 1994a). The valine 
side chain is thus predicted to lie close to the exofacial substrate binding site within the 
putative channel. The presence of a bulkier side chain at this crucial position may be 
sufficient to block binding or passage of substrate through the channel.
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3 . 2 . 7  Substitution of Extramembraneous Residues.
The majority of mutational studies to date have been confined predominantly to those 
regions of the transporter that are highly conserved between the GLUT isoforms, i.e. the 
transmembrane domains. Another common feature exhibited by all GLUT isoforms is a 
potential A-linked glycosylation site located within the large extracellular loop linking 
transmembrane helices 1 and 2. This site has been identified as Asn'^^ in GLUTl and its 
high degree of conservation in the other isoforms may suggest an important role for A- 
linked glycosylation in transporter function. Indeed, this was the aim of a study carried out 
by Asano and co-workers in 1991. Mutation of Asn^5 to asparagine, tyrosine or glutamine 
abolished A-linked glycosylation and led to a 2-fold reduction in the transporter affinity for 
2-deoxy-D-glucose. It was concluded that, although glycosylation of the transporter is not 
absolutely essential, it may play a role in maintaining a structure capable of high affinity 
substrate binding, thereby increasing transport activity (Asano et aL, 1991). This may 
account for some of the anomalies observed when comparing studies carried out in different 
heterologous expression systems, for example, the glycosylation pattern of a transporter 
expressed in Xenopus oocytes may be different from that obseiwed in the native cell.
Other studies concerning residues that are not confined to transmembrane regions of 
the transporter have been discussed previously (section 1.7.4). For example, the 
cytoplasmic C-terminal tail has been shown to play a role in transport activity and formation 
of the exofacial binding site (section 1.7.4a).
3 .2 .8  Generation and Characterisation of Chimeric Transporter Proteins.
Comparative studies have revealed that the GLUT isoforms exhibit distinct kinetic 
parameters for glucose transport and therefore display different sugar transport 
characteristics in the tissues in which they are predominantly expressed (Colville et aL, 
1993a; Colville et aL, 1993b; Gould et aL, 1991). It is the primary amino acid sequence of 
the transporter protein, and not the tissue in which it is expressed, that governs its affinity 
for glucose. In an effort to identify the structural determinants that account for these unique
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functional characteristics, the effects of exchanging various domains between isoforms has
Ibeen probed by the generation of chimeric transporters. This strategy makes use of site- 
specific oligonucleotide primers and recombinant PCR to generate the transporters, which ■
can then be heterologously expressed in a range of cell systems for functional 
characterisation.
To date, a variety of constructs have been reported (reviewed in Saravolac & v|
Holman, 1997). Chimeras in which the C-terminal tail is exchanged between human GLUTl
and rat GLUT4, or between human GLUT3 and GLUT4 exhibit 2-deoxy-D-glucose i
■Itransport activity that is comparable to wild type levels (Burant & Bell, 1992; Pessino et 
at., 1991). Thus, the role of the C-terminal region in transport catalysis appears to be 
identical between these pairs of isoforms. However, when the C-terminal 20 amino acids of |
the murine GLUTl isoform are replaced with those of human GLUT4, significant alterations I
in transport kinetics are observed. The GLUT1/GLUT4 chimera does not appear to exhibit 
accelerated equilibrium exchange, a property characteristic of GLUT 1. Accelerated exchange
7is not transferred to GLUT4 in the reverse chimera consisting of GLUT4 sequence with a 
GLUTl C-terminus. This suggests rapid equilibrium exchange is a property unique to 
GLUT 1 and it requires specific sequences in other regions of the protein in addition to the C- 
terminal region (Dauterive^r a/., 1996). IGLUT2 has a very specific tissue distribution and is characterised by high and 
Vmax values compared to the other isoforms. GLUT2 is also unique among the GLUTs in 
that it can transport both D-fructose and D-glucose (Colville et aL, 1993a; Colville et aL,
■ y'y1993b). Furthermore, this isoform exhibits distinct kinetics of cytochalasin B inhibition of
. JÎ
glucose transport and is only very poorly photolabelled (Axelrod & Pilch, 1983). These |
distinct properties are likely to be attributable to the more divergent regions of the transporter |
■ysequence. There have been a number of studies involving the C-terminal cytoplasmic tail 
region of GLUT2. Replacement of the C-terminal residues of human GLUTl with the 
corresponding 89 residues of the GLUT2 human isoform resulted in a 4-fold and 3.8-fold 
increase in Km and Vmax values for 2-deoxy-D-glucose transport, respectively. A decrease 
in the affinity for cytochalasin B was also observed compared to wild type GLUT 1 (Katagiri 
et aL, 1992). Together these observations suggest that the C-terminus confers GLUT2-like
I
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;kinetics onto the GLUTl transporter, but does not contribute to cytochalasin B binding.
Similar results were obtained from a study in which C-terminal regions of GLUT2 and 
GLUT4 were exchanged. Replacement of the carboxy-terminus of GLUT4 with that of |f
GLUT2 resulted in a 2-fold increase in the Km for 3-O-methyl-D-glucose. However,
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replacement of the region encompassing the large intracellular loop and transmembrane 
helices 7 and 12 was necessary to increase the Km to a value approaching that of wild type
GLUT2 (Buchs et al., 1995 ). Thus, in addition to the cytoplasmic C-terminal tail, i
1transmembrane helices 7 and 12 are also important for the distinctive affinity exhibited by
ÏGLUT2.
In an attempt to address which regions of GLUT2 and GLUT3 are responsible for 
substrate specificity, a series of chimeras containing various portions of the N- and C- #
terminal domains of these isoforms were constructed. Chimeras containing N- and C- 
terminal regions of GLUT2 including transmembrane helix 7 exhibited low affinity 2-deoxy-
pD-glucose uptake and were capable of D-fructose transport. In contrast, chimeras containing 
helix 7 sequence derived from GLUT3 exhibited high affinity 2-deoxy-D-glucose transport ®
and no detectable levels of D-fructose transport (Arbuckle et a l, 1996). It was concluded 
that helix 7 contributes to both high affinity 2-deoxy-D-glucose transport and substrate 
selectivity between GLUT2 and GLUT3 isofoims (discussed further in Chapter 6).
GLUT5 is the most divergent member of the mammalian GLUT family possessing 
only 40% identity with the other isoforms. An interesting but poorly understood property of 
this isoform is its ability to transport D-fructose and inability to transport D-glucose (Burant 
et al., 1992). A chimeric study was designed to address the biochemical properties of 
GLUT5 and to investigate the domains responsible for fructose transport. Expression of 
GLUT5 in CHO cells resulted in transporters localised at the plasma membrane of oocytes 
that were capable of transporting D-fructose but not D-glucose. In addition, fructose |
transport was not inhibited by cytochalasin B and no detectable levels of photolabelling were 
recorded (Inukai et al., 1995). Most GLUTl/GLUT5 chimeras expressed no measurable
fructose or glucose transport . However, chimeras consisting of N-terminal GLUTS ■•Isequence to the end of helix 6, or GLUTl sequence containing only the C-terminal 44 
residues derived from GLUTS, exhibited glucose transport and cytochalasin B binding.
a
These observations may support the hypothesis that transmembrane helix 7 is an important 
determinant for regulation of substrate specificity, since both chimeras that transport glucose 
contain the GLUTl helix 7 sequence. GLUTS on the other hand appears to have a more 
specific structural requirement for transport of D-fructose, involving regions of the 
transporter other than helix 7.
3 .3  Role of Transmembrane ProHne Residues in Membrane Transport
Proteins.
3 . 3 .1  Introduction.
There are several classes of protein that span the cell lipid bilayer that can be divided 
based on the structure and function of their transmembrane segments. Proteins such as the 
histocompatibility antigens, the immunoglobulin M heavy chain and the epidermal growth 
factor receptor contain a single transmembrane segment that serves to anchor these proteins 
to the membrane. Transport proteins such as the Ca^+, Mg2+-ATPase of the sarcoplasmic 
reticulum, the lac permease of E.coli and the mammalian facilitative glucose transporters are 
predicted to traverse the membrane several times. The transmembrane segments are 
conformationally ordered to create a specific transport channel. A high proportion of polar 
residues located within certain transmembrane segments impart the amphipathic 
characteristics required for the formation of a hydrophilic channel. Regulation of the channel 
itself must involve either the creation or accessibility of the channel.
Advances in recombinant DNA technology over the last 10-15 years have made 
available the sequences of many membrane proteins. However, the details of transporter 
function at the molecular level and the precise mechanism of regulation are poorly 
understood at present. Such advances are ultimately hindered by difficulties associated with 
obtaining high-resolution crystal stmctures for this class of protein. Molecular dynamics and 
molecular modelling, in combination with mutagenic studies, may provide some insights 
into the transport mechanism. Large conformational changes in protein structure are 
predicted to be necessary for substrate translocation across the lipid bilayer. Such
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structural/positional changes would have to be both reversible and dynamic events, resulting 
in specific conformational consequences. The observation, made from a survey of the 
transmembrane segments of integral membrane proteins (Brandi and Deber, 1986), that 
membrane-buried proline residues were found in nearly all transport proteins examined, led 
to the proposal that they play a specific functional role. In fact, proline residues were found 
to be selectively included in membrane-spanning regions (Jones et aL, 1994) and it was 
noted that they are conserved at similar positions in transport proteins that have common 
functions (Brandi and Deber, 1986).
3 . 3 .2  Characteristics of Proline Residues.
3.3.2a General Properties.
Membranous regions of proteins are largely comprised of hydrophobic residues that 
promote helical structure. Thus, the selective inclusion of proline residues within 
transmembrane a-helices is somewhat surprising, considering the relative rigid backbone 
angles of the imino acid and the fact that it lacks an amide proton for stabilisation of a-helical 
structure through hydrogen-bonding. Proline is thus known as a classical breaker of a- 
helical structure. In principle, proline residues create thermodynamically less stable 
stmctures when occurring within membranes. However, transmembrane helices are typically 
longer in length (-20 residues) and therefore are more stable due to increased hydrogen- 
bonding. Consequently, such helices are more capable of bearing the energetic cost of 
accommodating a membrane-buried proline residue.
There are however two specific properties of a proline-containing peptide bond that 
make it well suited for a functional role in substrate translocation across the membrane : (1) 
The tertiary amide character of the Xaa-Pro (where Xaa represents any amino acid) carbonyl 
group can participate in hydrogen-bonding, acting as a hydrogen-bond acceptor. It can also 
act as a transient liganding site for positively charged species. (2) Cis peptide bonds 
involving prolines are of comparable stability to the trans state when proline occurs at the 
carboxy-terminal side of the bond. Isomérisation of the Xaa-Pro peptide bond is a dynamic
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and reversible event that could bring about the required structural changes resulting in the 
realignment of amphipathic transmembrane helices to initiate the formation or opening of a 
hydrophilic channel (Figure 3.1). Such observations initiated several studies investigating 
the role of transmembrane proline residues in various membrane transport proteins.
3.3.2b Transmembrane Proline Residues Cause Kinks in Helices.
From a structural point of view, the ability of a proline to break the hydrogen- 
bonding pattern of an a-helix causes deviations from the ideal backbone internal parameters. 
One stmctural consequence of this is the creation of a kink or bend in the helix backbone. In 
globular proteins. Pro-kinked helices orientate themselves with their convex sides towards 
the solvent. In contrast, those found in multiple membrane-spanning proteins tend to be 
orientated with their convex sides towards the protein interior, since there are no other 
molecules but other regions of the protein itself that can provide hydrogen-bonding groups 
to the unpaired amide and carbonyl groups of the kink (von Heijne, 1991). In this regard, 
kinked helices may participate structurally to form a pocket which can bury a charged residue 
or chromophore.
3,3.2c Accommodation of a Czf-Proline in Transmembrane Helices.
Studies on the conformational changes occurring in bacteriorhodopsin and rhodopsin 
that are associated with the function of these proteins indicate that the Xaa-Pro peptide 
bonds can act as hinges (Ganter et al., 1989, Gerwert et al., 1990, Rothschild et al., 
1990).Isomerisation about Xaa-Pro peptide bonds are also known to be associated with the 
conformational changes that occur during visual transduction (Shieh et al., 1990). However, 
direct and conclusive evidence to reject or accept the involvement of cis~trans isomérisation 
of proline peptide bonds in membrane protein function can not be obtained from mutational 
studies that assay only for protein activity and do not detect conformational changes.
If cis-trans isomérisations were to take place during the functioning of membrane 
proteins, then one would expect that a cis-Pro could be accommodated in a transmembrane
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a-helix. The isomérisation event depicted in Figure 3.1 would result in the introduction of a 
helix-turn-helix motif, consequently making it difficult for the helix to traverse the 
membrane, resulting in drastic alterations in protein structure. In order to maintain a near 
native structure, the isomérisation event would have to be accompanied by changes in the 
local parameters. Although and l^C-NMR studies have demonstrated a good amount of 
main chain flexibility resulting from the presence of proline residues (Deber et aL, 1990), the 
presence of c/5'-Pro was not indicated in this study. Molecular dynamics simulation has been 
used to characterise the alternative conformation, flexibility and rigidity of transmembrane 
helices of bacteriorhodopsin and rhodopsin (Iyer & Vishveshwara, 1995). This technique 
has also been applied to hydrophobic peptides containing proline residues. It was concluded 
that cA-Pro can be accommodated in an a-helix, allowing access to multiple conformations 
from a helix-turn-helix-like motif to a straight helix. This is due to the introduction of local 
distortions only, such that the helical character and direction of propagation is maintained. 
These observations represent a plausible involvement for cis-trans isomérisation events in 
membrane protein function (and folding).
3 . 3 . 3  Mutation of Proline Residues in the lac Permease of E.coli,
The lac permease is a prototypic membrane transporter that catalyses co-transport of 
a B-galactoside molecule with a single H+ (Kaback, 1983). Based on CD studies and 
hydropathy analysis of its primary structure (Foster et aL, 1983), it is predicted to adopt a 
similar transmembrane topology to that of the GLUT isoforms. This protein contains twelve 
proline residues, nine of which are membranous. In a study designed to determine whether 
cis - trans isomérisation of Xaa-Pro peptide bonds are important for transport function, each 
of the nine transmembrane prolines were individually mutated (Consler et aL, 1991). Since 
this isomérisation event is unique to proline, replacement should render the transporter 
inactive. Alanine or glycine substitutions at any proline, with the exception of Pro^S 
(discussed below), resulted in significant retainment of lactose transport activity. Alanine or 
glycine substitutions at position 192 led to reduced steady state levels of lactose 
accumulation compared to wild type, which was attributed to partial uncoupling of the
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transporter. It was concluded that the cis-trans isomérisation of Xaa-Pro peptide bonds is not 
an absolute requirement for transport activity. In the same study, the importance of any 
structural discontinuities resulting by replacement of proline with glycine, alanine or leucine 
was investigated. No correlation was found to exist between transport activity and the ability 
of a substituted amino acid to promote or break a-helical structure. Rather it is the 
hydrophobicity and/or the size of the substituted amino acid that dictates the levels of 
transport activity attained. Replacement of Pro^S with either glycine, alanine or leucine leads 
to transporter inactivation. Substitution of serine at this position does not abolish substrate 
translocation or high affinity ligand binding. It was thus concluded that Pro^S is important 
for substrate recognition and binding.
In the absence of a high-resolution structure and the lack of any detailed kinetic 
analyses of these mutants, it is difficult to define a precise role for transmembrane proline 
residues in this study.
3 . 3 . 4  Mutation of Proline Residues in the Phosphate-Specific Transporter 
of E.coli,
The Pst system is a periplasmic phosphate permease (Gerdes & Rosenberg, 1974). It 
comprises two hydrophobic proteins, PstA and PstC, that are likely to form the membrane- 
spanning portion of the Pst system, each consisting of five or six transmembrane helices. 
There are two proline residues located at approximately equivalent positions within the 
membrane in adjacent helices of the PstA and PstC proteins. Individual substitution of the 
two prolines in either PstA or PstC to alanine results in partial loss of phosphate uptake 
activity (Webb et aL, 1992). Transport activity is completely abolished in the double alanine 
mutants. In contrast, individual replacement with leucine renders the transporter inactive. 
Thus, the prolines appear to act cooperatively such that substitution of one with the more 
bulky residue, leucine prevents the remaining proline from carrying out its functional role. 
Unfortunately, mutation to inactivity does not distinguish between a structural or dynamic 
role for these residues, but does confirm their requirement for transporter function.
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3 .3 .5  Role of Transmembrane Proline Residues in Bacteriorhodopsin.
Bacteriorhodopsin is present in the purple membrane of Halobacterium halobium 
(Stoeckenius & Bogomolni, 1982). Light activation leads to pumping of protons from the 
inside to the outside of the cell. There are three proline residues located within helices B, C 
and F at position 50, 91 and 186 respectively. Site-directed mutagenesis in combination with 
FTIR difference spectroscopy has been employed to probe the role of these prolines in the 
function of this protein (Braiman et aL, 1988; Gerwert et aL, 1990). It is well established 
that an isomérisation event around the Ci3=Ci4 double bond is crucial to proton pumping 
(Braiman & Mathies, 1980). Light-induced conformational changes of two prolines around 
the C-N bond have been detected in addition to the global movement of the polypeptide 
backbone during proton pumping, as deduced from strong difference bands in the amide 
I/amide II region. It was postulated that the higher degree of flexibility around the C-N 
amide bond of proline peptide bonds compared to that of other amino acids may be a hinge 
for functionally important conformational changes that facilitate the vectorial transport of a 
proton. Also, a full isomérisation event could establish a transient proton binding site 
((Dunker, 1982)). Absorption bands were assigned to transmembrane Pro^^ which, 
interestingly, is located close to Tyr^^^ in the retinal binding pocket which undergoes 
protonation changes upon photoactivation (Braiman & Rothschild, 1988). Tentative 
assignment of the other absorption bands have been made to Pro^O and Pro^l. Mutation of 
Prol86 to alanine or glycine has an impact on the chromophore and the ability to pump 
protons. Mutation of Pro^® or Pro^l to alanine or glycine led to reconstitution of the 
functional properties. Evidence from these studies suggest an involvement of Pro^^, in helix 
B, and Pro^^^ in conformational changes of the protein. The TyrlB5,prol86 region of helix F 
acts as a hinge that links chromophore isomérisation with structural changes. All three 
prolines may be structurally active and may act cooperatively.
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3 .3 .6  Mutation of Proline Residues in GLUTl.
Although there is much experimental evidence to suggest the occurrence of large 
conformational changes that result in the sequential exposure of the substrate binding site to 
the external and internal surfaces of the glucose transporter, the details of this dynamic event 
at the molecular level are still poorly understood. However, analysis of the amino acid 
sequence of the GLUT isoforms reveals the presence of a high proportion of membrane- 
buried proline residues, several of which are 100% conserved throughout the isoforms 
(Tables 3.1-3.2). Molecular modelling and dynamic studies have predicted that the highly 
conserved G ^ ^ ^ p o p jp  sequence located within helix 10 (Figure 3.2) is important for 
facilitating the opening and closing of the external binding site (Hodgson et aL, 1992). 
Mutation of Pro^^^ in this sequence of GLUTl to isoleucine (but not glycine or alanine) 
resulted in loss of transport activity associated with reduced ATB-BMPA labelling and 
retention of cytochalasin B labelling. These observations are consistent with the transporter 
adopting an endofacial conformation (Tamori et aL, 1994). In contrast, glycine substitution 
at this position resulted in retention of ligand binding at both inside and outside sites. Other 
transmembrane proline residues of potential interest are located within helix 6. There are 3 
prolines located at positions 187, 196 and 205 that are conserved in all GLUT isofonns 
except for the low affinity GLUT2, where histidine, arginine and phenylalanine are present 
instead. In the case of individual mutation of these residues to alanine, wild-type transporter 
activity was retained, suggesting that the presence of proline at these positions is not an 
absolute requirement for transport. Individual mutation of proline residues within helix 10 
also resulted in wild-type transport activity levels. Thus, despite the putative contribution of 
transmembrane proline residues to the structure and function of a protein, their individual 
replacement may not necessarily disrupt the transport mechanism. This is in line with the 
studies described for bacteriorhodopsin, lac permease and the Pst system. Substitution of 
proline residues to the neutral-polar amino acid glutamine considerably reduced transporter 
activity (Wellner, 1995). Since replacement with isoleucine also impairs transport activity 
(Tamori et aL, 1994), the polarity of the substituted residue cannot be the sole factor 
affecting catalytic activity. It may be that the specific chemical properties of the substituted
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side chain cause structural changes in the protein that hinder the conformational changes 
required for substrate translocation, thus, one might predict that the greater the size of the 
substituted residue, the lower the transport activity (Consler et aL, 1991).
A putative mode of operation of the transporter was suggested. Conformational 
flexibility about the prolines of helix 10 enables the alternate packing of helices 11 and 12 
against the outside substrate binding site comprising helices 7, 8 and 9, and the inner site 
located at the base of helix 10. The cytoplasmic tail at the base of helix 12 is also involved. 
Packing of this region against the base of helix 10 enables formation of the exofacial binding 
site. In the endofacial conformation, the cytoplasmic tail moves away from the base of helix 
10 exposing the cytochalasin B binding site. Retention of transport activity by the mutants 
containing glycine substitutions in this region can be rationalised on the basis that this 
residue provides a non-hindered atomic environment for conformational flexing. However, 
since Wellner etal and Tamori etal performed no detailed kinetic analyses of these mutants, 
such models are purely based upon speculation. A more thorough analysis, for example, 
measurement of the kinetic parameters associated with the binding of site-specific ligands, 
may highlight a more subtle role for proline residues in transporter function.
3 .3 .7  Mutation of Proline Residues in GLUT3.
There are several proline residues that are conserved throughout the GLUT isoforms 
(Tables 3.1 and 3.2). Regions particularly rich in prolines include transmembrane helix 6, 
including the start of the large intracellular loop at the base of this helix, and helix 10. The 
putative role of helix 10 in providing conformational flexibility required for substrate 
translocation has already been discussed above. The function of the conserved proline-rich 
motif located at the base of helix 6 has not yet been investigated. A mutagenic study was 
thus undertaken in which the proline residues located within these and other regions were 
mutated to alanine (Figure 3.3). Mutations were made at positions 203, at the base of helix; 
206 and 209, at the start of the large intracellular loop; 381, 383 and 385 within helix 10; 
399, at the base of helix 11; and 451, at the base of helix 12.
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GLUT 3 was chosen in preference to GLUTl and the other isoforms primarily due 
to the lack of information regarding the function of this transporter. In addition, there are 
distinct advantages of using GLUT3 for mutagenic studies. This isoform displays a 
relatively low for zero-trans uptake of 2-deoxy-D-glucose into Xenopus oocytes, thus 
any alteration in transport kinetics is predicted to be more measurable with this isoform 
compared to, for example, GLUT2. In order to further investigate the effects of proline 
mutations on the ability of the transporter to adopt both the exofacial and endofacial 
conformations, site-specific ligands will be used. The inhibitory effects of cytochalasin B on 
2-deoxy-D-glucose transport mediated by GLUT3 are much greater than by GLUT2, due to 
the higher affinity of GLUTS for this ligand. In addition, photolabelling of GLUT2 by 
cytochalasin B has not been successful to date (Axelrod & Pilch, 1983), and 
immunoprécipitation of GLUT2 is reported to be rather problematic (Jordan & Holman,
1992). Quantification of mutant and wild-type transporters expressed at the oocyte plasma 
membrane by comparative immunoblotting is a requirement for thorough mutant 
characterisation. The availability of membrane fractions containing known quantities of 
GLUTS favours the use of this isoform, since no such standards are available for GLUT2. 
An alternative strategy would be to perform equilibrium binding studies with 
pH]cytochalasin B, in the presence of various concentrations of non-labelled cytochalasin 
B, and in the presence or absence of D-glucose. The number of available D-glucose- 
sensitive cytochalasin B binding sites can be derived from a Scatchard analysis. Since 
cytochalasin B binds with a stoichiometry of 1:1, then the number of cytochalasin B binding 
sites is equivalent to the number of transporters at the plasma membrane. This would not be 
possible for GLUT2 since the Ka of this isoform for this ligand is so high (1.7//M - 
(Axelrod & Pilch, 1988) that the concentrations required for equilibrium binding studies 
would exceed the solubility limit of cytochalasin B in aqueous solution (about 50/fM).
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Figure 3.1
Structure and Isomérisation of a Xaa-Pro Peptide Bond.
This is a two-dimensional representation of the peptide bond formed between a 
proline and an N-terminal amino acid, denoted as Xaa. Most peptide bonds formed 
between two residues are in the trans configuration .This form is intrinsically favoured 
energetically due to fewer repulsions between non-bonded atoms. If the C-terminal 
residue is proline, however, the cyclic side chain diminishes the repulsions between 
atoms and the intrinsic stability of the cis isomer is of comparable stability to that of the 
trans form. Xaa-Pro peptide bonds can therefore undergo cis-trans isomérisation 
events, which would cause redirection of the local peptide chain.
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structure and Isomérisation of a Xaa-Pro Peptide Bond.
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Figure 3.2
Comparison of Amino Acid Sequences in Putative Transmembrane Helices 6, 10 
and 12 of the Human and Rat Facilitative Glucose Transporters.
This diagram shows a comparison of the amino acid sequences of the human 
GLUTs 1-5 and the rat GLUT? isoforms in the region of helices 6, 10 and 12. 
Conserved residues are in bold and the consensus sequence is given. GLUTS proline 
residues targeted for mutagenesis in this study are shown in red. Helix 12 contains a 
high proportion of phenylalanine residues (shown in blue), contributing to the highly 
hydrophobic nature of this segment..
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1
Figure 3.2
Comparison of Amino Acid Sequences in Putative Transm em brane Helices 6 
10 and 12 of the Human and R at Facilitative Glucose Transporters.
hGLUTl
hGLUT2hGLUT3
hGLUT4
hGLUT5
rGLUT?
Consensus
hGLUTl
hGLUT2
hGLUT3
hGLUT4
hGLUT5
rGLUT?
Consensus
hGLUTl
hGLUT2
hGLUT3
hGLUT4
hGLUT5
rGLUT?
Consensus
I------------------------- -TM6--------------   1
W P L L L S  I I F I  P A  L L Q C I V L P F C P E S F R . .
W H I  L L G L S  G V R A  I L Q S  L L L F  F C P E S P R . ,  
W P L  L L G F T  I L P  A I L Q S  A A L P F C P E S P R .
W P L  L L G L T  V L P  A L L Q  L V L L P F C P E S P R .
W P  I L L G L T  G V P  A A L Q L L L L P F F P E S P R .
W P H  L L S  L S  R I P A A L Q P A  I L P F P P E S P P .
I-------------------------- TM6------------------------ 1
* * A *  L Q * *  * L * F *  P Ë S P *
I------------------------ TMIO----------------------- 1
I V A  I F G F V A F F E V G P G P Ï P W F . .  
M I  A I F L F V  S F F E I G P G P I P W R .  
I G A I  L V F V  A F F E I G P G P I P W R .  
I V A  I F G F V A  F F E I G P G P I P W R .  
I V C V  1 S Y V I G H A L G P S P Ï P A L . .  
M T A I  F L F V S F F B I G P I P Ï F F R .
-TMIO- I
* $ $ * Y « * *  ^ G P* P I P * *.
I-------------------------------TM12----------------------------1
G P  Y V F I I F T  V L L V L  F F I  F T  Y F K V P E T K . .  
G P Y  V F  F L F  A G  V L L A  F T L  F T  F F K V  P E T  IC.. 
G A Y V F I  I F T  G F L I  T F L A  F T  F F K V P E T R . .  
G P Y V F L L F A V  L L L G  F F  I F T  F L R Y P E T R . .  
G P Y S F  I V F A V  I C L L T T  I Y I F L I  V P E T K . .  
G P Y H F W A F H G V V I  V W Y G N Y W  F K V P E T K .
I- — TM12- I
G * Y * F * * F *  * « * * * * * * * $ $ * V P E T *
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Figure 3.3
Location of Proline Residues Targeted for Mutagenesis.
This is a diagrammatic representation of the general topology of the GLUTS 
isoform based on that proposed for GLUTl by Mueckler and co-workers in 1985. The 
location of the proline residues targeted for mutagenesis in this study are shown in red, 
and their position within motifs that are conserved in the human GLUTs 1-5 and rat 
GLUT? isoforms are shown, as revealed by sequence dignments.
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Figure 3.3
Location of Proline Residues Targeted for Mutagenesis.
1
CYTOPLASM
NH2 COOH
\
Pro Residues To Be Mutated to Ala
GPGPIP Motif Conserved in GLUTs 1,2,3,4,5 & 7
VPET(K) Motif Conserved in GLUTs 1,2,3,4,5 & 7 
PE P(R) Motif Conserved in GLUTs 1,2,3,4,5 & 7
150
Table 3.1
Distribution of Proline Residues in Human GLUTs 1-5 and Rat GLUT7.
T ransporter Region hGLUTl hGLUT2 hGLUT3 hGLUT4 hGLUTS rGLUT7
N-TerminalTail 1 - 1 3 - -
TMl - - - - -
Extracellular Loop 1 2* 6* 3* 5* 2* 5*
TM2 - - - - 2
Intracellular Loop 2 - - - - - -
TM3 - - - 1 -
Extracellular Loop 3 - 1 - - _ 1
TM4 1* 1* 1* 1» 1» 1*
Intracellular Loop 4 1* 1* 1* 1* 1* P
TM5 - - - M- 1 -
Extracellular Loop 5 - _ _ - _
TM6 3 _ 3 3 3 3
Intracellular Loop 6 3** 3» * 5** 2»* 4$ »
TM7 - - - - - -
Extracellular Loop 7 1 1 1 1 1 1
TM8 - - - _ _
Intracellular Loop 8 - - - - -
TM9 - - - - - -
Extracellular Loop 9 1 - - 1 1 -
TMIO 3* * * 3* $ $ 3» * * 3* $ $ 3&*$
Intracellular Loop 10 2* 2* 2* 2* 1* 1»
TM ll - - - _ 1
Extracellular Loop 
11
- 1 - 1 -
TM12 1 1 - 1 1 1
C-TerminalTail 3* 2* 2* 4* 4* 3*
Ï
II
* represents a proline residue that is conserved in all isoforms.
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Table 3.2
Summary of the Distribution of Proline Residues in Human GLUTs 1-5 and 
Rat GLUT7.
hGLUTl hGLUT2 hGLUT3 hGLUT4 hGLUT5 rGLUT7
Total Proline Residues 23 21 21 30 25 25
TM Proline 
Residues
8 5 8 8 11 9
% TM Prolines 35% ,24% 38% 27% 44% 36%
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3 .4  Mutagenesis, Subcloning and Sequencing of GLUT3 cDNAs.
3.4.1 Introduction.
The method used for generation of mutant GLUT3 cDNAs made use of site-directed 
oligonucleotide primers and recombinant polymerase chain reaction (PGR). Oligonucleotides 
were designed to be complementary in sequence to the wild type GLUT3 cDNA in the 
region of the residues of interest except for a single base change such that alanine is encoded 
in place of proline.
3 .4 .2  Vectors.
Several vectors are available that contain the cDNA encoding individual members of 
the human facilitative glucose transporters. These are described in section 2.3.1 and are used 
as templates for the synthesis of transporter mRNAs which can be subsequently injected into 
Xenopus laevis oocytes for heterologous expression and characterisation.
The construct used in this study, pSPGT3, comprises the GLUT3 cDNA ligated into 
the multiple cloning site of pSP64T (Kayano et al., 1990), Figure 3.4. In this construct the 
protein coding region of the GLUT3 cDNA is under the transcriptional control of the strong 
SP6 promoter. SP6 RNA polymerase is a commercially available enzyme.
3 .4 .3  Recombinant Polymerase Chain Reaction.
This is a modification of the method described by Katagiri and co-workers in 1992. 
Oligonucleotides, 15 bases in length, were designed to have complementary sequences to the 
sense strand of pSPGT3 in the region of the proline residue to be mutated. A single base 
change was incorporated such that the codon corresponding to the required proline residue 
encoded an alanine. A second series of oligonucleotide primers were designed that were 
complementary to the anti sense strand of GLUT3, encompassing the same region as the 
sense strand oligonucleotide and incorporating the complementary base changes (Table 3.3).
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In addition, two 37'mer oligonucleotides were constructed that were identical to the 
untranslated regions of the GLUT3 cDNA at the 5' ends of the sense and antisense strands, 
termed G3-start and G3-end respectively (Table 3.3).
3.4.3a Primary PCR Reactions.
Two separate primary PCR reactions were performed. In the first reaction, G3-start, 
(corresponding to the 5' untranslated region of the GLUT3 sense strand) and the internal 
mutagenic primer, (corresponding to the antisense strand in the region encompassing the 
proline of interest), were incubated with pSPGT3 plasmid dsDNA. PCR under certain 
reaction conditions, (section 2.2), resulted in the production of primary PCR fragment-1 
(Figure 3.5).
A second identical reaction was carried out using G3-end, (corresponding to the 5' 
untranslated region of the GLUT3 anti sense strand) and the second internal mutagenic 
primer, (corresponding to the sense strand of GLUT3 in the region of the required 
mutation). Incubation under certain reaction conditions, again in the presence of pSPGT3, 
resulted in the production of primary PCR fragment-2 (Figure 3.5).
Both primary PCR fragments were separated by agarose gel electrophoresis and 
fragments of the correct size were identified and excised from the gel (Figure 3.6). Sizes of 
the primary products varied depending on which proline residue was mutated. DNA 
fragments were purified as described, (section 2.2.6), and used as templates for the 
secondary PCR reactions.
3.4.3b Secondary PCR Reactions.
The two PCR fragments generated in the primary reactions contain a complementary 
sequence of 20-24 bps and this forms the basis of the secondary PCR reaction. When 
incubated together under specific reaction conditions, (section 2.2), melting of the DNA 
double helix occurs and subsequent cooling enables the 3 'end of PCR fragment-1 to anneal 
to the complementary 3'end of PCR fragment-2. Each strand can then act as a primer for the
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3' extension of the opposite strand mediated by Taq or Pfu DNA polymerase, resulting in 
the generation of a full length GLUT3 cDNA sequence containing the specific point 
mutation. This then acts as a template for further amplification using the G3-start and G3- 
end external primers (Figure 3.5).
Final full length secondary PCR products were separated from non-specific products 
by agarose gel electrophoresis, excised from the gel and purified from the agarose as 
described in sections 2.2.6. Secondary fragments were then restricted with BstXI and 
EcoRV and ligated into pSPGT3 vector backbone also restricted with these enzymes (Figure 
3.7). Constructs were transformed into competent or ultracompetent JM109 E.coli cells 
(section 2.3.8 and 2.3.9). Plasmid DNA was purified from colonies (section 2.3.12) and 
screened for the required point mutation and any non-desirable mutations by automated DNA 
sequencing of both strands (section 2.4).
3.4.3c Results using Taq DNA Polymerase.
This was the initial DNA polymerase chosen to carry out the PCR reactions. Taq 
DNA polymerase is a thermostable enzyme produced from Thermus aquaticus. It is the 
theiTOOStability of Taq DNA polymerase that makes it ideal for use in PCR reactions since, 
after the initial primer extension step, the reaction mixture is heated to 95°C to allow the 
newly synthesised strands to detach from the templates (Figure 3.5). On cooling, more 
primers anneal at their respective positions, and as Taq DNA polymerase is unaffected by the 
heat treatment, a second round of DNA synthesis can take place. The reaction is continued 
through 30 cycles with DNA amplification proceeding in an exponential fashion.
After subcloning into the BstXl-EcoRX restricted pSPGT3 vector, screening of 
transformed E.coli colonies revealed that the frequency of mutant/wild-type colonies 
averaged at about 1:5, and this varied between mutants from 5:1 to approximately 1:40. 
Complete sequencing of the cDNAs revealed that, although the required mutation was often 
present, the error rate of Taq DNA polymerase was such that, on average 2 bps in every 
thousand was misincorporated into the final product. This is due to the absence of 3' to 5' 
exonuclease proof-reading activity of this enzyme. Therefore, upon identification of
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misincorporations occurred within the original BstXl-EcoRV cloning fragment, usually in 
close proximity to the required proline mutation.
1
sequence errors, the pSPGTS sequence was scanned for the presence of suitable unique 
restriction sites located within the coding sequence. These sites must be located at a distant 
far enough away from the desired proline mutation to produce a restriction fragment long 
enough to be restricted and subcloned into wild type pSPGTS, free from any such 
misincorporations. This however was not possible in the majority of cases, since most of the
cl
3.4.3d Results using Pfu  DNA Polymerase.
In an effort to address the infidelity problem associated with the use of Taq DNA
: iipolymerase, Pfu DNA polymerase, isolated from Pyrococcus juriosus, was used to generate 
the PCR fragments. Pfu DNA polymerase has 3'-5' exonuclease proof-reading activity and 
therefore has a much higher fidelity than Taq DNA polymerase, incorporating errors 30-fold 
less frequently. Reaction conditions used for Pfu DNA polymerase were similar to those
used for Taq DNA polymerase with some differences in the protocols (sections 2.2.2 to 
2.2.5). The major difference is the step at which Pfu DNA polymerase is added to the PCR
reaction mixture. Pfu DNA polymerase is much less stable than Taq DNA polymerase at 
high temperatures and is therefore added after the initial 95°C melting step. The yield of the 
PCR products generated by Pfu DNA polymerase was noticeably reduced, particularly with %3Kregard to the secondary products which were observed to be generally lower than the %
liprimary product yields. This observation was attributed to the thermo-instability of Pfu DNA
■lipolymerase relative to Taq DNA polymerase, and also due to the much lower extension rate ■Iof Pfu DNA polymerase (lkb/4mins and Ikb/min for Pfu and Taq, respectively)
The higher fidelity of Pfu DNA polymerase resulted in a higher ratio of mutant / i|
wild-type clones that, upon sequencing, were found to contain no misincorporations.
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3.4.4 Sequencing of Subclones.
Automated DNA sequencing was carried out as described in section 2,4. This 
method can be used to sequence up to 500 bps of ss or dsDNA from the site of primer 
binding, although only the first 300-350 bps are generally accurate. Sequencing Grade Taq 
DNA polymerase was used in all sequencing reactions. As this enzyme exhibits thermal 
stability at temperatures of up to 95°C, higher reaction temperatures can be used in the 
sequencing cycles. This decreases the secondary structure of the DNA template and therefore 
allows polymerisation through regions of the DNA containing strong secondary structure. 
High temperatures also increase the stringency of primer hybridisation. In the case of each 
mutant, both strands of the cDNA spanning the entire protein coding region was sequenced. 
This enabled confirmation of the required mutation and detection of any base 
misincorporations or errors that may have occurred during the PCR reactions and subcloning 
procedures. To facilitate this, a series of oligonucleotide primers were synthesised (Table 
3.4) and their annealing sites were designed such that the sequence obtained from one primer 
overlapped with that obtained from another (Figure 3.8). Sequence alignments and 
comparisons were analysed using Biosoft GeneJockey II software on an Apple Macintosh 
Performa 400 computer. Representative ABl chromatograph traces are shown in Figures 3.9 
and 3.10 for mutant wild type and GLUT3 sequences.
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Figure 3.4
Diagrammatic Representation of pSPGT3 Showing the Binding Positions of the 
PCR Primers.
The GLUTS cDNA was cloned into the pSP64T as a Bgl lllBamH I fragment 
into the untranslated regions of the Xenopus B-globin gene, which had previously been 
cloned into the multiple cloning site of pSP64T (Krieg and Melton, 1984). Thus, the 
GLUTS cDNA is flanked by 89bps of 5' untranslated region (UTR) and 141bps of the S' 
untranslated region. This serves to stabilise the in vitro synthesised mRNA in Xenopus 
oocytes. In addition, there is an SP6 polymerase promoter located 5' to the GLUTS 
cDNA and flanking sequences, and an ampicillin resistance gene for selection purposes.
Also indicated on the diagram are the oligonucleotide primers used for 
generation of the GLUTS Pro-Ala mutants. The external primers are referred to as G3- 
start and G3-end and they are complementary in sequence to the 3' and 5' untranslated 
regions flanking the GLUTS cDNA. The internal primers are mutagenic 
oligonucleotides and these are complementary in sequence to the GLUTS cDNA in the 
region of the proline residue to be mutated, with the exception of a single base change 
such that the proline is replaced by an alanine.
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Figure 3.4
Diagrammatic Representation of pSPGT3 Showing the Binding Positions o f  
the PCR Primers.
5' Xenopus UTR
G3-start
Amp resistance
BstXI(761)
GLUT3cDNA
pSPGT3
5696 bp
G3-end
Mutagenic primers
EcoRV(1632)
(2290) ^ Xenopus UTR
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Table 3.3
Mutagenesis Oligonucleotides.
Sequence Mutation
anti sense strand 
sense strand
ACGGGTGTCTGCGACTTTGAAGAA
TTCTTCAAAGTCGCTGAGACCCGT
Pro451->Ala
Pro45l_>Aia
antisense strand 
sense strand
CATCGCAGCTGCGCGGGGGCCCTG
CAGGGCCCCGGCGCAGCTGCGATG
Pro399_>Ala
Pro399_>Ala
antisense strand 
sense strand
AATAAACCAGGCAATGGGGCCTGG
CCAGGCCCCATTGCCTGGTTTATT
Pro385_>Ala
Pro385_>Ala
antisense strand 
sense strand
CCAGGGAATGGCGCCTGGTCCAAT
ATTGGACCAGGCGCCATTCCCTGG
Pro383_>Ala
Pro383_>Ala
antisense strand 
sense strand
AATGGGGCCTGCTCCAATTTCAAA
TTTGAAATTGGAGCAGGCCCCATT
Pro38l„>Aia
Pro381_>Ala
antisense strand 
sense strand
CAAAAATCTGGCACTTTCAGGGCA
TGCCCTGAAAGTGCCAGATTTTTG
Pro209_>Ala
Pro209_>Ala
antisense strand 
sense strand
GGGACTTTCAGCGCAAAATGGAAG
CTTCCATTTTGCGCTGAAAGTCCC
Pro206_>Ala
Pro206_>Ala
antisense strand 
sense strand
AGGGCAAAATGCAAGGGCTGCACT
AGTGCAGCCCTTGCATTTTGCCCT
Pro2tB_>Ala
Pro203_>Ala
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Table 3.3 (cont.)
Complementary
Sequence Sequence
G3-end GTCGACGTCGACGAGGGAGAGGT
(antisense strand) GGCTTTCCCATGCC
G3-start 
(sense strand)
GTCGACGTCGACTCACCCCTAGATC
TTCTTGAAGAC
Binds to 
sense strand at 
3’UTR
Binds to anti­
sense strand at 
3'UTR
Codons that contain the single base change such that alanine is encoded in place 
of proline are underlined.
1 6 1
#
Figure 3.5
Generation of GLUT3 Pro-Ala Mutant cDNAs by Recombinant PCR Reactions.
This diagram shows the binding positions of the reaction primers to the GLUT3 
cDNA template, followed by the sequence of events in both the primary and secondary 
PCR reactions. Two separate primary reactions are carried out, each using a specific 
combination of PCR primers. In reaction I, GLUTS template (pSPGTS) is incubated in 
the presence of G3-start and the mutagenic primer corresponding to the antisense strand 
of the GLUTS cDNA. Under certain reaction conditions, the GLUTS template strands 
melt, allowing the annealing of the primers to the template strands. New strands are 
then extended from these primers in the 5' to 3' direction by Taq or Pfu DNA 
polymerase (dotted lines). Melting, reannealing and extension occurs a further 30 times 
producing primary PCR product-1 corresponding to the 5' portion of the GLUTS cDNA 
with the Pro-Ala mutation located at the 3' end of the fragment (corresponding to the 
sense strand). In reaction 2, the second mutagenic primer in combination with G3-end 
are used, in essentially the same reaction as that described for reaction 1, to generate 
primary PCR product-2. This product corresponds to the S' end of GLUTS (sense 
strand), with the Pro-Ala mutation located at the 5'end of the fragment.
In the single secondary PCR reaction, equal quantities of the two primary PCR 
products are used as templates for a second round of reaction cycles using GS-start and 
G3-end primers. In the initial stages of the process the two templates melt and reanneal 
to form a single template. This is possible due to the presence of a short overlapping 
sequence of 18-24bps between the 3'end of the sense strand of primary PCR product-1 
and the antisense strand of primary PCR product-2, corresponding to the region of the 
Pro-Ala mutation. In the initial few cycles, these strands anneal and are extended in the 
5' to 3' direction (dotted lines) to form a full length secondary PCR product, which can 
then act as a template for the subsequent amplification with G3-start and G3-end. Only 
the sense strands of each of the primary PCR products can be extended after 
association, since binding of the antisense strand of product-1 and sense strand of 
product-2 leads to a complex which can not be extended in the 5' to 3' direction. In 
addition, the formation of product-1/product-2 complexes is relatively infrequent when 
compared to the frequency of self association of the primary product strands. Both these 
factors lead to lower secondary PCR yields than those obtained in the primary PCR 
reactions.
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Figure 3.5
G e n e r a tio n  o f  G L Ü T 3 P ro -A la  M u tan t cD N A s by R e c o m b in a n t PC R  
R e a c tio n s .
5 ’
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Sal I V_
G3st
I
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G3ed
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length product using 
external primers
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PRODUCT
Sal I
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Figure 3.6
1% Agarose Gel of PCR Products and Vectors Used for Cloning of GLUT3 Pro- 
Ala Mutants.
This shows photographs of various PCR products and vector cDNAs which 
have been subjected to 1% agarose gel electrophoresis and stained with ethidium 
bromide. Gel 1, Lane 1 contains 0.625/#g of BstP. Il-digested lambda DNA; Lane 2, 5jA 
(from total of 60}Â) of primary PCR product-1 generated using Pfu DNA polymerase; 
Lane 3, 5pi\ (from total of 60/<l) of primary PCR product-2 generated using Pfu DNA 
polymerase; Lane 4, 5]Â (from total of 20;<1) of secondary PCR product generated using 
Pfu DNA polymerase; Gel 2, Lane 1, contains 0.625^g of Bst^  Il-digested lambda 
DNA; Lane 2, 3pil (from total of 20/d) purified BstX l/EcoR V-digested pSPGTS 
vector, Lane 3 ,3/d (from total of 200/d of maxi-preparation of plasmid DNA) pSPGTS 
containing the Pro^^ÔAla mutation.
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Figure 3.6
1% Agarose Gel of PCR Products and Vectors Used for Cloning of GLUT3 
Pro-Ala Mutants.
Lane Lane 1 2 3
8454bps
5686bps
3675bps
2323bps
1929bps
1371bps1264bps
702bps
8454bps
5686bps
4822bps4324bps
3675bps
2323bps
1929bps
1371bps
1264bps
702bps
Gel 1 Gel 2
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Figure 3.7
Subcloning of Secondary PCR Products into pSPGTS.
pSPGTS was digested with BstX I and EcoR V to remove a 871 bp fragment of 
GLUTS, and the backbone vector purified. Secondary PCR products were also digested 
with the same enzymes to yield a fragment of 871bps which was subsequently purified 
and ligated into the BstX I!EcoR V sites of the pSPGTS backbone vector. This produced 
an intact pSPGTS vector incorporating a Pro-Ala mutation.
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Figure 3.7
Subeloiiing of Secondary PCR Products into pSPGT3.
5’ Xenopus UTR 
SP6
Secondary PCR 
product
BstXI (761)
Amp resistance
GLUT3cDNApSPGT3
5696 bp
Subclone
EcoRV(1632)
Pro-Alamutation
EcoRV(1632)
3' Xenopus UTR
bal
(2290)
Î
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Table 3.4
Sequencing Oligonucleotides.
G36T
G35T
G34T
G33T
G33T+
G32T
G31B
G32B+
1/535
G33B
G34B
G35B
G36B
GCTGTGATATTTGCC
CTGTGTAAAGTAGCT
CCTGAAAGTCCCAGA
ATCGGCGCGGGTGTG
ATCTATGCCACCATC
ACTGGACCTCCAACT
GGGAGAGGTGGCTTT
TAAATAGTGAGCAGC
ACAGTCATGAGCGTG
GTAGCTGGACACTCT
TGAGCAAAAATCTGG
AGCTACTTTACACAG
GGCAAATATCAGAG
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Figure 3.8
Diagram of the Binding Positions of Sequencing Oligonucleotides in the GLUT3 
cDNA.
This is a diagrammatic representation of the GLUTS cDNA coding sequence 
from the 5'end of the sense strand to the 3 'end. Position "0" corresponds to base "0" in 
pSPGTS. The GLUT3 open reading frame (ORF) begins at position 255 and ends 
(STOP) at position 1743. The approximate positions of the restriction enzymes used in 
the cloning procedures are shown, and the locations of the proline residues targeted for 
mutation are shown in red. The annealing positions of G3-Start and G3-End are shown 
in blue. Sequencing primers, shown in green, pointing from left to right and depicted 
above the GLUTS cDNA bind the antisense strand and are used to generate 300-350bps 
of cDNA sequence to their right. Primers pointing from right to left and depicted below 
the GLUTS sequence bind to the sense strand and are used to generate 300-350bps of 
cDNA sequence to their left. Comparison of the sequences generated by all the primers 
is sufficient to accurately describe the entire GLUTS cDNA sequence. Initial screening 
for the required Pro-Ala point mutation was achieved by utilising either G32B+ or 
G33B, depending on the position of the mutation. These primers were found to yield 
accurate sequences in the regions of the mutations.
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Figure 3.8
Diagram of the Binding Positions of Sequencing Oligonucleotides in the 
GLUT3 cDNA.
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Figure 3.9
ABI Trace of GLUTS Sequence Showing the Pro Ala Mutation.
The chromatograph shows part of the GLUTS cDNA sequence in the region 
encompassing the Pro^^^Ala mutation. The sequence of bases corresponding to each of 
the peaks is shown above the chromatograph and the single C-G mutation is indicated 
by the arrow. Data was generated by a 373A Automated DNA Sequencer, incorporated 
by an ABI Data Collection Program and analysed by an ABI Data Analysis Program.
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Figure 3.9
ABI Trace of GLUT3 Sequence Showing the Pro Ala Mutation.
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Figure 3.10
ABI Trace of Wild Type GLUT3 Sequence in the Region of Pro^^l.
The chromatograph shows part of the wild type GLUTS cDNA sequence in the 
region encompassing Pro^^l. The sequence of bases corresponding to each of the peaks 
is shown above the chromatograph. The single base targetted for mutation such that 
alanine is encoded in place of proline in the Pro^^^Ala mutant is indicated by the 
arrow. The data was generated by a 373A Automated DNA Sequencer, incorporated by 
an ABI Data Collection Program and analysed by an ABI Data Analysis Program.
173
Figure 3.10
ABI Trace of Wild Type GLUT3 Sequence in the Region of Pro^^l.
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3 .5  Discussion.
Despite the complexity of the mutagenic data, a number of interesting features have 
emerged from these studies. Many of the highly conserved residues such as Trp^^, Asn^^, 
Asn288  ^ Gln282  ^ Asn^l^ and most of the tyrosine residues of GLUTl can be mutated 
without any significant effect on transport activity. Thus, the selective pressure for 
maintaining these residues may be attributed to other essential functions such a protein 
folding rather than transporter activity. On the other hand, there are several point mutations 
that do severely diminish transporter function for example, Gln^^l, Val^^^, Tyr^93 and 
Pro^^^ of GLUTl. It may be that these residues are required to exist in a precise location 
such that they can participate in hydrogen bonding or hydrophobic interactions. Evidence 
emerging from chimeric studies suggest that much of the divergent transport kinetics 
exhibited by the different isoforms can be attributed to the more variant sequences.
This study investigates the role of conserved proline residues in the human GLUTS 
isoform. A survey of the bilayer-spanning regions of integral membrane proteins revealed 
that nearly all transport proteins examined contained proline residues that were evenly 
distributed between aqueous and membranous domains (Brandi and Deber, 1986). This 
observation led to the proposal that membrane-buried proline residues have a specific 
function in transport proteins, possibly contributing to protein folding, membrane insertion 
and/or stability. They may also be directly involved in the transport process due to the 
unique cis-tmns isomérisation property of the preceding peptide bond formed with proline 
residues.
Transmembrane proline residues have been the target of mutagenic investigation in a 
variety of membrane transport proteins. The lac permease of E.coli is one example of such a 
study. The importance of the cis-tram isomérisation of peptide bonds preceding nine 
transmembrane proline residues in the transport event was investigated by mutation of each 
residue to alanine and glycine (Consler et al., 1991). Since cis-trans isomérisation is a 
property unique to proline peptide bonds, then replacement should render the transporter 
inactive. Although glycine and alanine substitutions at position 192 resulted in lower steady- 
state levels of lactose accumulation, it was concluded that the cis-tram isomérisation event is
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not an absolute requirement for transport activity. In the same study, the importance of 
possible structural discontinuities arising as a consequence of prolyl replacement with either 
helix-breaking (glycine) or helix-promoting (alanine and leucine) residues was addressed.
There appeared to be no correlation existing between activity and the ability of a substituted 
amino acid to make or break a-helical structure, although some substitutions led to partial 
uncoupling. In the absence of a high-resolution structure and the lack of any detailed kinetic 
analysis of the mutants, it is difficult to define a precise role for transmembrane proline 
residues in this study. Other studies have suggested structural and/or dynamic roles for i
transmembrane prolines for example, in the "channel gating" mechanism of the E.coli
phosphate-specific transport system (Wellner et al., 1992) and in the isomérisation events 
crucial to the proton pump mechanism of bacteriorhodopsin (Gerwert et al., 1990; Tuzi et 
a l, 1994).
The human GLUT isoforms also contain a high proportion of transmembrane proline 
residues. GLUTl for example, contains twenty three proline residues and of these, eight are 
harboured within membranous domains. Interestingly, helices 6 and 10 each contain three 
proline residues with the unique proline-rich domain G^^^PGPIP of helix 10 conserved in 
all mammalian facilitative glucose transporter isoforms (Figures 3.2 and 3.3). In fact, 
sequence alignment of the human isoforms, GLUTs 1-5, and the rat GLUT? isoform reveal 
several interesting features, summarised in Table 3.2. Each isoform contains between 21 and 
30 prolines of which ten are 100% conserved. A further six are more than 80% conserved 
i.e. present in five of the six isoforms. The large intracellular loop connecting helices 6 and 7 
contains the PESPR motif which is located within one residue of the putative end of helix 6 
(Figure 3.3). The large extramembraneous regions of the transporters including the 
extracellular loop connecting helices 1 and 2, the intracellular loop connecting helices 6 and 7 
and the C-terminal cytoplasmic tail appear to be particularly rich in proline residues, at least 1
■■ ■■>
of which is 100% conserved implying a structural role.
The large body of experimental evidence in support of the existence of two distinct
■ii.
alternating conformational states (section 1.6 and 1.7), and the previously discussed 
proposals regarding a role for transmembrane prolines in membrane transport proteins 
prompted investigations into the functional importance of the highly conserved Pro-rich
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sequences located within helices 6 and 10 of GLUTL Molecular modelling and molecular 
dynamics studies suggested that prolines 383 and 385 could be particularly important in 
facilitating the alternate opening and closure of the exofacial binding site (Hodgson et ah, 
1992). This hypothesis was directly investigated by the mutation of Pro^SS to isoleucine 
which resulted in a loss of GLUTl transport activity and labelling by ATB-BMPA, but 
retention of cytochalasin B labelling suggested that the transporter is locked in an endofacial 
conformation (Tamori et al., 1994). Based on these observations, a putative model was 
proposed in which the prolines of helix 10 provide a point of conformational flexibility such 
that helices 11 and 12 can alternately pack against the exofacial binding site comprising 
helices 7, 8 and 9, or against the endofacial site at the base of helix 10. Retention of wild- 
type 2-deoxy-D-glucose transport rates were observed upon replacement of each of the 
proline residues located within helix 6 of GLUTl with alanine. Thus, it was concluded that 
the presence of proline in any of these positions is not an absolute requirement for transport 
activity. Replacement with more bulky residues significantly reduced transport rates but this 
was attributed to reduced targeting of the protein to the plasma membrane. Whilst such 
conclusions question the role of transmembrane proline residues in GLUTl, no information 
regarding the kinetics of the transport event were provided. It is possible then that subtle 
alterations in the transporter structure and function may have been overlooked.
3 .6  Summary.
Proline residues located at positions 203, 206 and 209 at the base of helix 6, 381, 
383 and 385 within helix 10,388 at the start of helix 11 and 451 at the base of helix 12 of 
GLUT3 were individually mutated to alanine. PGR technology was used to alter the base 
sequence of GLUT3 such that alanine was encoded in place of the prolines of interest. 
Mutated PGR fragments were subcloned into the pSPGT3 vector and the sequence of both 
strands were scanned for the presence of the required point mutation and any 
misincorporations that may have arisen during the PGR and cloning procedures.
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CHAPTER 4
Functional Studies of Heterologously Expressed 
Pro-Ala Mutants 
in Xenopus laevis Oocytes.
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4 .1  Aims
1. Mutant (Pro-Ala) and wild type GLUTS cDNAs will be used as templates for in vitro 
synthesis of niRNA. Subsequent injection of this mRNA into Xenopus laevis oocytes will 
allow kinetic characterisation of the heterologously expressed transporters.
2 . To measure Km values for zero-trans entry of 2-deoxy-D-glucose by each mutant.
Parameters for the wild-type GLUTS transporter will be determined in parallel.
3 . To investigate the effects of the site-specific ligands maltose and cytochalasin B on
the zero-trans uptake of 2-deoxy-D-glucose by GLUTS and Pro-Ala mutants.
4 . To discuss the results in temis of the proposed models for transporter structure.
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4 .2  Introduction.
4 .2 .1  General Information Regarding GLUT Tertiary Structure.
The major factor hindering the elucidation of the precise molecular mechanism of 
facilitative glucose transport across the cellular plasma membrane is the lack of a crystal 
structure defining the tertiaiy arrangement of the protein. In fact, the current knowledge 
regarding membrane transport protein structure and function is limited such that it is difficult 
to make accurate predictions in the absence of characterised models. However, a wealth of 
experimental data has been obtained to support the topological model of GLUT 1 (and the 
other GLUT isoforms) predicted by Mueckler, based on amino acid sequence alignments 
and hydropathy analyses (Figure 1.2). According to this model, transmembrane helices 3 ,5 , 
7, 8 and 11 are moderately amphipathic and, therefore, the protein is suggested to 
accommodate a water-filled glucose channel. Hydrogen-tritium and hydrogen-deuterium 
exchange data (Jung et al., 1986) obtained from studies using purified GLUTl is consistent 
with this prediction. Various spectroscopic techniques have been used to probe the 
secondary structural motifs of the protein, revealing a high helical content. The putative 
disposition of the hydrophilic loops connecting transmembrane helices and the N- and C- 
terminal segments have been confinned, although the sizes of the loops and the precise 
helical boundaries are not irrefutable.
A prime area of interest is the relationship between transporter structure and the 
mechanism of substrate translocation. Extensive biophysical and biochemical data exists to 
support the occurrence of large conformational changes occurring during transport catalysis. 
Two distinct conformational states exist such that alternation between the two allows 
sequential exposure of substrate to either side of the membrane. Exofacial and endofacial D- 
glucose binding sites have been demonstrated to be structurally separate, and the regions of 
the transporter that interact with site-specific ligands have been mapped to distinct areas of 
the protein. Mutagenic studies have highlighted specific residues or sequences within the 
protein that are crucial for substrate binding or for conformational changes (Figure 1.6).
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Glucose transport is a dynamic event that represents a reversible conformational 
process, dictated ultimately by the protein's amino acid sequence. The information regarding 
the actual amino acids involved in this process is minimal at present. Transmembrane helices 
are characterised by a preponderance of hydrophobic residues such as valine, leucine, 
isoleucine, alanine and phenylalanine. The somewhat surprising selective inclusion of 
proline, a classical breaker of ct-helical structure, in transmembrane helices (discussed in 
section 3.3) has prompted a variety of studies, utilising mutagenesis and modelling of Pro- 
containing helices, to investigate their functional importance in membrane spanning regions 
of proteins. Two distinct roles have been suggested in the literature- proline can act in a 
structural capacity (section 3.3.2b) or can have a more dynamic role through cis-trans 
isomérisation of Xaa-Pro peptide bonds (section 3.3.2c).
4 . 2 . 2  Conclusions from Previously Investigated Proline Residues of 
GLUTl.
Highly conseiwed Pro-containing motifs have been identified in the GLUT isoforms 
(section 3.3.6) and several transmembrane proline residues of GLUTl have been the target 
of mutagenic studies. One such study by Tamori and co-workers in 1994 investigated the 
relationship between conformational changes and the presence of proline and glycine 
residues in helix 10 (Tamori et al., 1994). Pro^^^ was targeted since it is located within the 
conserved GPGPIP sequence that has been implicated in the opening/closing of the 
exofacial binding site (Hodgson et ah, 1992). Reduced zero-trans uptake of 2-deoxy-D- 
glucose into CHO cells was observed when this residue was replaced by isoleucine (but not 
alanine or glycine). Reduced transport, abolishment of exofacial ATB-BMPA photolabelling 
and normal levels of cytochalasin B photolabelling led the authors to suggest that the ability 
of the protein to adopt the exofacial binding site was impaired as a direct consequence of the 
mutation (Data summarised in Table 4.1). No such effects were observed when Pro^^^ was 
replaced by alanine in this study, which appears to have overlooked the fact that transport of 
2-deoxy-D-glucose is a series of events involving substrate binding to the exofacial site, 
transporter reorientation to the endofacial conformation, dissociation of the substrate from
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the endofacial binding site and reorientation of the unloaded transporter to the exofacial 
conformation. Thus, it is possible that the effects of mutation of a single proline residue to 
alanine are not manifested in an altered overall rate of transport. Other aspects of the 
translocation mechanism may well have been altered and these effects may not be detectable 
by single measurement of transport rates at a single substrate concentration. A more 
extensive kinetic analysis of the mutants would define a more precise role for the proline 
residue. Effects mediated at the exofacial substrate binding site can be investigated by 
deteiTuining values for zero-trans influx of substrate using a range of external sugar 
concentrations. Subtle effects at either of the binding sites caused by the mutation are more 
likely to be detected by the use of non-transportable site-specific ligands.
A second study was undertaken in which the role of proline residues located within 
helices 6 and 10 were investigated, again using a mutagenic approach (Wellner, 1995). 
Individual replacement of prolines at positions 187, 196 and 205, within helix 6, to alanine 
resulted in retention of wild type transport activity, suggesting that the presence of prolines 
at each of these positions is not an absolute requirement for transport catalysis. The same 
substitutions, this time within helix 10, also resulted in retainment of wild type transport 
activity, however, the lack of a more extensive kinetic analysis of these mutants prevents 
detection of more subtle roles for these residues in transporter function.
4 .2 .3  Use of Site Specific Ligands as Transport Inhibitors.
Cytochalasin B is a non-competitive and competitive inhibitor of D-glucose influx 
and efflux, respectively, and thus, is proposed to interact with the endofacial side of the 
transporter. Since cytochalasin B competitively inhibits D-glucose binding at the endofacial 
binding site and vice versa, their sites of interaction with the transporter are proposed to be 
the same. In addition, the binding moiety of cytochalasin B has an arrangement of oxygen 
atoms that can be superimposed onto that of D-glucose. Therefore, the hydrogen bonding 
patterns formed between the transporter and cytochalasin B are predicted to be similar to 
those formed with D-glucose. Both GLUTl and GLUT3 have similar affinities for 
cytochalasin B (Ki values of '^2pM for both isoforms).
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Measurement of Ki values for cytochalasin B inhibition of substrate transport gives 
an estimation of the relative affinity at the endofacial binding site, proposed to be in the 
region at the base of helix 10 (Figure 1.6).
Maltose is a disaccharide composed of two D-glucose molecules joined by an a-(l- 
4) glycosidic linkage (Figure 4.2). It is a competitive inhibitor of D-glucose influx, and is 
therefore proposed to interact at the exofacial D-glucose binding site. Maltose is not 
transported due to steric hindrance. Therefore, measurement of Ki values for maltose 
inhibition of D-glucose influx are independent of the transporter turnover number, 
representing an effect mediated at the exofacial binding site only. GLUTl and GLUTS have 
similar reported values for maltose inhibition of 2-deoxy-D-glucose influx (20-30mM).
4 .3  Heterologous Expression of Proteins in Xenopus laevis Oocytes.
4 .3 .1  Use oi Xenopus laevis Oocytes.
Since the demonstration by Gurdon and co-workers in 1971 that Xenopus oocytes 
could efficiently translate exogenous mRNAs injected into their cytoplasm, the oocyte has 
become a favoured system for the study of transcript processing and translation (Gurdon et 
aL, 1971) . During oogenesis, the oocyte accumulates a vast cellular store of enzymes and 
organelles which are required for the early stages of development. Thus, an isolated oocyte 
can essentially be viewed as a miniature protein synthesis factory, containing --200,000 
more ribosomes and 10,000 more tRNAs than a typical somatic cell. The ability to rapidly 
and efficiently translate exogenous mRNA (or cRNA), coupled to the ability to correctly 
modify polypeptides by phosphorylation, glycosylation, cleavage of precursor proteins and 
assembly of multi-subunit proteins, has led to the extensive use of this system.
Oocytes that are ready for use, i.e. those that translate exogenous mRNA most 
efficiently, are at stage IV or V of development. They are the largest oocytes, and are 
characterised by a distinct sharp boundary between the animal (dark) and vegetal (pale 
green/yellow) poles. Healthy oocytes exhibit a uniform pigmentation of the animal pole.
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They are isolated from the toad by surgery and dissected from the surrounding vascular 
network and connective tissue prior to use (section 2.6.4).
Heterologous expression of proteins can be achieved in two ways: by microinjection 
of in vitro transcribed mRNA into the oocyte cytoplasm, or by microinjection of plasmid 
DNA into the nucleus. Although both methods result in adequate levels of protein expression 
for functional studies, microinjection of mRNA into the cytoplasm is much less technically 
demanding and thus, is the most commonly used approach. Typically, 50nl of -'Img/ml 
mRNA is injected into each oocyte. An incubation period of 48 hours in physiological 
medium (Barths - Table 2.1) results in sufficient levels of protein expression to allow 
accurate determination of transport activity in individual oocytes by quantitation of 
radiolabelled sugar accumulation.
4 .3 .2  Expression of Glucose Transporter Isoforms.
The low endogenous glucose transport rates exhibited by non-injected oocytes make 
them an ideal system in which to probe the structure-function relationship of glucose 
transporters utilising mutagenesis.
Translation and processing of injected GLUT mRNA (encoding a particular isoform) 
enables kinetic data to be obtained, essentially, for a single transporter isoform. Previously, 
it has been demonstrated that the rates of sugar transport for water-injected oocytes and non­
injected oocytes are identical (Gould & Lienhard, 1989),. This can be a problem in other cell 
types and thus, subtraction of water-injected values gives a value that represents that of the 
injected transporter only. Oocytes were initially used for a kinetic analysis of GLUTl 
(Gould & Lienhard, 1989), and since then, many groups have utilised oocytes for 
expression and characterisation of other GLUT isoforms, in addition to various chimeric 
transporters and other mutant transporters. GLUT2 and GLUT3 exhibit high rates of 3-0 
-methyl-D-glucose transport in oocytes, typically 20-fold higher than rates observed for non­
injected oocytes. GLUT4 expressing oocytes exhibited much lower rates of transport, 
consistent with the proposed intracellular localisation of this isoform. A variety of kinetic 
parameters have been measured for GLUTs 1, 2, 3 and 4 utilising this expression system
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(Table 4.2), including Km values for 2-deoxy-D-glucose zexo-tmns influx, 3-O-methyl-D- 
glucose transport (under both zero-trans influx and equilibrium exchange conditions) and 
alternative transported substrates. For example, GLUT2 has been demonstrated to be 
capable of D-fructose transport, whereas GLUT3 is capable of D-galactose transport to a 
greater extent than the other isoforms. These observations have formed the basis of other 
studies by this group in which the structural requirements of sugar binding to these isoforms 
were investigated using a variety of sugar analogues (Colville et aL, 1993a). A range of 
GLUT2/GLUT3 chimeric transporters were also generated, with a view to identifying the 
regions of GLUT2 and GLUT3 that are involved in substrate recognition and high affinity 
glucose binding (Arbuclde et aL, 1996).
The generation of specific point mutations within the transporters, coupled to the 
subsequent expression and analysis of the mutant proteins in oocytes or cultured cells, have 
provided important insights into the transport mechanism. Crucial residues that participate in 
various aspects of substrate translocation have been identified from such studies. Residues 
may interact directly with the transported sugar molecule or may act in a structural capacity to 
mediate the conformational changes requisite for translocation or formation of the binding 
sites. A putative role for proline residues in membrane protein function has already been 
discussed in Chapter 3 of this thesis.
Here a kinetic analysis of various mutant GLUT3 proteins heterologously expressed 
in Xenopus oocytes is presented to examine the role of conserved proline residues in 
GLUT3 function (Chapter 3 and Figure 3.3). Km values for zero-trans entry of 2-deoxy-D- 
glucose have been determined for each Pro-Ala GLUT3 mutant and the wild type 
transporter, for comparison. To establish whether any effects caused by the mutations are 
manifested in the ability of the transporter to correctly adopt endofacial and exofacial 
conformations, the inhibitory effects of the site-specific ligands cytochalasin B and maltose 
on 2-deoxy-D-glucose zero-trans 'mümi were measured. These results are discussed in terms 
of the proposed structural models for the transporters.
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Table 4.1
Summary of the Kinetic Data Available for Human GLUTl Proline Mutants.
Mutation Expression
System
Transport
Activity
Km Cytochalasin B 
Binding
ATB-BMPA
Binding
P187A Oocyte wt n.d
P187H I I wt I I
P196A 11 wt I I
P196R fl i I I +
P383A !l wt I I
P383Q 11 I I
P385A f( wt I I
P385Q i r I I
P387A u wt I I
P387Q n i I I
P383A
+P385A
I I wt I I
P385I CHO I I wt .
P385G u wt I I t
wt indicates comparable or identical to wild type GLUT 1.
t j indicates parameter was significantly increased or reduced respectively relative to
the wild type.
+ indicates activity was observed.
indicates no detectable activity (<5% wt). 
n. d not determined.
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Figure 4.1
Models of the Interaction of 6-D-Glucose with GLUTs 1 and 3.
These are generalised models showing the interactions formed between B-D- 
gliicose and GLUTl (a) and GLUT3 (b) at the exofacial binding site. Hydrogen bonds 
are illustrated by dashed lines and the C-6 hydrophobic interactions are shown by a 
dashed triangle. The hydrogen bond formed at the C-4 position of GLUT3 is likely to 
be less significant in substrate binding than with GLUTl and the other isoforms, 
(shown in red), since GLUT3 binds D-galactose, the C-4 epimer of D-glucose.
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Figure 4.1
Models of the Interaction of B-D-Glucose with GLUTs 1 and 3.
(a)
Œ2OH #
Ô
(b )
CH2OH ^
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Figure 4.2
Structure of B-D-GIucose and B-D-Maïtose.
This diagram shows the structures of p-D-glucose and p-D-maltose. Maltose is 
a disaccharide of D-glucose in a «(1-4) glycosidic linkage. Maltose is used as an 
inhibitor of sugar transport as it can bind to the transporter but is not transported.
The C-1 position of the first glucose "subunit" of maltose enters the exofacial 
binding pocket of the transporter in a "D-glucose-like" manner. The sugar hydroxyls at 
positions C-3 and C-6 are also analogous, so it is expected that these will interact with 
the binding site in a " p-D-glucose-like" manner. However, the bond with the C-4 
hydroxyl will not be formed because this carbon is involved in the glycosidic linkage 
with the other glucose "subunit" of maltose. This other glucose unit effectively acts as a 
large bulky group at the C-4 position of the first glucose unit, which prevents closing of 
the transporter around the sugar molecule. It is possible that the interaction of the C-3 
and C-6 carbons with the exofacial binding site may also be affected by the presence of 
the large bulky substituent at the C-4 position.
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Figure 4.2
Structure of B-D-Glucose and B-D-Maltose.
HOi
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Table 4.2
Kinetic Parameters of the Glucose Transporter Isoforms Expressed in 
Oocytes.
Isoform
Km  (mM)
DeGlc zero-trans entry (mM)
3-O-MGequilibriumexchange(mM)
Alternative substrates
GLUTl 6.9+1.5 20.9 +2.9 Galactose (K ^  17mM)
GLUT2 11.2+1.1 42.3+4.1 Fructose (Æm 66mM)
GLUTS 1.4+0.06 lO .^ l.S Galactose (Æ^ 8.5mM)
GLUT4 4.6+0.3 1.8 Not studied in oocytes
GLUT5 n.d. n.d. Fructose* (isTm 6mM)
The data from this table was taken from results published in a number of studies (reviewed
in Gould & Holman 1993).
n.d.  - no data, substrate not transported.
* Fructose is the preferred substrate of GLUT5, not the alternative substrate.
191
4 .4  Results.
4 .4 .1  Transport of 2-Deoxy-D-Glucose by GLUT3 Pro-Ala Mutants into
Xenopus Oocytes.
After construction and sequencing of each mutant, the cDNAs were linearised with 
Xba I (section 23.4) and used as templates for in vitro synthesis of mRNA (section 2.5). In 
addition, wild type GLUTS mRNA was also synthesised. The relative mRNA 
concentrations were assessed by agarose gel electrophoresis (Figure 2.3) and adjusted to 
approximately Img/ml. 50nl of mRNA was injected into each oocyte, and, after an 
incubation period of 48 hours in sugar-free medium (Table 2.1), oocytes were assayed for 
uptake of pH]2-deoxy-D-glucose over a period of 30 mins. Groups of 6-10 oocytes were 
assayed for 2-deoxy-D-glucose transport at each external sugar concentration. The 
radioactive tracer taken up by each oocyte was measured, and the mean for each group was 
calculated. By measuring the rates of zero-trans entry as a function of substrate 
concentration, the value for transport of this substrate can be deduced from construction 
of a Lineweaver-Burk plot. Oocytes expressing the wild type GLUT3 transporter and non­
injected oocytes were also assayed under identical conditions. Non-injected oocytes were 
used to measure non-specific endogenous transport levels at each substrate concentration 
used, and were subtracted from transport rates obtained for mutant and wild type injected 
oocytes to obtain specific rates of transport. It has been shown previously that the amount of 
label accumulating within the oocyte increases linearly over this time period, suggesting that 
transport of sugar is the rate-limiting step and not the subsequent phosphorylation mediated 
by hexokinase (Colville et aL, 1993b).
Three to four mutant mRNAs, in addition to wild type GLUTS mRNA, were 
individually injected into oocytes isolated from a single toad. This is mainly due to the fact 
that the mutant cDNAs were generated over a period of time, and also to limit the size of the 
transport assays. Km values obtained for 2-deoxy-D-glucose zero-trans entry by GLUTS 
and Pro-Ala GLUTS mutants expressed in Xenopus oocytes are shown in Table 4.3. The 
values represent the mean of at least three separate experiments for each mutant and those of
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GLUTS were determined in parallel at least once for each mutant. Km values were calculated 
from Lineweaver-Burk plots in which 1/rate of transport is plotted against 1/substrate 
concentration, according to the equation;-
1/v = 1/Vmax + max[^]
where v is the rate of transport measured, Vmax is the maximum rate of transport. Km is the 
substrate concentration at which half-maximal transport activity is attained, and [S] is the 
substrate concentration. Representative plots are shown in Figures 4.3 and 4.4 for the wild 
type transporter and the Pro^^l Ala mutant, respectively
4 . 4 . 2  Determination of Kj Values for Cytochalasin B Inhibition of 2- 
Deoxy-D-Glueose Zero-trans Uptake.
Individual oocytes injected with either wild type or mutant mRNA, together with 
non-injected control oocytes were assayed for zero-tram uptake of pH]2-deoxy-D-glucose 
over a range of external sugar concentrations as described above. The effects of cytochalasin 
B on zero-tram uptake was investigated in parallel by incubating oocytes, expressing either 
wild type, mutant GLUT3 or neither, in the presence of 2phA cytochalasin B in Barths 
medium (Table 2.2). Oocytes to be exposed to the inhibitor were treated with 2mg/ml 
collagenase solution for 30 mins (section 2.7.2) and then cytochalasin B for 15 min prior to 
assay. This serves to break down the follicular cells of the oocyte enabling the inhibitor to 
penetrate tlie cell plasma membrane more readily. This extra step does not alter the kinetics 
of 2-deoxy-D-glucose (Gould and Colville, unpublished data). Transport was initiated by 
addition of radiolabelled sugar, and terminated after a 30 min incubation period.
Ki values were determined from the construction of Lineweaver-Burk plots by 
application of the equation:-
gradient of line (inhibitor) = Km / Vmax • ( 1 + [I] / Ki )
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where [I] is the concentration of cytochalasin B and Ki is the concentration of inhibitor that 
causes a 50% reduction in the rate of transport. A summary of the Ki values determined for 
the non-competitive inhibition of 2-deoxy-D-glucose zero-trans influx by GLUTS and Pro- 
Ala GLUTS mutants is given in Table 4.3 and Lineweaver-Burk plots for P206A, P381A, 
P383A and P385A are shown in Figures 4.5-4.8.
4 .4 .3  Determination of Kj Values for Maltose Inhibition of 2-Deoxy-D- 
Glucose Zero-trans Uptake.
To investigate the inhibitory effects of the exofacial ligand maltose on 2-deoxy-D- 
glucose transport by GLUTS and GLUTS Pro-Ala mutants, transport rates were measured, 
as described above, in the presence and absence of 50mM maltose in Barths medium. 
Oocytes to be exposed to the inhibitor were pre-incubated in maltose solution for at least 15 
mins prior to initiation of transport by the addition of radiolabelled sugar. Again, transport 
rates were measured over a range of external sugar concentrations and non-injected oocytes 
were assayed in parallel under identical conditions to obtain endogenous transport rates.
The effects of maltose on 2-deoxy-D-glucose transport by GLUTS and Pro-Ala 
GLUTS mutants are shown in Figures 4.9-4.14. Ki values were calculated from these 
graphs by the application of the equation quoted in section 4 .4 .2  and are summarised in 
Table 4.3.
4 .5  Conclusions.
4 . 5 .1  Expression of Pro-Ala GLUT3 Mutant Transporters and Their
\Ability to Transport 2-Deoxy-D-Glucose in Xenopus Oocytes.
All mutated GLUTS cDNAs generated by recombinant PCR reactions were capable 
of acting as templates for in vitro synthesis of mRNA with efficiencies approaching that of 
wild type GLUTS. Upon injection into Xenopus oocytes, expression of the mutant 
transporter proteins resulted in increased rates of zero-trans uptake of 2-deoxy-D-glucose to
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levels comparable to wild type GLUT3 (between 3-6 pmoles/niin/oocyte), which were 
consistently several-fold higher than rates observed in non-injected oocytes (typically 0.3- 
0.6 pmoles/min/oocyte). Measurement of kinetic parameters for 2-deoxy-D-glucose 
transport mediated by Pro^OSAla and Pro^^Ala was not possible due to low levels of 
transport activity consistently observed for these transporters.
4 . 5 . 2  Kinetics of 2-Deoxy-D-Glucose Transport Mediated by Pro-Ala 
Mutants and Wild Type GLUT3.
Comparison of the Km values measured for 2-deoxy-D-glucose zero-tram influx in 
oocytes for each of the mutants with that obtained for GLUT3 reveal that none of the 
mutations affected the ability of the protein to transport this substrate. In fact, no significant 
alterations were obseiwed in the affinities of the mutants for substrate compared to wild type 
GLUTS. Mutants exhibited Km values of 0.62+0.3-1.7±0.2mM compared to 1.2±0.03mM 
determined for wild type GLUTS, which is in good agreement with previously reported 
GLUTS Km values (Colville et al., 1993b).
4 . 5 .3  Competitive Inhibition of 2-Deoxy-D-Glucose Zero-trans Influx by 
Maltose.
Kj values for maltose inhibition of transport are presented in Table 4.3. The value 
determined for wild type GLUTS is in good agreement with values previously reported for 
GLUTS expressed in oocytes (Colville et aL, 1993b). All Pro-Ala mutations resulted in an 
increase in the Ki value for maltose (to various extents) compared to GLUTS, indicating a 
decrease in the affinities of the mutant transporters for this exofacial ligand. Only values 
obtained for Pro^(^, Pro^^l, Pro^^3 and Pro^^l were statistically significant, with values 2-3 
fold higher than that obtained for the wild type transporter. Lineweaver-Burk plots for these 
mutants are shown in Figures 4.10-4.12 and 4.14.
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4 .5 .4  Non-Competitive Inhibition of 2-Deoxy-D-Glucose Zero-trans 
Influx by Cytochalasin B.
Ki values for cytochalasin B inhibition of transport are presented in Table 4.3. 
Again, the value detennined for the wild type transporter was comparable to that previously 
reported in this expression system (Colville et aL, 1993b) Only mutation of proline 
residues to alanine at the base of helix 10, Pro^^l, Pro^^ and Pro^^^, resulted in a 
significant increase in the Ki values (Figures 4.6-48), indicating a decrease in affinity for 
this inhibitor at the endofacial binding site of 3-4 fold compared to wild type. Mutation of 
prolines at positions 206, 209 and 451 to alanine did not significantly affect the Ki value, as 
detennined by application of a Students t-test.
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Table 4.3
Kinetic Parameters of GLUT3 Wild-Type and Pro-Ala Mutants Expressed in 
Xenopus  Oocytes,
Mutant Km deGlc 
(mM)
Ki Maltose 
(mM)
Ki Cytochalasin B
ipM)
Wild type 
GLUT3
1.2±0.03 33±2 2 . 8±0 .6
P203A n.d. n.d. n.d.
P206A 1.7±0.2 76+17* 2.1+0.9
P209A 0.95+0.5 56+13 2.1+1.2
P381A 0.96+0.1 80±14* 0.5+0.4***
P383A 1.46+0.6 71+2** 1.0+0.5***
P385A 0.62+0.3 43±9 0.97+0.7***
P399A n.d. n.d. n.d.
P451A 1.23+0.2 67+9** 1.76+0.5
Statistically significant changes from wild type are indicated by *(p=0.05), **(p<0.05), 
***(p<0.02).n.d., not determined.
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Figure 4.3
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by GLUT3 Injected
Oocytes.
Each point is the mean of the transport rate determined from groups of at least 7 
oocytes (section 2.7). The rate of transport was determined by exposure of the oocytes 
to radiolabelled 2-deoxy-D-glucose for 30 mins and the counts per minute determined 
as described (section 2.7). For each experiment endogenous oocyte transport was 
measured by a parallel incubation of non-injected control oocytes in trace radiolabelled 
2-deoxy-D-glucose. Values obtained for control oocytes were subtracted from the 
values obtained from the GLUTS injected oocytes to obtain the heterologous transport 
rate. Transport rates measured for control oocytes were typically 10% of the rates 
obtained for injected oocytes. The data shown is this plot is representative of at least 
four separate experiments.
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Figure 4.3
Lineweaver-Burk Plot of 2-Deoxy-D-GIucose Transport by GLUT3 Injected 
Oocytes.
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Figure 4.4
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P451A Injected
Oocytes.
Each point is the mean of the transport rate determined from groups of at least 7 
P451A-injected oocytes. Rates of transport were determined by exposure of the oocytes 
to radiolabelled 2-deoxy-D-glucose for 30 mins and the counts per minute determined. 
Values are corrected for endogenous rates of transport as described (Figure 4.3 legend). 
The range of errors were typically ±10% at each point. Error bars are omitted for 
clarity. This plot is representative of at least four separate experiments.
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Figure 4.4
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by F451A Injected 
Oocytes.
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Figure 4.5
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P206A Injected
Oocytes in the Presence and Absence of Cytochalasin B.
Transport rates of 2-deoxy-D-glucose into oocytes expressing P206A were 
determined as described. Each point is the mean of at least seven separate oocytes at 
each sugar concentration. Values are corrected for endogenous rates of transport 
(Figure 4.3 legend). Transport rates were measured in the presence and absence of IptM 
cytochalasin B as indicated. The range of errors were typically ±10% at each point. 
Error bars are omitted for clarity. This plot is representative of at least four separate 
exjDeriments.
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Figure 4.5
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P206A Injected 
Oocytes in the Presence and Absence of Cytochalasin B.
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Figure 4.6
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P381A Injected
Oocytes in the Presence and Absence of Cytochalasin B.
Transport rates of 2-deoxy-D-glucose into oocytes expressing P381A were 
determined as described. Each point is the mean of at least seven separate oocytes at 
each sugar concentration. Values are corrected for endogenous rates of transport 
(Figure 4.3 legend). Transport rates were measured in the presence and absence of 2piM 
cytochalasin B as indicated. The range of errors were typically ±10% at each point. 
Error bars are omitted for clarity. This plot is representative of at least four separate 
experiments.
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Figure 4.6
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P381A Injected
Oocytes in the Presence and Absence of Cytochalasin B.
I
i-H
80 6 10■2 44 2
□ -C B
+ 2 jjM  CB
1/S (mM-l)
205
Figure 4.7
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P383A Injected
Oocytes in the Presence and Absence of Cytochalasin B.
Transport rates of 2-deoxy-D-glucose into oocytes expressing P383A were 
determined as described. Each point is the mean of at least seven separate oocytes at 
each sugar concentration. Values are corrected for endogenous rates of transport 
(Figure 4.3 legend). Transport rates were measured in the presence and absence of 
cytochalasin B as indicated. The range of errors were typically ±10% at each point. 
Error bars are omitted for clarity. This plot is representative of at least four separate 
experiments.
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Figure 4.7
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P383A Injected
Oocytes in the Presence and Absence of Cytochalasin B.
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Figure 4.8
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P385A Injected
Oocytes in the Presence and Absence of Cytochalasin B.
Transport rates of 2-deoxy-D-glucose into oocytes expressing P385A were 
determined as described. Each point is the mean of at least seven separate oocytes at 
each sugar concentration. Values are corrected for endogenous rates of transport 
(Figure 4.3 legend). Transport rates were measured in the presence and absence of 2/<M 
cytochalasin B as indicated. The range of errors were typically ±10% at each point. 
Error bars are omitted for clarity. This plot is representative of at least four separate 
experiments.
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Figure 4.8
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by F385A Injected
Oocytes in the Presence and Absence of Cytochalasin B.
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Figure 4.9
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by GLUT3 Injected
Oocytes in the Presence and Absence of Maltose.
Transport rates of 2-deoxy-D-glucose into oocytes expressing GLUT3 were 
determined as described. Each point is the mean of at least seven separate oocytes at 
each sugar concentration. Values are corrected for endogenous rates of transport 
(Figure 4.3 legend). Transport rates were measured in the presence and absence of 
50mM maltose as indicated. The range of errors were typically ±10% at each point. 
Error bars are omitted for clarity. This plot is representative of at least four separate 
experiments.
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Figure 4.9
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by GLUT3 Injected
Oocytes in the Presence and Absence of Maltose.
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Figure 4.10
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P206A Injected
Oocytes in the Presence and Absence of Maltose.
Transport rates of 2-deoxy-D-glucose into oocytes expressing P206A were 
determined as described. Each point is the mean of at least seven separate oocytes at 
each sugar concentration. Values are corrected for endogenous rates of transport 
(Figure 4.3 legend). Transport rates were measured in the presence and absence of 
50mM maltose as indicated. The range of errors were typically ±10% at each point. 
Error bars are omitted for clarity. This plot is representative of at least four separate 
experiments.
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Figure 4.10
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P206A Injected 
Oocytes in the Presence and Absence of Maltose.
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Figure 4.11
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P381A Injected
Oocytes in the Presence and Absence of Maltose.
Transport rates of 2-deoxy-D-gIucose into oocytes expressing P381A were 
determined as described. Each point is the mean of at least seven separate oocytes at 
each sugar concentration. Values are corrected for endogenous rates of transport 
(Figure 4.3 legend). Transport rates were measured in the presence and absence of 
50mM maltose as indicated. The range of errors were typically ±10% at each point. 
Enor bars are omitted for clarity. This plot is representative of at least four separate 
experiments.
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Figure 4.11
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P381A Injected
Oocytes in the Presence and Absence of Maltose.
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Figure 4.12
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P383A Injected
Oocytes in the Presence and Absence of Maltose.
Transport rates of 2-deoxy-D-glucose into oocytes expressing P383A were 
determined as described. Each point is the mean of at least seven separate oocytes at 
each sugar concentration. Values are corrected for endogenous rates of transport 
(Figure 4.3 legend). Transport rates were measured in the presence and absence of 
50mM maltose as indicated. The range of errors were typically ±10% at each point. 
Error bars are omitted for clarity. This plot is representative of at least four separate 
exjDeriments.
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Figure 4.12
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by F383A Injected
Oocytes in the Presence and Absence of Maltose.
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Figure 4.13
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P385A Injected
Oocytes in the Presence and Absence of Maltose.
Transport rates of 2-deoxy-D-glucose into oocytes expressing P385A were 
determined as described. Each point is the mean of at least seven separate oocytes at 
each sugar concentration. Values are corrected for endogenous rates of transport 
(Figure 4.3 legend). Transport rates were measured in the presence and absence of 
50mM maltose as indicated. The range of errors were typically ±10% at each point. 
Error bars are omitted for clarity. This plot is representative of at least four separate 
experiments.
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Figure 4.13
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P385A Injected
Oocytes in the Presence and Absence of Maltose.
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Figure 4.14
Lineweaver-Burk Plot of 2-Deoxy-D-Glucose Transport by P451A Injected
Oocytes in the Presence and Absence of Maltose.
Transport rates of 2-deoxy-D-glucose into oocytes expressing P451A were 
determined as described. Each point is the mean of at least seven separate oocytes at 
each sugar concentration. Values are corrected for endogenous rates of transport 
(Figure 4.3 legend). Transport rates were measured in the presence and absence of 
50mM maltose as indicated. The range of errors were typically ±10% at each point. 
Error bars are omitted for clarity. This plot is representative of at least four separate 
experiments.
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Figure 4.14
Lineweaver-Burk Plot of 2-Deoxy-D-Giucose Transport by P451A Injected
Oocytes in the Presence and Absence of Maltose.
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4 .6  Discussion.
4 .6 .1  Location of GLUTS Proline Residues and Mutation to Alanine.
In the light of previous reports that proline residues may play a significant role in the 
structure and function of membrane proteins, a study was undertaken to investigate the role 
of several proline residues in transport mediated by GLUTS. The prolines targeted for 
mutation were located at the putative end of helix 6, (Pro^ OB)^  the start of the large 
intracellular loop at the base of transmembrane helix 6, (Pro^^ and Pro^O^), within 
transmembrane helix 10, (Pro^^l, Pro^^, and Pro^^^), the putative start of helix 11, 
(Pro399)  ^and at the start of the cytoplasmic C-terminal tail near the base of helix 12 (Pro^^l) 
(Figure 3.3). These residues were individually replaced with alanine. The basis for this 
substitution is two-fold. Firstly, as cis-trans isomérisation is unique to Xaa-Pro peptide 
bonds, replacement of a proline residue with alanine should remove flexibility around such a 
bond, if in fact Xaa-Pro isomérisation is crucial for transport. Secondly, alanine is a 
relatively small residue and is a good helix former. The substituted residue should not be so 
large as to potentially block transport of a substrate through the channel and, since some of 
the prolines targeted are within helices, should not disrupt the helical structure by 
introduction, for example, of a charged species. Replacement by alanine should, essentially, 
remove any flexibility around the peptide bond without significant disruption of the local 
protein structure.
Previous mutagenic studies have investigated the roles of proline residues within 
transmembrane helix 6 of GLUTl. These residues are conserved in all GLUT isoforms, 
except for GLUT2, and were concluded not to be crucial for transport. Proline residues 
investigated in this study included those contained within the highly conserved sequence 
PESP(R), located at the base of helix 6. These residues have not previously been 
investigated, despite their high degree of conservation. This motif is mirrored by the 
conserved sequence VPET(K), located at the base of helix 12, at the start of the cytoplasmic 
tail. Since this region has been implicated in correct formation of the exofacial binding site, 
the proline residue contained within this sequence was also mutated to alanine in this study,
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Transmembrane helix 10 is predicted to be a highly mobile region of the transporter 
that is suggested to form a pivotal point for the conformational changes required for 
substrate translocation (Gould and Holman, 1993). The endofacial half of this helix contains 
the conserved sequence, GPGPIP. Since proline does not possess an amide hydrogen 
atom, the hydrogen bonding pattern of the helix is predicted to break down in this region. 
This, coupled to the presence of the small residue glycine, is predicted to create a non­
hindered atomic environment for conformational flexing around this region. The ability of 
Xaa-Pro peptide bonds to undergo cis-trans isomérisation has also been suggested to 
contribute to conformational flexibility in membrane proteins (section 3.3.2a). The proline 
residues within helix 10 (at positions 381, 383 and 385) of GLUT3 were targeted for 
mutagenesis in this study, despite the publication of a recent study investigating the 
corresponding residues of GLUTl (prolines 383,385 and 387). The reasons for this are 2- 
fold- (1) mutation of the corresponding residues in GLUT3 will assess the generality of the 
results obtained from GLUTl, and (2) a more extensive kinetic analysis of the Pro-Ala 
mutant GLUT3 transporters expressed in oocytes, with the use of site-specific ligands, 
should reveal whether the effects of the mutations are manifested in the ability of the protein 
to expose groups that constitute the endofacial or exofacial binding sites. It is possible that 
such effects may have been overlooked in the absence of detailed kinetic analyses of 
previously reported mutants of GLUTl, particularly since individual replacement of proline 
residues may be compensated for by the presence of other prolines in the protein. In 
addition, the consequences of mutation of proline residues predicted to lie close to the 
endofacial side of the membrane at the start of the large central loop and the C-terminal tail 
were investigated.
4 . 6 . 2  Proline Residues and GLUT3 Function.
All Pro-Ala mutants generated and expressed in this study exhibited broadly 
comparable rates of 2-deoxy-D-glucose transport into oocytes relative to wild type GLUT3. 
Since no significant changes in the Km for 2-deoxy-D-glucose influx was observed, it can 
be concluded that none of the proline residues are absolutely required for transport catalysis.
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The results also infer that the mutations did not greatly perturb protein folding and targeting. 
After 2-deoxy-D-glucose influx, the substrate is rapidly phosphorylated (not rate-limiting) 
enforcing its retention inside the oocyte. The interaction of this substrate with the endofacial 
binding site is negligible and, therefore, measurement of the Km value is a function of the 
affinity at the exofacial binding site. Use of this substrate is preferential to the use of D- 
glucose in this regard.
It is important to remember however, that the is a function of substrate binding at 
the exofacial site, an exofacial to endofacial reorientation of the loaded carrier, substrate 
dissociation at the endofacial binding site and reorientation of the unloaded carrier. Therefore 
the Km can be affected by the catalytic turnover of the transporter. In this study, 
measurement of Km is used to assess the affinity of the exofacial binding site in each of the 
mutants relative to GLUT3. Since wild type transport levels were retained for all point 
mutants and no significant changes in Km observed, it is unlikely that the catalytic turnover 
of the transporter has been affected. However, direct measurement of the turnover numbers 
for each mutant expressed in this system must be carried out in order to verify this (Chapter 
5).
4 .6 .3  Effects of Pro-Ala Mutations Mediated at the Exofacial 
Binding Site.
As mentioned above, the Km measured for 2-deoxy-D-glucose transport can be 
affected by the catalytic turnover of the transporter. However, the ability of maltose to inhibit 
2-deoxy-D-glucose uptake can be used to further identify changes in the affinity of the 
mutants for substrate at the exofacial binding site. This is because maltose is a non­
transportable sugar analogue, composed of two D-glucose molecules joined by an a-(l-4)- 
glycosidic linkage (Figure 4.2). It binds to the transporter in a D-glucose-like manner, 
forming similar hydrogen bonding patterns with the transporter (Figure 4.1). The rate 
constants that govern the binding of maltose to the transporter are not dependent on the 
movement of the loaded carrier to the endofacial conformation (k^), dissociation of the 
substrate (Kgi) or reorientation of the unloaded carrier (k _i) (Figure 4.15). Kj values for
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maltose inhibition of 2-deoxy-D-glucose influx therefore represent a true measure of events 
mediated at the exofacial binding site which is independent of transporter turnover number. 
It can also be considered as a measure of the affinity of the exofacial binding site for 
maltose.
Comparison of the Ki values determined for the Pro-Ala mutants with the wild type 
GLUTS value has revealed some interesting changes in the phenotype of several of the 
mutants. Discussion of the data in terms of the putative tertiary arrangement of the helices 
has provided a further insight into the role of proline residues in transporter function.
Mutation of the first proline in the sequence, p206j5Sp209(R)^ located at the base of 
transmembrane helix 6 at the start of the large intracellular loop, to alanine, resulted in a 2-3 
fold reduction in the affinity of this transporter for maltose. Although the Pro^O^Ala mutation 
also resulted in a decrease in affinity, unlike Pro^^ôAla, this was not statistically significant 
Two putative models for the tertiary arrangement of the transmembrane helices of GLUTl 
have been proposed and are represented in Figure 1.7. A putative structural role for the large 
intracellular loop is proposed in model 2. It places helix 7 in close proximity to helices 1 and 
2, on the far side of the protein relative to helix 6. Helix 7 contains the highly conserved 
sequence, QQXSGXNXXXY, and is predicted to move up in the membrane to accept 
exofacial ligands (Holman and Rees, 1987). Thus, it may be hypothesised that the 
PESP(R) motif at the start of the large intracellular loop plays a structural role in that it 
allows the upward movement of helix 7 in the membrane. Replacement of the proline 
residues in this sequence may have restricted this upward movement such that the groups 
that interact with maltose at the exofacial binding site are not sufficiently or correctly 
exposed, thus reducing the affinity. The upward movement of helix 7 in the membrane is 
based on the observation that the transporter becomes less susceptible to thermolysin 
cleavage at the base of this helix in the presence of exofacial ligands (Holman & Rees, 
1987) . If replacement of Pro^06 (and to a lesser extent Pro^^) with alanine has restricted 
this movement sufficiently, then it would be predicted that, in the presence of exofacial 
ligands, the protein may become more susceptible to thermolytic cleavage compared to wild 
type.
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The fact that the reduced affinity at the exofacial binding site does not manifest itself 
in the Km for 2-deoxy-D-glucose uptake can be rationalised in terms of the fact that this 
effect may be small in comparison to the other events that constitute transporter turnover.
The PESP(R) motif is paralleled by the sequence VPET(K), located at the base of 
transmembrane helix 12, at the start of the C-terminal cytoplasmic tail. Interestingly, 
mutation of the proline residue within this motif, Pro^^lAla also resulted in a 2-3 fold 
decrease in the affinity for maltose at the exofacial binding site. The C-terminal cytoplasmic 
tail has been implicated as important for the correct formation of the exofacial binding site. 
Truncation analyses of GLUTl have identified a minimum structural requirement of all but 
the last carboxy-terminal 24 amino acids for correct formation of the exofacial binding site. 
The current hypothesis for formation of the exofacial site is that the cytoplasmic tail packs 
against the base of helix 10, blocking the endofacial site. Helices 11 and 12 are predicted to 
move relative to helices 7, 8 and 9 by conformational flexing around the base of helix 10. 
Data obtained for the Pro^^lAla mutant suggests that the conseiwed VPET(K) sequence at 
the base of helix 12 may be involved in allowing the cytoplasmic tail to correctly pack 
against the base of helix 10, thus resulting in correct formation of the exofacial binding site.
Helix 12 is predicted to undergo positional changes during substrate translocation 
(See above). Analysis of the amino acid sequence of this helix reveals that it contains a high 
proportion of hydrophobic residues which appear to be clustered toward the endofacial end 
of the helix (Figure 4.16). In fact, this helix is the most hydrophobic helix in the transporter, 
with a hydrophobicity of 0.89 compared to 0.52 of helix 7 (Mueckler et al., 1985). There 
are seven phenylalanine residues in this helix, compared to one to four found in other 
helices. Due to its high hydrophobic nature, it is unlikely that this segment moves up or 
down in the membrane. Instead, this helix could tilt in the membrane such that the 
cytoplasmic tail moves towards the base of helix 10 in the presence of exofacial ligands. The 
VPET(K) sequence contains strong helix-formers and thus would facilitate the movement of 
the base of helix 12 into or toward the membrane.
Pro-Ala substitutions at residues 381 and 383 within helix 10 also affected maltose 
binding, causing a 2-3 fold reduction in the affinity of the transporter for this ligand. The Ki 
value determined for Pro^^^Ala was not statistically different from wild type, suggesting that
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this mutation did not significantly perturb exofacial ligand binding. Mutation of Pro^^^ in 
GLUTl to isoleucine reduced transport activity and this was associated with reduced ATB- 
BMPA photolabelling (Tamori et al., 1994). Replacement of this residue with glycine 
resulted in retainment of wild type transport levels but, interestingly, this mutant exhibited a 
50% reduction in exofacial ligand photolabelling. It was concluded that this residue is 
important for the exofacial to endofacial conformational change. Perturbation of maltose 
binding caused by the Pro^^Ala mutation in GLUTS is consistent with this. This study also 
extends the hypothesis to include Pro^^k Although the mutation at Pro^^^ resulted in a slight 
decrease in the affinity of this transporter for maltose, it is concluded that this residue may 
not be as important as the prolines at positions 381 and 383. This may be explained in terms 
of the interaction of this proline with the immediate residues on either side. Pro^^l and 
Pro^^ are flanked by glycine residues which are structurally important in proteins in that 
they allow unusual main chain conformations. It is postulated that they provide a non­
hindered atomic environment for flexing around the prolines at positions 381 and 383, and 
that this is more restricted around position 385 due to the presence of the more bulky 
residues isoleucine and tryptophan which flank this residue.
4 . 6 .4  Effects of Pro-Ala Mutations Mediated at the Endofacial 
Binding Site.
Measurement of Ki values for the inhibition of 2-deoxy-D-glucose transport by
cytochalasin B are a reflection of the effects mediated at the endofacial binding site of the 
transporter. Individual mutation of all proline residues of helix 10 to alanine resulted in a 3-4 
fold increase in the affinity for this ligand. These results are best considered in conjunction 
with the data obtained for the maltose inhibition studies, since measurement of Ki values for 
cytochalasin B inhibition of transport are performed under influx conditions in this study 
(see section 4.6.5). Tamori and co-workers have already suggested that Pro^^S of GLUTl 
plays an important role in allowing the exofacial to endofacial conformational change. 
Mutation of this residue to isoleucine stabilises the endofacial conformation such that 
retention of endofacial ligand photolabelling is associated with a corresponding decrease in
I
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the level of exofacial ligand photolabelling. Data obtained for this residue of GLUTS, 
Pro383^  is in good agreement for this role, since retainment of cytochalasin B inhibition of 2- 
deoxy-D-glucose influx was associated with a decrease in the affinity of the transporter for 
maltose. This observation can also be extended to include Pro^^l. A role for this residue was 
not previously detected in the GLUTl studies, as affinities at the substrate binding sites were 
not investigated. The reduction in the Pi'o^ ®^  Ki value for cytochalasin B was not associated 
with a significant effect at the exofacial binding site, as was the case for Pro^^l and Pro383 
(see above). It may be that this residue is not as important for allowing the correct formation 
of the exofacial binding site through conformational flexing in this region, as it is predicted 
to lie in a more hindered atomic environment. The increase in affinity for cytochalasin B 
exhibited by all helix 10 mutants may be related to the close proximity of Trp^^ô (Figure 
4.17). This residue of GLUTl (Trp^^), maybe a site of covalent attachment upon UV 
irradiation and therefore a possible site of contact for cytochalasin B. It is possible that 
mutation of any of the three prolines to alanine causes local structural alterations such that the 
tryptophan becomes more accessible for interaction with the ligand, thus resulting in an 
increase in affinity. Interestingly, the ProS85Giy mutation in GLUTl exhibited increased 
levels of cytochalasin B photolabelling (146±13.6% of wild type levels).
Mutation of proline residues at the base of helices 6 and 12 had no significant effect 
on the ability of the transporter to bind endofacial ligands. This would be consistent with the 
suggestion that these residues are more important for determining the coiTect formation of 
the exofacial binding site through structural changes involving helix 7 and the cytoplasmic 
tail respectively. No perturbation of endofacial ligand binding would be predicted since this 
region involves the base of helices 10 and 11.
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4.6.5 Problems with this Study.
i
This study has been successful in that it has provided further evidence for a 
functional role for proline residues in transport catalysis mediated by the facilitative glucose 
transporter isoforms. Molecular modelling and mutagenic studies have implicated a role for 
prolines in transport catalysis mediated by GLUTl, however, an extensive kinetic
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characterisation of the mutants generated was not undertaken and so it was not possible to 
speculate on a more defined role for these residues. In this study, although individual 
mutation of several proline residues in GLUTS to alanine did not alter the Km for 2-deoxy- 
D-glucose transport, a more subtle role for these residues could be implicated on the basis of 
small but significant alterations in the affinity of the transporter for ligands at the exofacial 
binding site. Measurement of Kj values for maltose inhibition of substrate influx are a direct 
representation of effects mediated at the exofacial substrate binding site, since maltose and 
D-glucose are assumed to compete for the same site under these conditions. Direct 
measurements of any effects mediated at the endofacial binding site are more difficult to 
measure under ZQVo-trcms influx conditions of 2-deoxy-D-glucose transport since the nature 
of inhibition is non-competitive (unlike maltose inhibition which is competitive). Ideally, to 
obtain this information, measurement of Ki values for inhibition of transport should be 
performed under zero-trans efflux conditions such that the inhibitor and the substrate 
compete at the same side of the transporter. However, there are several problems associated 
with performing such experiments in oocytes. Firstly, the substrate must be capable of being 
transported out of the cell and therefore, 3-0-methyl-D-glucose would need to be used 
instead of 2-deoxy-D-glucose. This substrate is not ideal as it can be transported back into 
the oocyte and so, the time period within which the rate of sugar efflux remains linear, i.e. 
before sugar influx occurs, is of the order of a few minutes (--3 mins). A further 
complication in this regard is the fact that the oocytes would need to be pre-loaded with 
radiolabelled tracer. The extracellular medium is then rapidly removed and replaced with 
sugar-free medium and the initial rates of sugar exit are measured by testing the amount of 
radioactivity in the external medium. The high dilution factor of the radiolabel on the external 
medium and the short time period over which transport rates would need to be measured 
increase the error margin substantially.
Secondly, in order to fully characterise the mutants generated in this and other 
studies, it is necessary to determine the turnover number of the transporters. This is an 
important parameter which would more precisely define the effects of a particular mutation 
on the function of the transporter. Since the turnover number is dependent on the number of 
transporters at the cell surface, and because this will vary between oocyte preparations from
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different animals, determination of this parameter requires an accurate and reproducible 
method for isolating plasma membranes from oocytes. However, as discussed in detail in 
Chapter 5, problems associated with obtaining a pure and reproducible plasma membrane 
fraction from oocytes precluded the measurement of turnover numbers in this study.
In addition, more general problems have been encountered whilst using the Xenopus 
oocyte system for heterologous expression. Seasonal variation of oocyte batches, animal 
housing problems and infection have impeded characterisation of the GLUTS mutants in 
terms of photolabelling and more extensive inhibition studies. Subcloning and expression of 
these constructs in an alternative expression system, where the membrane fractionation 
procedures are simpler and more reproducible, will not only allow measurement of turnover 
numbers but also enable more detailed inhibition studies to be performed (Chapter 7).
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Figure 4.15
King-Altman Diagram Showing the Competition of 2-Deoxy-D-Glucose and 
Maltose at the Exofacial Binding Site of the Transporter.
The model proposed in this diagram is based on kinetic data which has been 
established for GLUTl, although it is generally believed that this model also applies to 
the other GLUT isoforms. The diagram describes the cycling of the transporter from an 
exofacial conformation, Tq, to an endofacial conformation, T;, and back again in the 
presence and absence (±S) of deGlc. Kgo and Kg# represent the dissociation constants at 
the exofacial and endofacial sites respectively, and kj, k2, k_i and k_2 describe the rate 
constants of the steps indicated. This schematic also describes the competition between 
deGlc and maltose at the exofacial binding site. Maltose binds to the exofacial binding 
site (To) but is not transported to the other side of the membrane. Therefore the rate 
constants that govern this event are not dependent on the movement of the loaded 
carrier to the inward-facing conformation (k2), dissociation of the sugar (Kgi), or 
reorientation of the empty carrier (k-i). The kinetics of deGlc transport are dependent 
on all these steps. Thus, while the interaction of deGlc at the exofacial substrate binding 
site is influenced by other steps in the transport cycle, the interaction of maltose is 
dependent only on the rate of association and dissociation of this sugar at the exofacial 
site. Hence, measurement of the ability of maltose to inhibit deGlc transport (Kj), is 
independent of the turnover number of the transporter.
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Figure 4.15
King-Altman Diagram Showing the Competition of 2-Deoxy-D-Glucose and 
Maltose at the Exofacial Binding Site of the Transporter.
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Figure 4.16
Predicted a-Heiical Structure of GLUT3 Transmembrane Helix 12.
This shows the predicted secondary structure of GLUTS putative 
Iransmembrane helix 12. The helix is viewed from the endofacial to exofacial direction 
with the amino acid sequence beginning at Gly^^^ at the "top" of the helix (numbered 
1). The positions of the following residues rotate in a clockwise direction until residue, 
Phe^WS is reached at the "bottom" of the helix (numbered 21). The diagram highlights 
the highly hydrophobic nature of this helix, due to a high proportion of phenylalanine 
residues.
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Figure 4.16
Predicted a-Helical Structure of GLUT3 Transmembrane Helix 12.
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Figure 4.17
Predicted a-Helical Structure of GLUT3 Transmembrane Helix 10.
The predicted secondary structure of the putative transmembrane helix 10 of 
GLUTS is shown. The helix is viewed from the endofacial end up through the helix 
such that the first residue, IIe368 (numbered 1) is at the "top" of the helix. The following 
residues rotate in a clockwise direction until Phe^^ (numbered 21) is reached at the 
bottom of the helix. The diagram shows the relative orientation of the highly conserved 
GPGPIP motif and also the position of the single charged residue Glu379 which may be 
buried in a hydrophobic pocket.
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Figure 4.17
Predicted a-Helical Structure of GLUT3 Transmembrane Helix 10.
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4 .7  Summary.
A collective role for proline residues in the global structure and function of GLUTS 
is not yet clear in the absence of high resolution structural information. However, their 
selective inclusion within transmembrane domains together with a high degree of 
conservation of proline-containing sequences, suggests some important functionality. Based 
on the data obtained from other membrane proteins, e.g. bacteriorhodopsin and rhodopsin, 
and from the use of mutagenesis and molecular dynamics studies, proline residues have been 
implicated in providing conformational flexibility through their ability to cause kinks and by 
the cis-trans isomérisation of Xaa-Pro peptide bonds. Modelling studies have predicted that 
transmembrane helices are capable of accommodating cis-Pro and thus, the isomérisation 
events within helices can cause local structural changes without grossly affecting the overall 
propagation of the main chain. Such properties are consistent with a role for proline residues 
in the functionality of membrane proteins.
To date, several prolines of GLUTl have been investigated by site-directed 
mutagenesis. The Pro-Gly rich region of helix 10 has been implicated in the confonnational 
flexibility requisite for the alternate and subsequent exposure of substrate to either side of the 
transporter. These conclusions are based upon individual replacement of prolines with 
residues that either abolish or significantly reduce transport catalysis. However, in the light 
of other mutagenic studies, it should be remembered that protein inactivation by mutation 
does not distinguish between a structural or dynamic role for these residues. Additionally, it 
has been demonstrated that individual replacement of certain proline residues to alanine may 
not cause any detectable change in protein activity, probably due to the compensatory effects 
of other prolines. However, subtle structural perturbations may have gone undetected in 
these studies in the absence of more detailed kinetic analysis of the Pro-Ala mutants. It is 
possible that effects caused by these mutations are small in comparison to the overall 
turnover of the transporter.
A thorough kinetic analysis was undertaken in this study to investigate the role of 
conserved proline residues in the function of GLUTS. The data corroborates the finding that 
no individual proline is essential for transport catalysis. However, on the basis that small but
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significant alterations in the nature of ligand binding at the exofacial binding site were 
observed, prolines are important for transporter function. In some cases, a reduction in 
exofacial ligand binding affinity was associated with an increased affinity for ligands at the 
endofacial site. Proline residues of helix 10 are suggested to contribute to the flexibility 
requisite for conformational changes. The PESP(R) motif at the base of helix 6 and the 
VPET(K) motif at the base of helix 12 may be important for allowing the structural changes 
required for correct fonnation of the exofacial substrate binding site.
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CHAPTER 5
Isolation of Plasma Membrane Fractions 
from Xenopus Oocytes.
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5 .1  Aims.
1 . To devise a reliable and reproducible protocol for the isolation of a plasma membrane 
fraction from GLUT3~injected oocytes. The method should provide a clean fraction of 
plasma membranes, free from contaminating yolk protein and internal membranes.
2 . To determine the number of GLUT3 transporters expressed at the plasma membrane 
surface by quantitative Western blotting against GLUT3 standards.
3 . To use this system to measure turnover numbers for GLUT3 and each of the Pro-Ala
mutants previously genemted.
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5 .2  Introduction.
5 .2 .1  Use of Xenopus Oocytes for Kinetic Studies.
Xenopus oocytes have proved to be a useful and efficient system for the 
heterologous expression of mammalian facilitative glucose transporters (section 4.3). All of 
the human GLUT isoforms have been expressed in oocytes, and some of their kinetic 
properties accurately determined. This has proved difficult in their native cell environments, 
since there is often more than one glucose transporter isoform expressed in any given cell, 
and also due to the rapid equilibration of the cell water space which further complicates the 
analysis. Thus, it is difficult to know whether the measured kinetic parameters are truly 
representative of the heterologously expressed transporter unless kcat values are also 
determined. In addition, a transporter heterologously expressed in CHO-cells for example, 
would need to be present at high enough levels to produce a substantial-fold increase in 
transport activity over endogenous levels of transport to enable accurate determination of 
kinetic parameters. The main advantage of the oocyte system over the native cell type is the 
low endogenous levels of transport. Oocytes also provide a useful system in which to 
explore the properties of mutant proteins and to determine the functional consequences of 
these mutations.
5 . 2 .2  Measurement of Turnover Numbers.
In the experiments described in Chapter 4 of this thesis, measurement of Km values 
for zexo-trans uptake of substrate into oocytes represents a value that is essentially a 
reflection of the affinity of the transporter for this substrate at the exofacial binding site. As 
2-deoxy-D-glucose is not transported back out of the oocyte, the interaction of the substrate 
at the endofacial site is assumed to be negligible. However, the Km of 2-deoxy-D-glucose is 
a function not only of substrate association and dissociation events at the exofacial and 
endofacial sites, but also re-orientation of the transporter between the two conformational 
states. The Km value can therefore be influenced by the catalytic turnover of the transporter
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(i.e. the rate of transporter re-orientation). Since measurement of Km and Ki values were 
used as a method of comparing the affinity at the exofacial binding site of the mutant 
transporters for substrate and ligand, the next stage in the kinetic analysis would be to 
determine the effects of the mutation on the catalytic turnover of the transporter proteins.
By analogy with enzyme systems, the steady-state flux is characterised in terms of 
Km (the half saturation constant, which is a measure of the apparent affinity of the transport 
system for substrate) and Vmax (the capacity for translocation when the transport system is 
saturated with glucose). Vmax , which is dependent on the amount of transporter expressed 
at the plasma membrane of the oocyte, is given by;
^max ~  kcat l^ T ]
where [GT] is the concentration of glucose transporters at the plasma membrane and kcat is 
the number of times the transporter turns over per unit time. Therefore, unlike Km values, 
the Vmax will vary between oocyte preparations from different animals. As a result, use of 
this expression system is useless for determination of turnover numbers unless a reliable and 
reproducible method is available for quantitation of glucose transporters expressed at the 
plasma membrane.
For any vesicle, the first-order rate constant for equilibration (kobs) at a substrate 
concentration below the Km is given by:
kobs = k(T)t/KmVi
where k is the turnover number for equilibrium exchange, (T)t is the moles of transporter per 
vesicle. Km is the half-saturation constant for equilibrium exchange, and Vj is the internal 
volume of the vesicle. All of these parameters are measurable in oocytes, with the exception 
of (T)t which requires a method for isolation of a purified plasma membrane fraction and a 
method for quantitating the number of transporters (e.g. immunoblotting against membrane 
fractions containing known amounts of transporter).
242
The main aim of this chapter is therefore to describe a method for the isolation of 
purified plasma membrane fractions from oocytes expressing GLUTS. This methodology 
should then prove useful in the further characterisation of the glucose transporter mutants 
generated in this study and others.
5 .3  Subcellular Fractionation of Xenopus Oocytes.
There have been many published papers that describe methods for the isolation of 
plasma membrane fractions from oocytes. Most of these protocols have involved either 
manual dissection of plasma membrane "ghosts", produced by squeezing individual oocytes 
to expel the yolk and cellular contents into the incubation buffer, or the use of 
homogenisation and centrifugation procedures. Manual dissection of oocytes is a demanding 
and time-consuming task, and the homogenisation methods previously described have 
resulted in extensive fragmentation of the fragile plasma membrane sheets. A second major 
problem is that oocytes contain a large amount of intracellular yolk protein, comprising about 
80% of the total cellular protein. As yolk protein is very glutinous, it is difficult to obtain 
plasma membrane fractions that are free from contaminating yolk protein and other 
intracellular components. This, coupled with the extremely fragile nature of the plasma 
membranes, has led to low and variable yields.
The development of a relatively simple procedure for the preparation of large plasma 
membrane complexes from oocytes was reported by Wall and Patel in 1989. The absence of 
any centrifugation steps and minimal homogenisation conditions resulted in little 
fragmentation. Good yields and enrichment of plasma membrane marker enzymes were 
reported (Wall & Patel, 1989). No individual dissection and rinsing procedures were 
required and the protocol was reported to be suitable for use with small numbers of cells as 
well as for large preparative procedures. This method formed the basis of the fractionation 
procedure used in this study.
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5 .4  Methods.
5 . 4 .1  Cell Surface Labelling of Oocytes by Biotinylation.
Intact oocytes were incubated in the presence of either sulfo-NHS-biotin or NHS- 
LC-biotin (section 2.8.3b and 2.8.4b). Both reagents are analogues of NHS-biotin which 
reacts with primary amines (generally lysine groups) to form amide bonds. The reaction 
occurs via a nucleophilic attack of an amine towards the NHS ester (Figure 5.1), resulting in 
fonnation of a stable amide bond and the release of N-hydroxysuccinimide as a by-product. 
Incubation of oocytes in the presence of these reagents at 4*^ C results in cell surface labelling. 
Excess biotin is removed by the addition of a solution of L-lysine which quenches the biotin. 
Labelled oocytes were then rinsed in homogenisation buffer containing protease inhibitors 
(Table 2.2) and subjected to subcellular fractionation procedures (section 2.8.3 and 2.8.4). 
Levels of expressed GLUT3 were then quantitated by either dot blot analysis or Western 
immunoblotting.
5 . 4 . 2  Subcellular Fractionation Procedures.
Two methods are described for the isolation of plasma membrane complexes from 
oocytes, both of which are based on the method of Wall and Patel, 1989 with some minor 
modifications. Biotinylated oocytes (typically 100), were disrupted either by gentle 
homogenisation in a Dounce homogeniser (no more than 6-7 strokes) or using a P200 
Gilson pipette (section 2.8.3c and 2.8.4c). The crude homogenate was allowed to settle by 
gravity for 10-30 mins, and the initial supernatant was removed which consisted mainly of 
yolk granules. Plasma membrane complexes were then subjected to a series of washes with 
gentle disruption using a pasteur pipette when necessary. Supernatants obtained after each 
wash were removed, pooled and subjected to centrifugation (1000 x gav) to collect residual 
yolk protein. Three fractions were obtained, referred to as the Y (yolk), PM (plasma 
membrane) and S (supernatant) fractions. The protein concentration of each fraction was
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determined by the Lowry microassay (section 2.8.3d) or the BCA Quantigold assay (section 
2.8.4d).
5 . 4 .3  Dot Blot Analysis.
After subcellular fractionation of the oocytes, equal amounts of protein from each 
fraction were transferred onto nitrocellulose membranes (section 2.8.4e). After blocking of 
non-specific sites, the nitrocellulose membranes were incubated with l^^I-streptavidin. 
Labelled membranes were then prepared for autoradiography and the amount of 
streptavidin associated with each membrane fraction determined by y-counting.
5 . 4 .4  Quantitative Immunoblotting.
In addition to the dot blot analysis described above, oocyte fractions were also 
analysed by SDS PAGE and Western blotting (section 2.17.1-2.17.2). Plasma membrane 
standards obtained from cells engineered to stably express a known amount of GLUT3 
protein were used for comparison purposes (Maher et al., 1992). A rabbit polyclonal 
anti serum (1 in 250 dilution) raised against a synthetic peptide corresponding to the C~ 
terminal 14 amino acids of human GLUT3 (Brant et al., 1993) and l^^I-labelled goat anti­
rabbit IgG were used for detection by autoradiography. Alternatively ECL methodology was 
used.
5 .4 .5  Plasma Membrane Marker Assay.
Each fraction was assayed for the plasma membrane marker enzyme 5'nucleotidase 
(section 2.8.5b). This enzyme activity was used to estimate the relative enrichment of plasma 
membranes obtained compared to the Y and S fractions. Oocyte fractions were incubated in 
the presence of the substrates, pH]5'-AMP and 2',3'-AMP, and the rate of production of 
the product, adenosine, with time was determined by liquid scintillation spectrometry.
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Figure 5.1
Reaction of NHS-Biotin and Sulfo-NHS-Biotin with Protein Amines.
N-hydroxysuccinimide esters react with primary amines to form amide bonds. 
The reaction occurs via a nucleophilic attack of an amine (generally lysine groups) 
towards the NHS ester, resulting in the formation of a stable amide bond and the release 
of N-hydroxysuccinimide as a by-product. In the experiments described here, biotin 
analogues are used to label the surface of intact oocytes which can be quantitated 
following subsequent fractionation procedures by reaction with l^^I-streptavidin.
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Figure 5.1
Reaction of NHS-Biotin and Sulfo-NHS-Biotin with Protein Amines.
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5 .5  Results.
5 .5 .1  2-Deoxy-D-Glucose Zero-trans Influx Mediated by GLUTS
Expressing Oocytes.
Oocytes were isolated and injected with 50nl of Img/ml GLUTS mRNA (section 
2.6.4). After incubation for 48 hours at 18-20°C, groups of 10 injected and 5 non-injected 
oocytes were assayed for zero-trans uptake of 2-deoxy-D-glucose as described (section 2.7). 
Transport rates mediated by GLUTS injected oocytes were typically between 2-5 
pmols/min/oocyte, compared to between 0.2-0.7 pmols/min/oocyte for non-injected 
controls. Only oocytes exhibiting transport rates within or above this range expressed 
GLUTS at sufficient levels and were subjected to subcellular fractionation procedures.
5 . 5 .2  Surface Labelling and Fractionation of Oocytes.
Two biotin analogues were used for labelling of intact oocytes. Initially NHS-LC- 
biotin was used however since this analogue was not water soluble it was dissolved in the 
organic solvent, DMSO, before addition to the oocytes. To avoid any possible adverse 
effects caused by the DMSO during the following fractionation procedure, an alternative 
compound, sulfo-NHS-biotin, was subsequently used. This analogue was easily dissolved 
in aqueous buffers and therefore avoided the use of DMSO.
Biotinylated oocytes prepared as previously described, were then subjected to 
subcellular fractionation procedures. Initially, groups of 100 oocytes were gently disrupted 
with the use of a Dounce homogeniser and loose fitting pestle. The number of strokes 
required to disrupt the oocytes varied between oocyte preparations from different animals. 
Care was taken not to over-homogenise the oocytes, as this was found to cause extensive 
fragmentation of plasma membranes leading to decreased yields at the end of the procedure. 
The initial homogenate was allowed to settle by gravity, thus avoiding any centrifugation 
steps which also causes fragmentation. The large plasma membrane sheets settled to the 
bottom of the tube, with much of the yolk protein remaining in the initial supernatant. Any
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remaining yolk protein, pigment granules and other intracellular contaminants were removed 
from the plasma membrane sheets by a series of washes, with gentle agitation using a glass 
pasteur pipette. All rinsing procedures were performed in the same tube, rather than 
transferring the plasma membrane sheets to a clean tube after each rinse, since the plasma 
membrane fractions adhered tightly to the sides of the tube resulting in the progressive loss 
of material. The same pipette was used throughout the procedure for the same reason. 
Again, the number of rinses required to remove contaminants varied between oocytes 
obtained from different animals. This procedure yielded three fractions, PM (containing 
enriched plasma membranes), Y (yolk protein and pigment granules), and S (intracellular 
components).
A second method used for oocyte fractionation was described (section 2.8.4) and 
was similar in many aspects. The major difference was the method used to initially disrupt 
the oocytes. The homogenisation procedure was often found to be too harsh resulting in 
very low recovery of plasma membranes, particularly when the oocytes were fragile. An 
alternative method was to use a P200 Gilson pipette fitted with a pipette tip cut to a suitable 
diameter such that passage of oocytes through the tip resulted in their disruption. Typically, 
100 oocytes were disrupted in this way. Yolk and other intracellular contaminants were 
removed from the plasma membrane complexes by a series of washes, with gentle 
disruption using the same pipette when necessary. After each wash, the supernatant was 
removed and subjected to a slow speed centrifugation step (1000 x gav for 5 mins), to 
collect residual yolk which was pooled. Each resulting supernatant was pooled and all 
fractions were pelleted at the end of the procedure to obtain three fractions PM, Y and S.
The protein concentration of each fraction was deteiinined (Table 5.1). The Lowry 
protein microassay was used initially, but, due to the low amounts of protein recovered in 
the S and PM fractions, the more sensitive Quantigold protein assay was subsequently used, 
which was capable of detecting protein within the range of 5-200ng. The amount of protein 
recovered in the PM fraction varied considerably between oocyte preparations, with an 
average of 4.0±3.6/^g protein per oocyte (n=6).
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5 .5 .3  Activity of Plasma Membrane 5'Nucleotidase in Xenopus Oocyte 
Fractions.
The amount of 5'nucleotidase activity was determined for each oocyte fraction, and 
the results of a typical assay are shown in Figure 5.2. The protein concentration used in the 
assay was adjusted such that the rate of adenosine release was linear with time. Comparison 
of these enzymic activities with those obtained for intact oocytes indicated average yields of 
64% of the cell surface activity of this plasma membrane marker in the PM fraction, 
corresponding to a 20-fold enrichment. However, the PM fraction contained at least 80% of 
the total 5'nucleotidase activity recovered when activities were compared with total 
homogenate levels shown in Figure 5.3. This suggests some loss of activity during the 
fmctionation procedure.
5 .5 .4  l25i_Dot Blot Analysis of Oocyte Fractions.
The recovery of biotinylated plasma membranes was assessed by determining the 
level of l^^I-streptavidin associated with each fraction (Figure 5.4). The average results 
from five separate experiments are shown in Figure 5.5. Typically, only 30% of the total 
radioactivity was associated with the PM fraction and this value varied between oocyte 
preparations (Table 5.2). The level of radioactivity associated with the S and Y fractions was 
attributed either to non-specific binding, or to extensive fragmentation of the PM during the 
fractionation procedure, resulting in contamination of the other fractions with biotin.
5 . 5 .5  Western Blot Analysis of Oocyte Fractions.
In an attempt to quantify the amount of GLUT3 protein in each fraction, equal 
amounts of protein were subjected to SDS PAGE alongside GLUT3 standard membranes. 
Proteins were transferred electrophoretically onto nitrocellulose membranes which were 
probed with/polyclonal antiserum raised by immunising a rabbit with a synthetic peptide 
corresponding to the C-terminal 14 amino acid residues of GLUT3 (Shepherd, 1992a). A
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representative immunoblot is shown in Figure 5.6. The GLUTS protein was detected as a 
broad band migrating at an apparent molecular weight of approximately 40kDa. This band 
was not detected in non-injected control oocytes, but was present in all of the prepared 
oocyte fractions. In addition, two sharp bands of higher molecular weight which were not 
detected in the oocyte fractions but were present in the total membrane fraction of both 
injected and non-injected oocytes are likely to be associated with the yolk.
Unfortunately, an accurate quantitative determination of the GLUTS protein 
associated with each fraction was not possible from any of the immunoblots obtained. This 
was due either to low levels of protein being resolved which were beyond the limits of 
detection of the antibody used, or to poor resolution of the GLUTS standards making it 
difficult to draw conclusions from the immunoblots.
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Table 5.1
Protein Yields of Oocyte Fractions.
Oocyte Fraction Protein Concentration  ^
(mg/ml)
Protein Yield 
(^g/oocyte)
PM 1.56+0.98 4.0±3.6
Y 20±12 163+102
S 7.4±5.6 26±22
determined by Lowry protein microassay or Quantigold protein assay.
Î
■:ï-
I
252
:3:;
L
#
:g
Figure 5.2
Measurement of the 5 Nucleotidase Activity of Oocyte Fractions.
An aliquot of the subcellular fractions prepared from 100 oocytes were 
incubated in the presence of 5mM 2',3'-AMP and 0.2mM [^H]5'-AMP (l/<Ci/ml). At 
various time points (0-30 mins) duplicate samples were removed and added to 0.25M 
ZnS0 4 , followed by the addition of BaCl2. This serves to precipitate the phosphate 
produced during the reaction. The amount of radioactivity associated with the 
supernatants from these samples was determined by liquid scintillation spectrometry. 
The protein concentration was adjusted such that the rate of adenosine release was 
linear with time. A total oocyte fraction was prepared by extensive homogenisation of 
20 oocytes and was assayed for 5'nucleotidase activity in the same way.
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Figure 5.2
Measurement of the 5'Nucleotidase Activity of Oocyte Fractions.
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Figure 5.3
5'Nucleotidase Activities in Oocyte Membrane Fractions.
5'Nucleotidase activities were measured for oocyte fractions as described. 
Activities are expressed as a percentage of the total activity recovered and represent the 
mean (± S.D.) of six determinations from ooeyte fractions obtained from different 
animals.
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Figure 5.3
5'Nucleotidase Activities in Oocyte Membrane Fractions.
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Figure 5.4
Specific Recovery of l^^I-Streptavidin Associated With Oocyte Fractions.
Intact oocytes were labelled with NHS-biotin and subsequently fractionated to 
obtain a purified plasma membrane fraction. Oocyte fractions were subjected to dot blot 
analysis and the recovery of the biotinylated plasma membranes was assessed by 
determining the level of l^I-streptavidin associated with each fraction. This graph 
shows the results obtained from a typical experiment in which the 1^1-label associated 
with the plasma membrane fraction was enriched approximately 21-fold compared to 
that associated with the total oocyte sample.
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Figure 5.4
Specific Recovery of l^^I-Streptavidin Associated With Oocyte Fractions.
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Figure 5.5
Recovery of l^I-labelled Biotinylated Plasma Membranes from Oocytes.
Intact oocytes were labelled with NHS-biotin and subsequently fractionated to 
obtain a purified plasma membrane fraction. Oocyte fractions were subjected to dot blot 
analysis and the recovery of the biotinylated plasma membranes was assessed by 
determining the level of l^I-streptavidin associated with each fraction. Results 
represent the mean (± S.D.) of five separate experiments using oocytes obtained from 
different animals.
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Figure 5.5
Recovery of l^^I-labelled Biotinylated Plasma Membranes from Oocytes.
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Table 5.2
Data obtained from a Typical Dot Blot Analysis.
Oocyte Fraction Total Protein (mg)* Associated 
12^1-label 
(% cpm)
cpm cpm/mg protein
PM 0.42 41% 27352 65124
Y 14.74 29% 18834 1278
S 1.2 30% 19838 16532
Total 16.36 100% 66024 4036
^determined by the Lowry protein microassay or the Quantigold protein assay.
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Figure 5.6
Western Blot Analysis of Ooeyte Fractions Expressing GLUTS.
Oocytes expressing GLUTS were subjected to subcellular fractionation. Total 
membrane fractions were prepared from GLUTS expressing and non-injected oocytes. 
30/ig of each fraction was subjected to electrophoresis on 10% polyacrylamide gels and 
proteins were transferred to nitrocellulose membranes which were probed with a rabbit 
polyclonal antiserum (1 in 250 dilution) raised against a synthetic peptide 
corresponding to the C-terminal 14 amino acids of human GLUTS. l^I-labelled goat 
anti-rabbit IgG (l/<Ci/20ml) was used for detection by autoradiography. The GLUTS 
protein is identified as a broad band migrating at an apparent molecular weight of 
approximately 40kDa.
Lane 1, total membranes prepared from non-injected oocytes; Lane 2, total 
membranes prepared from GLUTS-injected oocytes; Lane 3, Sinitial fraction prepared 
from GLUTS-injected oocytes; Lane 4, PM fraction prepared from GLUTS-injected 
oocytes; Lane 5, wash fraction prepared from GLUTS-injected oocytes. Positions of 
molecular weight markers are indicated to the right of the immunoblot.
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Figure 5.6
Western Blot Analysis of Oocyte Fractions Expressing GLL1T3.
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5 .6  Discussion.
The absence of a reliable method for the isolation of a pure plasma membrane 
fraction from Xenopus oocytes has precluded a more complete kinetic characterisation of 
wild type and mutant GLUT isoforms in this expression system. Transporter protein 
expression at the plasma membrane varies with different batches of cells, time after mRNA 
injection and also with the type of transporter introduced. Measurement of Ki and Km values 
for transport of a substrate under the conditions described in this thesis are not dependent on 
the amount of transporter expressed at the plasma membrane surface. The oocyte system is 
therefore an ideal system in which to measure these parameters, which yield information 
regarding effects mediated at the substrate binding sites. However, in addition to 
measurement of Km values, the transport process is also characterised by the Vmax value 
which is related to the catalytic turnover over of the protein. Vmax is dependent on the 
concentration of functional glucose transporters expressed at the plasma membrane and thus, 
varies between oocyte batches obtained from different animals. Therefore, in order to 
measure such parameters, it is necessary to have a method for estimating the actual amount 
of transporter expressed at the plasma membrane surface. This is further complicated by the 
fact that the oocyte plasma membrane contains only a small fraction of the total transporters 
synthesised from injected mRNA. Previous studies have reported that between 4-12% of 
GLUTl is expressed at the cell surface in oocytes (Due et al., 1995; Garcia et al., 1992; 
Nishimura, 1993). Thus, any contamination of the plasma membrane fraction with 
intracellular membrane structures will cause an over-estimation of the transporter content at 
the plasma membrane.
Essentially pure plasma membrane "ghosts" can be prepared by manual dissection of 
oocytes (Garcia et al., 1992; Geering et ah, 1989; Keller et al., 1989), however, this 
methodology is time-consuming and involves individual rinsing of prepared plasma 
membrane sheets. Collagenase treatment for removal of oocytes from their follicular cell 
layer was not suitable due to weakening of the envelope structure, resulting in fragmentation 
of plasma membrane sheets during the rinsing process to remove intracellular yolk and 
membranes (Wall & Patel, 1989). Use of a homogeniser to disrupt the oocytes is a faster
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method for the isolation of plasma membranes from large numbers of oocytes but, as was 
observed over a series of experiments, there were large variations in the final yields of 
plasma membranes obtained. This was attributed to extensive fragmentation of the fragile 
plasma membranes. Also, it was more difficult to separate the plasma membrane sheets from 
underlying yolk protein. Better separation was obtained if the oocytes were gently disrupted 
with a P200 Gilson pipette tip. The resulting plasma membrane sheets obtained in this way 
were much larger (clearly visible by eye) and generally sedimented at a faster rate than the 
yolk protein, the majority of which could be removed in the initial supernatant. 
Centrifugation of the plasma membrane-containing fractions was avoided at all stages of the 
fractionation procedure, as this was found to cause fragmentation resulting in low final 
yields. Plasma membranes were therefore allowed to settle by gravity after each rinse until 
the final fraction was obtained which could then be collected by centrifugation.
Although more than 80% of the plasma membrane marker activity was recovered in 
the PM fraction, the actual yield of plasma membranes was found to vary considerably 
between oocyte preparations, and this was attributed to the unavoidable fragmentation of 
plasma membrane sheets. Results from both dot blot and Western blot analyses indicated 
that preparation of a plasma membrane fraction free from other cellular contaminants was 
extremely problematic. It was therefore concluded that, for this expression system, the 
methodology was not suitable for a reliable determination of transporter turnover numbers.
Alternative methods for determination of kcat values include the application of a 
Scatchard analysis to data generated by equilibrium binding of pHJcytochalasin B to isolated 
oocyte plasma membranes. Obviously, this methodology also requires a fractionation 
procedure for oocytes. The number of molecules at the cell surface of intact oocytes can be 
determined by equilibrium binding of pH]ATB-BMPA. This takes advantage of the fact that 
essentially all bound ATB-BMPA can be covalently attached to the transporter upon 
exposure to ultra-violet light to derive a value for the total binding sites, Bmax- 
Unfortunately, this procedure is not convenient for use with the oocyte system due to the 
large numbers of mRNA injections. A more advantageous system in this respect would be, 
for example, heterologous expression in CHO cells. This approach will be discussed further 
in Chapter 6 of this thesis.
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CHAPTER 6
Construction of GLUT2/GLUT3 
Chimeric Glucose Transporters
266
i
I
6 .1  Aims.
1. In a previous study, a series of GLUT3/GLUT2 chimeric transporters were 
generated and expressed in Xenopus oocytes to address the structural basis for the different 
substrate selectivities and distinct transport kinetics exhibited by these isoforms. Mirror 
image GLUT2/GLUT3 constructs were also constructed, however, functional expression of 
all chimeras in this series was not achieved. The aim of this chapter was therefore to use 
recombinant PCR reactions to reconstruct the two GLUT2/GLUT3 chimeric transporters that 
were not successfully expressed in oocytes.
1 a . Resulting recombinant GLUT2/GLUT3 cDNAs will be purified and subcloned into a 
pSP64T derivative for subsequent expression in Xenopus oocytes.
l b .  Both strands of the constructs will be fully sequenced using automated DNA 
sequencing to ensure that no sequence errors were incorporated during the PCR reactions 
and subcloning procedures.
2 . The GLUT2/GLUT3 cDNAs will be used as templates for in vitro synthesis of 
mRNA which will be subsequently expressed in Xenopus oocytes. Individual oocytes will 
then be assayed for the ability to transport 2-deoxy-D-glucose, before a more extensive 
kinetic characterisation of the chimeras is undertaken.
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6 .2  Introduction.
The glucose transporter isoforms mediate transport catalysis by alternating between 
two distinct conformational states in which the substrate binding site is exposed to either side 
of the membrane (section 1.5.3). This mechanism has been well characterised and much of 
the work on GLUTl has focused on mapping the exo- and endofacially exposed substrate 
binding sites. Site-specific ligands have proved useful in demonstrating that these sites are 
located in different regions of the protein. For example, ATB-BMPA, an exofacial-specific 
ligand, interacts with the GLUTl transporter in the region of helices 7 to 9 (Hashiramoto et 
al., 1992) , whereas cytochalasin B interacts with the transporter in the endofacial 
conformation in the region of helices 10 and 11 (Holman & Rees, 1987). Structural 
separation of the binding sites has further been proposed on the basis of kinetic studies 
(section 1.7).
The six C-terminal helices are fundamental for the formation of the glucose binding 
sites. Ligand binding and proteolysis studies have demonstrated that the C-terminal half of 
GLUTl contains sufficient information to bind both cytochalasin B and ATB-BMPA. 
However, in a study utilising the baculovirus Sf9 system to express separate N- and C- 
terminal halves of GLUTl, it was suggested that binding of these ligands to the C-terminal 
half of GLUTl can only occur when both constructs encoding the N- and C-terminal halves 
are co-expressed (Cope et al., 1994). Thus, although the C-terminus is directly involved in 
formation of the binding sites, the N-terminus may provide a packing surface which allows 
correct exposure of the ligand binding sites in the C-terminal half (section 1.7.4). 
Alternatively, it is possible that one of the initial steps in substrate binding may involve a 
transient association with groups from the N-terminal half, or both halves combined. Further 
support for the involvement of the C-terminal domain in substrate binding has come from 
site-directed mutagenesis studies. A summary of this work is given in Chapter 3. Several 
residues have been identified that are important for exofacial and endofacial sugar binding, 
and in the conformational changes occurring during the transport process. All but one of 
these residues are located in the C-terminal domain of the transporter (Figure 1.6).
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Furthermore, the C-terminus is suggested to contribute three amphipathic helices to channel 
formation (section 1.9), as predicted from molecular modelling studies.
6. 2,1  Regions Involved in Substrate Selectivity.
The membrane topology of GLUTl has been well characterised (section 1.4.2), and 
much evidence exists in support of the alternating conformer model of transport (section 
1.5.3b). In addition, regions of the transporter involved in substrate binding at the exofacial 
and endofacial sites have been defined and the various kinetic parameters governing sugar 
transport have been exhaustively measured (section 1.5.3c).
The high degree of sequence identity and the virtually superimposable hydropathy 
plots of the GLUT isoforms suggest that the topology and mechanism of transport predicted 
for GLUTl will extend to the other members of the GLUT family. However, an interesting 
feature exhibited by the mammalian GLUT isoforms is their ability to transport different 
substrates with distinct kinetic parameters, despite their high degree of sequence homology 
(Table 4.1). At present however, there is little published work that investigates the structural 
determinants that govern isoform specific substrate selectivities and transport kinetics. 
Elucidation of these factors would, for example, explain why only GLUT2 and GLUT5 are 
capable of recognising and transporting D-fructose whereas, GLUT3 can bind and transport 
D-galactose with a high affinity. The few studies reported to date which have addressed this 
point have used a chimeric transporter approach to investigate the structural basis of 
substrate selectivity and isoform specific kinetics, reviewed in section 3.2.8. While this 
methodology has been successful in identifying regions of importance, it may not be 
possible to assume that the regions that dictate isoform specific substrate selectivity and 
kinetics are the same. Furthermore, the relative importance of these regions may vary 
between isoforms.
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6 .2 .2  Expression and Characterisation of GLUT2/GLUT3 Chimeras.
It has previously been demonstrated in this laboratory that the liver-type transporter, 
GLUT2, is unique among the GLUT isoforms by virtue of its ability to transport both D- 
fructose and D-glucose. GLUT2 also has a high Km for zevo-trans entry of 2-deoxy-D- 
glucose into oocytes (11.2mM). In contrast, the brain-type isoform, GLUTS, exhibits a 
relatively low Km for this transport event (L4mM) and is a high affinity D-galactose 
transporter. The distinction between the two isoforms is also apparent in the Km values for 
3-O-methyl-D-glucose equilibrium exchange (42.3mM and 10.6mM for GLUT2 and 
GLUTS respectively). Such distinct properties exhibited by these two isofoims formed the 
basis of a study in which the regions of the transporters involved in substrate selection and 
high affinity 2-deoxy-D-glucose transport were investigated (Arbuckle et aL, 1996 ). GLUT2 
and GLUTS were chosen as candidates for the generation of chimeric transporter, utilising a 
PCR based approach (chimeras were generated by Dr.M.Arbuckle, Glasgow University, 
UK.) Two series of chimeras were constructed (Figure 6.1). The GLUT2 series comprised 
GLUT2 transporters in which lengths of sequence from the start of helix 7, or another 
distinct point nearer the C-terminus, were replaced with the corresponding sequences of 
GLUT3. Characterisation of these mutants delineated important sequences for the property 
of D-fructose recognition by GLUT2. (In the context of this study, fructose "recognition" 
means that these transporters contain the sequence information which facilitates fructose 
binding.) Mirror image constructs were also produced, referred to as the GLUT3 series, 
comprising N-terminal GLUT3 sequence with various lengths of the C-terminal sequence 
replaced by that of GLUT2 (Figure 6.1). Characterisation of these mutants provided 
information regarding the "GLUT3^-like" properties of high affinity 2-deoxy-D-glucose 
transport and D-galactose recognition.
Extensive characterisation of these constructs in Xenopus oocytes has been 
successful in identifying regions of importance for substrate selectivity and for determining 
the affinity of 2-deoxy-D-glucose transport. A summary of the data available to date is given 
in Table 6.1. The data shows that sufficient information is retained within the region of 
GLUT2 encompassing transmembrane helix 7 to the C-terminus to enable a chimeric
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transporter containing this region, (G3(7St)), to transport D-fructose, and to exhibit a 
for 2-deoxy-D-glucose approximating that of wild type GLUT2. In contrast, a chimera that 
contains the helix 7 sequence derived from wild type GLUT3, G3(7Ed), but which is 
otherwise identical to G3(7St), is not capable of transporting D-fructose and exhibits Km 
values for both 2-deoxy-D-glucose and D-galactose that resemble those of GLUT3. On this 
basis, it is proposed that helix 7 contributes to the exofacial binding sites of both GLUT2 
and GLUT3 in such a way as to define substrate recognition by GLUT2 (or lack of D- 
fructose recognition by GLUT3). This helix also plays a role in defining the kinetic 
behaviour of the transporters. This is consistent with the evidence provided by Hashiramoto 
and co-workers, showing that helix 7 constitutes part of the binding site for the exofacial 
ligand, ATB-BMPA (Hashiramoto et aL, 1992). Furthermore, a region lying between the 
end of helix 7 and the end of helix 10 also contributes to the affinity of the exofacial binding 
site for the ligand, maltose (as evidenced by measurement of Ki values for maltose inhibition 
of 2-deoxy-D-glucose influx). Data is also presented that implicates sequences in the N- 
tenninal half of the protein that influence the kinetics of transport by GLUT2 and GLUT3.
Although this study has been successful in identifying these important regions, it 
remains somewhat incomplete for two reasons. Firstly, expression of the entire GLUT2 
series in oocytes was not achieved, thus hindering a more comprehensive investigation of 
these chimeras. In an attempt to address this problem, the chimeras G2(7St) and G2(10Ed) 
were reconstmcted by PCR, subcloned and sequenced to scan for errors. Secondly, general 
problems associated with the oocyte expression system impeded a detailed investigation of 
the GLUT3 series. Expression of these constructs in a mammalian cell line will enable 
further analysis of the constructs in terms of obtaining data regarding inhibition and 
competition studies, and also will permit determination of turnover numbers, measurement 
of which was also absent from the oocyte study.
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Figure 6.1
Junction Points of the GLUT2/GLUT3 Chimeric Transporters,
This diagram shows the junction points chosen for the generation of the 
GLUT2/GLUT3 chimeric transporters. GLUT2 sequence is shown in black and GLUT3 
sequence in red. Amino acid numbers correspond to either GLUT2 or GLUT3 cDNA 
sequences and refer to the sequences above which they are positioned. The 
nomenclature is such that the N-terminal sequence is referred to followed by the 
junction site, given in brackets i.e. G2(7St) comprises N-terminal GLUT2 sequence up 
to the start of helix 7 and the corresponding GLUT3 sequence from this site to the end 
of the C-terminus.
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Figure 6.1
Junction Points of the GLUT2/GLUT3 Chimeric Transporters. 
GLUT2 Series
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end of helix 10449-496
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GLUT3 Series
1-268
1-290
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Table 6,1
Kinetic Parameters for Transport of Substrates by GLUT2/GLUT3 Chimeras.
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6 .3  Methodology Used to Generate GLUT2/GLUT3 Chimeric
Transporters.
6 .3 .1  Recombinant PCR Reactions.
The GLUT2 and GLUTS cDNAs have previously been cloned into the polylinker 
site of pSP64T to form the constructs pHTL.217 and pSPGTS, as previously described in 
section 2.3.1. These constructs were used as templates in the recombinant PCR reactions 
described below.
Two series of oligonucleotide primers were designed for use in the PCR reactions, 
referred to as the internal and external primers. The external primers are 37'mers and 
correspond to the extreme 5' and 3' sequences of the sense strands of the GLUT2 and 
GLUT3 and are called G2st and G3ed, respectively. These primers encode Sal I restriction 
sites for subsequent cloning into pSP64T. The internal primers are 61 bases in length and 
are designed such that half of the oligonucleotide sequence corresponds to the GLUT2 
sequence and the other half to the GLUT3 sequence either side of the junction site (at the 
start of helix 7 or the end of helix 10 for G2(7St) and G2(10Ed), respectively). The 
sequences of these primers are given in Table 6.2.
Two rounds of PCR reactions are carried out. In the two primary reactions, GLUT2 
and GLUTS wild type sequences are used as templates to amplify the appropriate N-terminal 
and C-terminal fragments, respectively (Figure 6.2). Thus, G2st is used in conjunction with 
GLUT2 template and the appropriate internal primer to amplify the N-terminal fragment in a 
single primary PCR reaction. In the second primary reaction, GLUTS template is incubated 
in the presence of G3ed and the appropriate internal primer to amplify the C-terminal 
GLUTS fragment. In a single secondary PCR reaction, the two primary products themselves 
act as the templates. Under certain reaction conditions, the strands of the primary fragments 
dissociate and re-anneal. The overlapping S' tail regions bind and serve as primers for 
extension of the complementary strand. In the subsequent reaction cycles, G2st and GSed 
then act to amplify the full length GLUT2/GLUT3 sequence to produce the final secondary
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PCR reaction product. PCR reactions were carried out using Vent DNA polymerase and the 
reaction conditions were altered according to the manufacturers recommendations.
The PCR products were purified by agarose gel electrophoresis followed 
electroelution of the DNA and passage through a DEAE-Sephacel column (Elutip-D). 
Primary products were purified in this fashion before the subsequent overlap extension 
secondary PCR reaction.
6 .3 .2  Cloning Procedures.
Purified secondary PCR fragments contain sequences encoding Sal I resriction sites 
at the 5' and 3' ends, allowing subcloning into the pSP64T vector for subsequent expression 
in Xenopus oocytes. The backbone of this vector was obtained by digestion of pSPGT4 
with Sal I (Figure 6.3). Three fragments were produced, corresponding to the backbone 
pSP64T vector containing the 5'UTR sequence, the GLUT4 protein coding sequence and a 
smaller fragment which is part of the 3'UTR sequence. The backbone vector was purified by 
electrophoretic extraction from agarose gel slices, followed by passage through a DEAE- 
Sephacel column (Elutip-D) and ethanol precipitation. The secondary PCR fragment was 
also digested with Sal I and purified using the same procedure before ligation into the vector 
backbone and transformation into competent E.co/i cells. Plasmid DNA was prepared from 
several colonies to identify potential positive clones by restriction digestion analysis. Upon 
identification of positive clones, large scale plasmid preparations (section 2.3.12) were 
performed to obtain sufficient quantities of DNA for complete sequencing of the protein 
coding regions of the constructs. To facilitate this, a series of oligonucleotide primers were 
designed such that extension from their annealing sites resulted in the production of 
overlapping sequences.
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6 .3 .3  Expression of GLUT2/GLUT3 Chimeras in Xenopus Oocytes.
The resulting chimeric constructs were linearised with Xba I and used as templates 
for in vitro synthesis of mRNA (section 2.5). Upon subsequent injection of mRNA, 
individual oocytes were assayed for the ability to transport 2-deoxy-D-glucose as described 
in section 2.7.
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Figure 6.2
Generation of GLUT2/GLUT3 Chimeras Using Recombinant PCR Reactions.
This diagi-am describes the PCR method used to construct G2(7St) and G2(10Ed), 
which comprise N-terminal GLUT2 sequence to the start of helix 7 and the end of helix 
10, respectively, followed by C-terminal GLUTS sequence to the end of the protein. The 
GLUT2 and GLUTS-based primary products are generated in two separate primary PCR 
reactions in which wild type GLUT2 and GLUTS are incubated with the appropriate 
primers. The external primers anneal to the S' regions of the antisense and sense strands of 
GLUT2 and GLUTS respectively, and are referred to as G2Start and GSEnd. These 
primers also have tails which encode Sal I restriction sequences for use in the subsequent 
cloning procedures. The internal primers are designed to anneal in the region of the 
junction site and have tails that are complementary in sequence to the opposite primary 
PCR product. Thus, in a single secondary PCR reaction, the two primary PCR products act 
as templates, and under certain reaction conditions, undergo strand dissociation and re­
anneal in the region of the overlapping sequences which are subsequently extended to 
produce a full length secondary PCR product. The external primers then act to amplify this 
product which is restricted with Sal I prior to ligation into Sal 1 restricted vector.
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Figure 6.2
Generation of GLUT2/GLUT3 Chimeras Using Recombinant PCR Reactions.
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Figure 6.3
Restriction Digestion of pSPGT4 with Sal I and Cloning of GLUT2/GLUT3 Chimeric 
cDNAs.
The pSP64T vector backbone was obtained by restricting pSPGT4 with Sal I. 
Three fragments were produced corresponding to the backbone vector, the GLUT4 protein 
coding region, and a 200bp fragment corresponding to the 3' untranslated region of the 
Xenopus B-globin gene. The backbone vector was treated with alkaline phosphatase to 
prevent re-ligation, purified and ligated to the Sal I restricted GLUT2/GLUT3 cDNA. 
Tmnsfected colonies were selected on the basis of resistance to ampicillin.
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Figure 6.3
Restriction Digestion of pSPGT4 with Sal ï and Cloning of GLUT2/GLUT3 
Chimeric cDNAs.
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6 . 4 .2  Subctoning of Chimeric Constructs.
I
6 .4  Results.
.'Jl
6.4 .1  PCR Using Vent Polymerase.
Previous attempts to generate G2(7St) and G2(10Ed) utilised Taq DNA polymerase 
to perform the PCR reactions. However, in an attempt to reduce the number of sequence
iferrors, Vent DNA polymerase was used. This enzyme has 3' to 5' exonuclease proofreading 
activity and therefore is of higher fidelity than Taq DNA polymerase. Use of this enzyme 
resulted in high yields of secondary PCR products for both G2(7St) and G2(10Ed) (Figure 
6.4) and also reduced the number of clones that were screened before identifying a clone that 
was completely free of sequence errors.
The parameters used in the PCR reactions with Vent DNA polymerase were similar
:to those used with Pfu DNA polymerase (section 2.2.4) with minor modifications. Hot start
-fPCR was performed and extension times were strictly controlled to i min per kilobase of 
sequence. This prevents the exonuclease activity of the enzyme digesting the ends of the 
synthesised fragments and therefore destruction of the Sal I restriction sites and overlapping 
sequences. In addition, this enzyme required the presence of Mg^+ ions in the reaction 
mixture and a final concentration of ImM was determined to be optimal for these reactions.
Blunt ended secondary PCR products were digested with W  I before ligation into
fithe pSP64T backbone vector, also digested with Sal I. The resulting constructs were then 
transformed into competent E.coli cells for propagation and isolation of the plasmids. The 
correct orientation of the insert was determined by restriction digestion analysis with Bgl II 
and Xba I. Insert ligated in the correct orientation, i.e. for subsequent mRNA synthesis
1reactions, yielded two fragments of 4550 and 150bps (Figure 6.5), whereas insert ligated in 
the incorrect orientation yielded fragments of 3150 and 1550bps in length. The restriction Iand ligation stages of the subcloning procedure proved difficult as evidenced by the fact that f
a large fraction of the colonies screened by restriction digestion analysis contained religated
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vector without insert. This is probably because the blunt ended PCR products generated by 
Vent DNA polymerase are difficult to digest with Sal I .
Upon identification of clones containing vector in the correct orientation, large scale 
plasmid preparations were performed and the constructs were sequenced fully to scan for 
sequence errors using an ABI Automated Sequencer (section 2.4). Suitable clones 
containing no sequence errors were identified for both G2(7St) and G2(10Ed).
6 . 4 . 3  In Vitro Synthesis of mRNA from G2(7St) and G2(10Ed) 
Constructs.
G2(7St) and G2(10Ed) constructs were linearised with Xba I and used as templates 
for in vitro mRNA synthesis reactions. Both chimeric cDNAs were transcribed into mRNAs 
of the correct predicted size, with efficiencies that were comparable to both wild type 
GLUT2 and GLUT3 cDNAs (Figure 6.6).
6 . 4 . 4  Measurement of 2-Deoxy-D-Glueose Zero-Trans Influx Mediated by 
G2(7St) and G2(10Ed) Expressing Oocytes.
Individual oocytes expressing either G2(7St), 02(1 OEd) or the wild type GLUT2 or 
GLUT3 transporters were assayed for the ability to mediate 2-deoxy-D-glucose uptake. 
Non-injected control oocytes were also assayed in parallel under identical reaction conditions
to obtain endogenous transport rates. The results of a typical transport assay are shown in
;;Figure 6.7. The rates of transport obtained for G2(7St) and G2(10Ed) expressing oocytes 
were consistently much lower than those obtained for oocytes expressing the wild type 
transporters, with rates that were virtually indistinguishable from non-injected control 
oocytes.
I
i ' :#
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Figure 6.4
GLUT2/GLUT3 PCR Products Generated Using Vent DNA Polymerase.
This diagram shows a 1% agarose gel of the various primary (Lanes 2 and 3), and 
secondary (Lane 1), PCR products generated by Vent DNA polymerase, pSPGT4 
restricted with Sal I and CIP treated (Lane 4), and backbone pSP64T vector containing the 
secondaiy PCR fragment (Lane 5).
Transformed JM109 colonies which contained the cloned PCR product were 
screened by restriction digestion analysis of the plasmid DNA isolated from the clones, 
followed by agarose gel electrophoresis.
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Figure 6.4
GLUT2/GLUT3 PCR Products Generated Using Vent DNA Polymerase.
Lane 1
4822bps
2323bps
1929bps
1371bps
1264bps
702bps
224bps
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Figure 6.5
Restriction Digestion Analysis of GLUT2/GLUT3 Constructs.
This diagram shows the positions of the cleavage sites of the restriction enzymes 
used to determine the orientation of the GLUT2/GLUT3 cDNA in the vector. GLUT2 
sequence is shown in black and GLUT3 sequence in red. The extreme C-terminal portion 
of GLUTS contains a unique Bgl II restriction site which is not present in the GLUT2 
sequence or the vector. A unique Xba I site is located S' to the chimeric sequence in the 
vector. Therefore, restriction digestion with Bgl II and Xba I yields different sized 
fragments depending on the orientation of the ligated insert. Chimeric sequence inserted in 
the correct orientation i.e. for transcription driven by the SP6 promoter, yields two 
fragments of 4450 and 150bps. Insert ligated in the incorrect orientation results in the 
production of two fragments of 3150 and 1550bps in length. The fragments produced by 
restriction digestion were separated by agarose gel electrophoresis and the sizes were 
determined by comparison against molecular weight markers loaded onto the same gel.
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Figure 6.5
Restriction Digestion Analysis of GLUT2/GLUT3 Constructs.
Correct Orientation
Sail
Bgl II Xba I
Sail
150bps
Incorrect Orientation
Bgl 11
Sal 1
Xba 1
Sail
1550bps
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Figure 6.6
1 % Agarose Gel of In Vitro Synthesised mRNA.
pSP64T vector containing the wild type GLUTS cDNA or G2(7St), G2(7Ed), 
02(1 OEd) or 02(12Ed) chimeric cDNAs were linearised with Xba I and used as templates 
For the synthesis of mRNA. A 3pi\ aliquot (from a total of AOptl) of each reaction was 
analysed by 1% agarose gel electrophoresis. Molecular weight markers are loaded (Lane 
1), followed by mRNA samples of GLUTS (Lane 2), G2(7St) (Lane 3), G2(7Ed) (Lane 4), 
G2(10Ed) (Lane 5) and G2(12Ed) (Lane 6).
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Figure 6.6
1% Agarose Gel of In Vitro Synthesised mRNA.
Lane
Linear DNA template
mRNA
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Figure 6,7
Measurement of 2-Deoxy-D-GIueose Uptake by Oocytes Expressing GLUT2, GLUT3, 
G2(7St) and G2(10Ed).
Oocytes were microinjected with 50ng of mRNA encoding wild type GLUT2 or 
GLUTS, or 50ng of mRNA encoding the G2(7St) or G2(10Ed) chimeric transporters. After 
incubation at 18-20°C for 48 hours, transport was determined by a SO min incubation with 
O.lmM 2-deoxy-D-glucose. Non-injected control oocytes were assayed in parallel under 
identical reaction conditions. The results presented are representative of a typical 
experiment, and are the mean ± S.D. of seven oocytes.
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Figure 6.7
Measurement of 2-Deoxy-D-Glucose Uptake by Oocytes Expressing GLUT2, GLUTS,
G2(7St) and G2(10Ed).
Transport rate 
(pmol/min/oocyte)
4  _
Imol>- I
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.6 .5  D iscussion.
'In this initial attempt to resolve the expression problems encountered with the 
G2(7St) and G2( lOEd) transporters, these chimeras were reconstructed using recombinant 
PCR technology. Previously, PCR reactions were performed using Taq DNA polymerase 
which does not have 3' to 5' exonuclease proofreading activity. Thus, although the 
constructs were originally reported free of sequence errors, it is possible that 
misincorporations may have remained undetected. In order to reduce the number of 
incorporated errors Vent DNA polymerase was used in this attempt to reconstruct the 
chimeras. This enzyme does possess 3' to 5' exonuclease proofreading activity and thus has
,a higher fidelity compared to Taq DNA polymerase. Clones were identified for both 
chimeras that contained no sequence errors, and the chimeric cDNAs could be translated into 
a protein of the correct predicted size with efficiencies comparable to the wild type cDNAs. 
However, the low level of transport activity exhibited by these chimeras in oocytes
precluded any functional or kinetic analysis. Thus, the lack of any measurable transport 
activity was concluded not to be due to sequence or cloning errors.
With regard to other previously generated GLUT2 series chimeras, low levels of 
functional expression were consistently observed for G2(7Ed) compared to wild type 
GLUT2. In fact, G2(12Ed) was the only transporter in the GLUT2 series that exhibited 
levels of functional expression approaching that obtained for wild type GLUT2. Some 
kinetic parameters were measured for these transporters, but the study remains incomplete in
the absence of a functional and kinetic characterisation of the remaining chimeras in this
3
series (Arbuckle et ah, 1996).
Expression of chimeric transporters which contain the GLUT2 amino-terminus have 
proved difficult not only in this study but also in those reported by other laboratories. Buchs ■
and co-workers have obtained functional expression of a series of GLUT4/GLUT2 chimeras 
in oocytes, as evidenced by an increase in transport activity compared to non-injected 
oocytes. Interestingly, although chimeras containing N-terminal GLUT2 sequence could be 
efficiently translated into proteins of the correct size, an increase in transport activity was not 
detectable (Buchs et al., 1995a), Similarly, chimeras of the rat GLUT2 and rat GLUT4
cDNAs have been demonstrated to be functionally inactive but were immunologically 
detected at comparable levels to GLUT4 protein in the total oocyte membrane fraction . 
Problems have also been reported expressing chimeras containing the GLUT2 amino- 
terminus in other cell types (Piper, 1993).
Possible reasons for the inactivity of certain chimeras containing N-terminal 
sequences derived from GLUT2 have not been pursued or discussed at any great length. 
Potential explanations include mistargeting of the chimeras to an intracellular location in the 
oocyte. Both GLUT2 and GLUTS isoforms have previously been demonstrated to be 
expressed predominantly at the plasma membrane of oocytes (Gould & Holman, 1993). 
However, approximately 40% of GLUT2 was detected in an intracellular fraction compared 
to 15% of GLUTS. Thus, it may be that the relative distribution of the chimera at the plasma 
membrane is altered when certain N-terminal GLUT2 and C-terminal GLUTS sequences are 
present in the same protein. Unfortunately, an accurate determination of plasma membrane 
associated chimeric transporters is precluded by the inability to reproducibly obtain pure 
plasma membrane fractions from oocytes (Chapter 5). Another handicap in this regard is the 
inability to determine the relative distribution of GLUT2 by a Scatchard analysis of 
equilibrium pHjcytochalasin B binding to membranes due to the low affinity of this isoform 
for this inhibitor (Axelrod & Pilch, 1983). A further complication is presented by the 
inability to directly compare the levels of expression of G2(7St) and G2(10Ed) with GLUT2 
as these chimera contain the GLUT3 carboxy-terminus.
A further explanation is that the chimeras may be prematurely degraded due to 
alterations in the conformations of the proteins resulting from their chimeric nature. Whilst 
this is a possibility, it is more likely that the interactions that form between the N- and C- 
termini in the tertiary structure of the protein are sufficiently perturbed in the chimeras such 
that the transporters are functionally inactive. It has previously been suggested that the N- 
terminal domain exerts an influence on the ability of the protein to correctly form the ligand 
binding sites, by providing a surface for the structural packing of helices in the tertiary 
structure. This view is favoured over a direct involvement of N-terminal domain residues in 
the formation of the exofacial binding site. An investigation of the exact role of the N- 
terminus in formation of the substrate binding sites and the ability of the transporter to be
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Ifunctionally active would require generation of chimeric transporters with junction sites 
located throughout this domain. In the light of the expression problems discussed above, an 
alternative approach would be to construct a series of transporters in which the regions that 
are important for substrate binding are exchanged between GLUT2 and GLUTS. For 
example, replacement of the GLUT2 helix 7 sequence, (and therefore the other individual
:l'3helices), with that of GLUTS would provide information regarding the nature and extent of 
the contribution made by the N-terminus. Such an approach may avoid the expression 
problems encountered when an entire domain, (or a large portion of a domain), of one
iîtransporter is replaced with that of another, since the foreign sequences are internal and are
itherefore predicted less likely to disrupt the global packing of the protein. Unfortunately,
such attempts have been made by members of this laboratory, but the methodology has
proved problematic (see Susan Kane, PhD Thesis, 1997, Glasgow University, U.K.).
Nevertheless, in the absence of a protein structure, the use of the chimeric transporter
,approach in future studies will no doubt provide important information regarding the 
functional role of defined regions of the transporters.
1
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CHAPTER 7
Expression of GLUT2 and GLUT3
in CHO-Cells.
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7 .1 Aims
»
î,:ÿ
1. To establish stable CHO-cell lines expressing the GLUT2 and GLUTS isoforms, as
an alternative to heterologous expression in Xenopus oocytes. Western blot analysis utilising 
anti-GLUT antibodies will be used to identify G418-resistant stable CHO-cell lines 
individually expressing GLUT2 and GLUTS.
2 . To undertake a functional analysis of GLUT2 and GLUTS expressed in CHO-cells
by measurement of kinetic parameters for 2-deoxy-D-glucose, D-fructose and D-galactose 
transport. This will provide a basis for a more complete characterisation of the GLUTS Pro- 
Ala mutants previously generated and studied in oocytes.
3 . To subclone the GLUTS series of chimeras into a suitable vector for high-level
expression in mammalian cells. This will enable further characterisation of these mutants that 
have been previously studied in oocytes.
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7 .2  Introduction.
7 .2 .1  Heterologous Expression of Proteins in Mammalian Cell-Culture
Lines.
7 . 2 . 2  Further Characterisation of GLUT3 Pro-Ala Mutants and the GLUTS 
Series Chimeras in CHO-Cells.
Î
A number of genes encoding either foreign or native membrane proteins have been 
expressed in cultured mammalian cells. This approach has been successfully used to 
investigate the properties of genes encoding transporters, channels and receptors, to study 
the trafficking of membrane proteins and membrane sorting events, and also to analyse the 
effects of introducing specific mutations into the cDNA of interest. For some proteins, 
expression in mammalian cells is necessary when post-translational modification is requisite 
for correct functional activity, e.g. if the membrane protein requires glycosylation, then 
expression in bacterial cells is not appropriate since such modifications can not be achieved.
There are generally two approaches used for heterologous expression in mammalian 
cell-culture lines. The first is to generate a transient expression system in which the cDNA of 
interest is introduced into a population of cells, but is not integrated into the host cell 
genome. The second method is the generation of stably transfected cell lines in which the
. . .cDNA of interest is integrated into the host cell genome. This latter method offers many 
advantages as an expression system. Once generated, stably transfected cell lines can be 
Stored and propagated for long periods of time, often years, without the need to repeat the 
transfection/selection procedure. Thus, if a protein is being repeatedly studied then this 
methodology offers distinct advantages when compared to transient expression or, for
,example, the use of oocytes (Chapters 4 and 5).
Î
4
.1.
In the light of the problems associated with the use of the Xenopus oocyte system for 
expression and characterisation of the GLUT3 Pro-Ala mutants generated in this study
(section 4.6), stable expression in the Chinese Hamster Ovary (CHO-) cell line is a possible
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I-salternative to complete these studies. The generation of CHO-cells that stably express the 
wild type GLUT3 isoform would provide a suitable base-line for comparison with cell lines §
expressing individual Pro-Ala mutants at comparable levels of expression to the wild type 
transporter. This system, although not as suitable for the kinetic studies already discussed 
utilising oocytes (section 4.23), is more convenient for use in photolabelling studies with |
both cytochalasin B and ATB-BMPA, avoiding the need for repeated oocyte injections. In 
addition, simple fractionation protocols exist for the isolation of plasma membrane fractions 
and therefore, measurement of the levels of GLUTS wild type and mutant transporters at the
I'cell surface would be possible, which, in turn would enable measurement of turnover
numbers. Determination of this parameter was not possible using the oocyte system (Chapter g
"Î
Additionally, although the GLUTS series of chimeras were successfully expressed in 
oocytes enabling some functional and kinetic characterisation, expression in an alternative 
system would facilitate a more detailed analysis such as the measurement of turnover |;
■'ê;numbers and the use photolabelling studies to further understand the relationship between 
the isoform-specific substrate binding requirements of GLUT2 and GLUTS.
: - ■ -   -■ > '■  ' - " '  ':L.' ■...........................................I'. -> I r " J: .
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7 .3  Methods.
7 . 3 .1  Expression Vectors.
Stable expression of a foreign gene in a eukaryotic cell can be achieved using |
plasmid constructs in which the cDNA of interest is inserted downstream of a eukaryotic ’■
RNA polymerase II promoter. There are several types of promoter available including the 
SV40 based promoters and promoters from the human cytomegalovirus, (CMV), which S
work well in most cell types, and are commercially available.
In addition to enhancer-promoter sequences to drive transcription of the cDNA, the 
vector must also possess polyadenylation and transcription termination sequences to enhance 
RNA stability. A selectable antibiotic resistance gene, e.g. the neomycin gene, is also 
required for isolation of resistant stable cell lines subsequent to transfection. f
GLUT2 has previously been subcloned into the mammalian expression vector, 
pLK444 (Figure 7.1), and is under the transcriptional control of the human B-actin promoter %
and a simian virus (SV40) polyadenylation signal. This vector contains the neomycin 
resistance gene for selection purposes.
The GLUT3 cDNA has been cloned as a BamHl-Xba I fragment from pSPGT3 into 
the Bgl ll-Xba I sites of the pCMV-4 vector (Figure 7.2). The cDNA is under the 
transcriptional control of the enhancer-promoter sequences from the immediate early gene of 
the human cytomegalovirus (CMV). The polyadenylation signal and transcriptional 
termination sequences are derived from the bovine growth hormone (BGH) gene and
enhance RNA stability. However, this vector does not have a selectable resistance gene. f
i,y
7 . 3 . 2  Subcloning of GLUT3/GLUT2 Chimeras for Expression In CHO- 
Cells.
The GLUT3 series of chimeras have previously been cloned into the pSP64T 
plasmid for expression in Xenopus oocytes (Dr.M.Arbuckle, Glasgow University, U.K.) 
For expression in CHO-cells, these cDNAs were subcloned into the mammalian expression
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vector, pcDNA3, thus placing the cDNAs under the transcriptional control of the CMV 
promoter. This vector also contains the BGH polyadenylation signal and a neomycin gene 
for selection (Figure 7.3).
7 .3 .3  Transfection of CHO-Cells and Selection of Stable Transfectants.
The method of transfection used was calcium phosphate precipitation, a procedure 
which is especially suitable for fibroblastic cell lines such as CHO-cells. DMA was mixed 
directly with a calcium chloride solution and phosphate buffer to form a fine precipitate 
which was dispersed over the cultured cells. This protocol is routinely used for stable 
transfection (section 2.13). A DMSG shock step was included in the protocol. Application of 
a 10-20% DMSG solution to the cells for a few minutes after DNA association serves to 
increase the efficiency of transfection. The exact mechanism of action is unknown, but the 
treatment may modify the cell membrane structure to enhance uptake of DNA.
The selection agent used for isolation of individual transfected colonies was the 
application of G418 (600/fg/ml) to the growth medium. pLK444 and pcDNA3 both possess 
a neomycin resistance gene for selection, however, the pCMV-GT3 construct does not 
possess the required selectable marker gene and therefore was co-transfected with pcDNA3. 
A 10:1 ratio of pCMV-GT3:pcDNA3 was used.
7 .3 .4  Western Blotting and Immunodetection of GLUT2 and GLUT3.
Upon selection and propagation of individual clones, several were screened for 
expression of either GLUT2 or GLUTS by Western blotting and immunodetection. Cell 
lysates were prepared from a number of individual G418-resistant clones and subjected to 
SDS/PAGE (section 2.17.1). Proteins were transferred to nitrocellulose membranes which 
were subsequently probed with anti-GLUT2 or anti-GLUTS anti serum (section 2.17.3). 
Nitrocellulose membranes were developed using the ECL detection system so that the 
presence of low levels of protein could be detected (section 2.17.5).
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7 ,3 .5  Functional Studies in CHO-Cells.
Transfected and non-transfected CHO-cells were grown as described (section 
2.13.1) in preparation for measurement of transport activity. Cells were assayed for uptake 
of radiolabelled 2-deoxy-D-glucose and D-fructose in the presence and absence of 
cytochalasin B.
-s:
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Figure 7.1
Schematic Representation of pLK444 Containing the Human GLUT2 cDNA.
The pLK444 is a mammalian expression vector which utilises the 6-actin promoter 
to drive transcription of the cloned cDNA. The vector also contains three unique restriction 
sites for cloning purposes, a neomycin gene for selection purposes, and an SV40 
polyadenylation signal. The GLUT2 cDNA was cloned as a Bgl II fragment (excised from 
pHTL.217, Kayano et al., 1990) into the BamH I site of pLK444.
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Figure 7.1
Schematic Representation of pLK444 Containing the Human GLUT2 cDNA.
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Figure 7.2
Schematic Representation of pCMV-4 Containing the Human GLUT3 cDNA.
This diagram shows the GLUT3 cDNA cloned as a BamH \-Xba I fragment 
(excised from pSPGT3) into the Bgl ll-Xba I sites of the pCMV-4 vector. The cDNA is 
under the transcriptional control of the enhancer-promoter sequences from the immediate 
early gene of the human cytomegalovirus (CMV). The polyadenylation signal and 
transcriptional termination sequences are derived from the bovine growth hormone (BGH) 
gene and enhance RNA stability. This vector does not contain a suitable selectable marker 
gene and therefore is co-transfected with another vector such as pcDNA3 which contains 
the neomycin resistance gene.
305
Figure 7.2
Schematic Representation of pCMV-4 Containing the Human GLUT3 cDNA.
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Figure 7.3
Schematic Representation of pcDNA3.
pcDNA3 is a mammalian expression vector designed for high-level expression of 
proteins. The cDNA of interest is placed under the transcriptional control of the enhancer- 
promoter sequences from the immediate early gene of the human cytomegalovirus (CMV). 
Polyadenylation signal and transcription termination sequences are derived from the 
bovine growth hormone (BGH) gene and serve to enhance RNA stability. There is a 
neomycin resistance gene for selection of G418 resistant stable cell lines.
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Figure 7.3
Schematic Representation of pcDNA3.
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7 . 4 .3  Immunoblotting of Lysates Prepared from GLUT3-Transfected 
CHO-Cells.
3
7 .4  Results.
7 . 4 .1  Restriction Digestion Analysis of pcDNA3-G3/G2 Constructs.
All four chimeric cDNAs of the GLUTS series were excised from the pSP64T vector
as Sail fragments of approximately 1.6kb in length. Fragments were subsequently purified 
and ligated into the Xho I site of the pcDNAS polylinker sequence (Figure 7.4). The 
resulting constructs were successfully transformed into competent E.coli cells for large scale 
preparation of plasmid DNA and the DNA obtained from several individual transformed 
clones was screened for the presence of the G3/G2 insert by restriction digestion analysis. 
The orientation of the insert was determined from the size of the restriction fragments. 
Restriction with BstX  I yielded two fragments of approximately 0.5kb and 6.5kb or, 
approximately Ikb and 6kb, depending on the orientation (Figure 7.5).
7 . 4 . 2  Immunoblotting of Lysates Prepared from GLUT2-Transfected 
CHO-Cells.
Cell lysates were prepared from a number of GLUT2-transfected G418-resistant 
clones and were subjected to SDS/PAGE. Proteins were transferred to nitrocellulose 
membranes which were then probed with anti-GLUT2 antibodies (section 2.17.3). A 
representative immunoblot is shown in Figure 7.6. 25//g of rat liver membrane was included
i f ;
as a standard, and GLUT2 could be identified as a broad band migrating with an apparent 
moleculai* weight of approximately 50 
weight was identified in clone G2-2b.
kDa. A band migrating at the same apparent molecular
Cell lysates were prepared from a number of GLUTS-transfected G418-resistant
clones,After SDS/PAGE and transfer to nitrocellulose, the membranes were probed with
"I:
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anti-GLUT3 antibodies. 25]Ag of rat brain was included as a standard and GLUTS could be 
identified as a broad band migrating with an apparent molecular weight of approximately 
40kDa. The level of GLUTS expression in all GLUTS-transfected CHO-cell lines screened 
was below the limits of detection of the antibody used, with the exception of clone G3-lb. A 
faint band migrating with the same molecular weight as the GLUTS standard was identified 
in this clone.
7 . 4 .4  Immunoblotting of Lysates Prepared from GT3/GT2-Transfeeted 
CHO-Cells.
Cell lysates were prepared from a number of GTS/GT2 transfected G418-resistant 
clones and subjected to Western blotting. Since all chimeras in the GLUTS series have C- 
terminal GLUT2 sequence, the immunoblots were probed with anti-GLUT2 antibodies 
targetted against the C-terminus. A band migrating with the same molecular weight as 
GLUT2 was identified in the cell lysate prepared from clone G3(7St)-C6 (Figure 7.6).
7 . 4 . 5  Transport Measurements in Transfected and Non-Transfected 
CHO-Cells.
CHO-cells were grown to confluency on 6-welI plates and pH]2-deoxy-D-glucose 
and [l^CjD-fructose uptake (l/^Ci/ml) was determined over a 3 min period as described, 
(section 2.15.3). Uptake values were corrected for any non-specific association of sugajr 
with the cells by subtracting uptake values measured in the presence of lOjwM cytochalasin 
B. Assays were performed in triplicate for all incubation conditions and data from 
representative experiments for GLUTS and GLUT2 transfected cells are shown in Figures 
7.7 and 7.8, respectively. The values measured for transport activity mediated by clone GS- 
Ib were determined to be significantly increased above non-transfected CHO-cells, 
(P<0.05), by application of a Students t-test.
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Figure 7,4
Subcloning of the GLUT3 Series of Chimeras into pcDNA3.
The GLUT3/GLUT2 recombinant cDNAs were excised as 1.6kb Sal I fragments 
from pSP64T. Fragments were purified and ligated into the Xho I site of pcDNAS, thus 
placing the cDNAs under the transcriptional control of the CMV promoter for expression 
in mammalian cells.
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Figure 7.4
Subcloning of the GLUT3 Series of Chimeras into pcDNA3.
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Figure 7.5
Restriction Digestion Analysis of pcDNA3-G3/G2 Constructs.
In order to detect the presence of the G3/G2 inserts, and to determine their 
orientation in the vector, plasmid DNA was prepared from a number of transformed E.coli 
cell colonies and subjected to restriction digestion analysis followed by 1% agarose gel 
electrophoresis. Restriction with BstX I yields two fragments, the sizes of which depend on 
the orientation of the insert in the vector. Upon restriction of the vector containing the 
insert in the correct orientation, fragments of 569bps and 6503bps were generated. An 
insert cloned into the vector in the opposite direction yields fragments of 5949bps and 
1123bps.
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Figure 7.5
Restriction Digestion Analysis of pcDNA3-G3/G2 Constructs.
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Figure 7.6
Immunological Detection of GLUT2 and G3(7St) in Lysates Prepared from CHO- 
Cells Individually Transfected with GLUT2 and G3(7St).
Cell lysates were prepared from a number of 0418-resistant CHO-cell clones 
transfected with either GLUT2 or G3(7St). 60/<l volumes of each sample (from a total of 
lml/6cm plate) were subjected to electrophoresis using 10% polyacrylamide gels and 
proteins were transferred to nitrocellulose membranes (section 2.17.2). The nitrocellulose 
membranes were then probed with anti-GLUT2 antibodies, and the blots were developed 
using the ECL detection system. Positions of the molecular weight markers in kilodaltons 
are indicated on the left hand side of the immunoblot.
Samples contain untransfected CHO-cell lysate (Lane 1), clone G2-3b (Lane 2), 
clone G2-2b (Lane 3), clone G2-8 (Lane 4), clone G2-10 (Lane 5), clone G3(7St)-6 (Lane 
6), 25pcg rat liver membranes (Lane 7).
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Figure 7.6
Immunological Detection of GLUT2 and G3(7St) in Lysates Prepared from CHO 
Cells Individually Transfected with GLUT2 and G3(7St).
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Figure 7.7
Measurement of 2-Deoxy-D-Glucose Transport in GLUT3-Transfected CHO-
Cells.
[3H]2-Deoxy-D-glucose uptake was measured in non-transfected and GLUT3- 
transfected CHO-celis. Cells were grown on 6-well plates and glucose uptake was 
initiated by the addition of O.lmM, 1/fCi/ml pH]2-deoxy-D-glucose (final 
concentration). Uptake was measured over a period of 3 mins. Non-specific [^H]2- 
deoxy-D-glucose transport was corrected for by subtracting uptake measured in the 
presence of 10/<M cytochalasin B. Results represent the mean (±S.D.) of two separate 
experiments, * indicates a significant difference from control values, (P<0.05).
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Figure 7.7
Measurement of 2-Deoxy-D-Glucose Transport by GLUT3-Transfected
CHO-Cells.
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Figure 7.8
Measurement of 2-Deoxy-D-Glucose and D-Fructose Transport in GLUT2-
Transfected CHO-Cells.
[3H]2-Deoxy-D-glucose and [14c]D-fructose uptake was measured in non- 
transfected and GLUT2-transfected CHO-cells. Cells were grown on 6-well plates and 
sugar uptake was initiated by the addition of O.lmM sugar, (final concentrations) 
containing l/^Ci/ml . Uptake was measured over a period of 3 mins. Non-specific sugar 
transport was corrected for by subtracting uptake measured in the presence of 10/<M 
cytochalasin B. Results represent the mean (±S.D.) of two separate experiments.
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Figure 7.8
Measurement of 2-Deoxy>D-Glucose and D-Fructose Transport in GLUT2-
Transfected CHO-Cells.
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7. S Discussion.
Although the Xenopus oocyte expression system has proved a valuable tool for the 
functional and kinetic characterisation of the GLUT3 Pro-Ala point mutations generated in 
this study, the GLUTS series chimeras and a variety of other mutants constructed previously 
in this laboratory, several problems were encountered that impeded a more thorough 
investigation (section 4.6.5 and Chapter 5). Heterologous expression in the Chinese 
Hamster Ovary (CHO-) cell line was therefore considered as a possible alternative to the 
oocyte system, with the view that simple and reproducible fractionation protocols available 
for this cell line would facilitate a more accurate measurement of cell surface transporters and 
hence, determination of turnovers numbers. In addition, the establishment of stable cell lines 
expressing a particular transporter, (either wild type or a mutant), would avoid the need for 
repeated oocyte injections which is both tedious and time consuming. In this regard, CHO- 
cells provide a more convenient system in which to perform photolabelling and other 
inhibition studies. However, CHO-cells, like many other cell types, express endogenous 
facilitative glucose transporters (GLUTl in the case of CHO-cells), and therefore are not as 
suitable as the oocyte system for measurement of the various kinetie parameters already 
described (Chapter 4). Thus, use of the CHO-cell system also presents limitations but can be 
used to furthercomplement and extend the data obtained in oocytes.
An attempt was therefore made to generate stable CHO-cell lines expressing either ;f
wild type GLUT2 or GLUTS. Expression of the wild type transporters is necessary to 
establish base-line parameters against which the mutants can be compared. Additionally, the 
GLUTS series of chimeras were successfully subcloned into a suitable vector for expression 
in this system. Unfortunately, within the restricted time available to establish stable 
transfectants, none of the G418-resistant clones that were screened expressed the 
heterologous transporters at levels sufficient to undertake any functional or kinetic
; >characterisations. There are several potential reasons for the low levels of expression |
observed in these cells. An alternative method of transfection, e.g., the lipid based DOTAP 
method, may increase the efficiency of DNA uptake by the cells, although the calcium 
phosphate method employed is routinely and successfully used for transfection of
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fibroblastic cells including CHO-cells. Another consideration is the choice of promoter used 
to drive transcription of the cDNA of interest. GLUT2, in the pLK444 vector, is under the 
transcriptional control of the B-actin promoter. Although the B-actin gene is common to all 
cell types it has a relatively weak promoter. Thus, the use of a stronger promoter to drive 
transcription of the GLUT2 cDNA may elevate the level of expression attained. For 
example, the commercially available SV40, CMV and MTH promoters have all previously 
been successfully used for expression in CHO-cells. With regard to the GLUT3 construct, 
the cDNA is under the transcriptional control of the strong CMV promoter. However, a 
possible reason for the low levels of expression observed may be related to a low efficiency 
of uptake of this plasmid which does not possess the neomycin resistance gene for selection. 
It was therefore necessary to co transfect this plasmid with one that does contain the 
selectable marker, on the basis that the cells that take up this plasmid are resistant to the 
selection agent and also are likely to carry the plasmid containing the cDNA of interest. 
Expression levels of the GLUT3 series chimeras were below the level of detection of the 
antibody used, but this may be because insufficient numbers of clones were screened due to 
time constraints.
Other, more general considerations include further optimisation of the transfection 
conditions used for this cell type. For example, the DNA to be transfected must be of high 
purity and free from protein, RNA and chemical contamination. The transfection procedure 
should be carried out at 22-25®C at a pH of 7.1. Furthermore, the cells should be healthy and 
in an exponential growth phase at the time of transfection. Also, the time of exposure to 
DMSO after DNA association and the concentration used may require careful optimisation 
for different cell types, since this reagent is toxic to cells.
This attempt to establish stably transfected CHO-cell lines expressing wild type and 
mutant glucose transporters has been unsuccessful. However, achievement of these 
objectives in future work will provide a useful system whereby a more comprehensive 
understanding of the kinetic behaviour and ligand binding properties of these transporters 
can be obtained.
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CHAPTER 8
Discussion
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Glucose occupies a central position in mammalian cellular homeostasis and 
metabolism. A prime example of this is the fact that the brain exhibits a requirement for 
glucose as its major energy source. Other mammalian cells are capable of utilising glucose as 
an immediate source of energy or, alternatively, can convert glucose into glycogen for 
storage in the liver and muscle, to be released when the body's demand for glucose is high. 
Cellular mechanisms have thus evolved to facilitate the sensing, uptake and release of this 
important metabolite which are essential for the maintenance of whole body glucose 
homeostasis. The tissue-specific expression of the mammalian facilitative glucose 
transporters is a key component of this system, and the structural and functional diversity 
exhibited by this family of proteins reflects the differing needs of tissues for glucose.
Transport of glucose into certain tissues is under both acute and chronic control by 
circulating hormones, insulin for example, is the primary effector of sugar transport in 
mammals. The mechanisms by which hormones are able to regulate the rate of glucose 
transport into cells, in addition to abnormal expression and/or dysfunctionality of the various 
isoforms may underlie certain diseased states. For example, peripheral insulin resistance 
may be caused by GLUT4 depletion or inactivation of this transporter in muscle and fat, 
leading to a condition known as non-insulin dependent diabetes mellitus (NIDDM). 
Expression of GLUT5 is also abnormal in insulin responsive tissues. In addition, due to its 
localisation to the insulin secreting pancreatic 6-cells, GLUT2 is predicted to play an 
important role in the glucose sensing mechanism. Clearly then, the elucidation of the 
mechanisms by which these membrane proteins mediate glucose transport in non-diseased 
states will contribute to an understanding of transporter dysfunction in a variety of diseased 
states.
GLUTl is the most extensively investigated isoform of this transporter family, due 
to its abundance in erythrocytes and the ability to reconstitute this protein in a purified and 
functional form. Kinetic, biochemical and biophysical studies have led to the construction of 
a topological model for GLUTl, and also to the characterisation of the transport mechanism. 
The protein is proposed to adopt a structure comprising twelve transmembrane helices which 
cluster together in such a way as to form an aqueous channel through which glucose can 
pass. Specific conformational changes in the protein structure are predicted to occur such
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that a substrate binding site is alternately and sequentially exposed to the extracellular and 
cytoplasmic surfaces of the transporter, and these events can occur in the presence or 
absence of sugar. The sites at which glucose can associate ad dissociate are structurally 
distinct and have been mapped to specific regions of the transporter on the basis of both 
kinetics and inhibitor selectivity. Thus, exposure of these binding sites represents distinct 
conformational states of the transporter. This model for the mechanism of transport is 
known as the single site alternating conformation model, and it is supported by the majority 
of the existing kinetic, biochemical and biophysical data.
In the absence of a high resolution crystal structure for GLUTl, the precise 
molecular mechanism of transporter function has not been elucidated. Thus, in the advent of 
recombinant molecular biology techniques and the availability of the transporter cDNAs, 
mutagenesis has provided the main strategy for probing the mechanism of action of these 
proteins. This approach has been successful in the identification of specific residues and 
stretches of sequence within the transporter that are involved in the substrate binding events 
or the conformational changes requisite for transport catalysis. Sequence alignments have 
revealed that the GLUT isoforms possess a number of highly conserved proline residues. 
Furthermore, the somewhat surprising selective inclusion of this classical helix breaker in 
the transmembrane regions, and the extension of this observation to the wider family of 
membrane transporters, predicts that these residues have specific functionality. Molecular 
dynamics and modelling studies predict that the highly conserved Pro-Gly rich sequence 
located within transmembrane helix 10 of the GLUT isoforms is important for facilitating the 
opening and closing of the external binding site. Further evidence in support of this 
hypothesis was provided by mutagenic studies in which the proline residues of this sequence 
were individually replaced with certain amino acids, resulting in a variety of phenotypic 
changes that affected both transport activity and ligand binding. This led to the suggestion of 
a putative mode of transporter operation in which confoimational flexibility about the proline 
residues of helix 10 enables the alternate packing of helices 11 and 12 against the exofacial 
and endofacial substrate binding sites localised to helices 7, 8 and 9, and the base of helix 10 
respectively. However, these predictions were based purely on simple measurement of 
transport rates, in the absence of any detailed kinetic measurements. Thus, a series of
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GLUTS mutant cDNAs were generated in which specific proline residues, located within 
helix 10 and in other highly conserved motifs present in the cytoplasmic loops, were 
individually replaced with alanine, with a view to determining the generality of the results 
obtained with GLUTl. Although individual mutation of the targeted proline residues had no 
significant effect on the Km value for 2-deoxy-D-glucose uptake, the use of site-specific 
ligands to probe any effects mediated at the exofacial and endofacial substrate binding sites 
revealed some interesting phenotypic changes which were not previously detected in the 
GLUTl studies. Furthermore, these effects not only apply to the specific proline residues 
identified in GLUT 1, i.e. those of helices 6 and 10, but are extended to those that are located 
in highly conserved motifs which were not previously investigated. Mutation of the proline 
residues of helix 10 resulted in a significant perturbation of exofacial ligand binding, with an 
associated increase in affinity for endofacial ligands. In contrast, mutation of proline 
residues located in the highly conserved motifs at the base of helices 6 and 12 appeared to 
affect the ability of the transporter to correctly form the exofacial ligand binding site, with no 
associated effects detected at the endofacial site. No individual proline residue was found to 
be absolutely crucial for transport catalysis. It is however likely that they play a collective 
role in providing the local flexibility required for the conformational changes and the coiTect 
exposure of the exofacial substrate binding site. Obviously, conclusions drawn from such 
studies can only be confirmed by the generation of a high resolution crystal structure.
Measurement of the kinetic parameters for substrate transport under the conditions 
described are not dependent on the amount of transporter expressed at the plasma membrane. 
However, in addition to the Km value, the transport cycle is also characterised by the Vmax 
value which is related to the catalytic turnover of the protein. Since Vmax is dependent on the 
concentration of functional transporters expressed at the cell surface, and the fact that this is 
variable between oocyte batches, the absence of a reliable method for isolating pure plasma 
membrane fractions from Xenopus oocytes has precluded a more complete kinetic 
characterisation of these mutants. There are a variety of alternative heterologous expression 
systems that are available for the study of protein structure and function. Generation of 
stably transfected cultured mammalian cells expressing the wild type transporter isoforms 
would provide a useful base-line for further investigation of the effects of mutations on
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protein function. These systems are not completely ideal for measurement of the kinetic
parameters that govern transport catalysis, due to higher levels of endogenous transport.
However, the ease with which cell surface transporters can be quantitated and the
.reproducibility of the subcellular fractionation procedures makes them more convenient for 
use in photolabelling studies and the determination of transporter turnover numbers. In 
addition, use of such systems would avoid other extreme drawbacks such as seasonal 
variation of oocyte batches, which restricted the measurement of reliable data to a very 
limited time period within the year. This restriction was further compounded by animal
■ ■
housing problems, since Xenopus laevis are extremely sensitive to their environment which
V-has a direct effect on the viability of the oocytes that aie produced.
Although the isoforms exhibit similarities with regard to their general topology and 
mode of action, previous work in this lab has demonstrated that they differ not only in 
substrate selectivity, but, they also exhibit distinct kinetic profiles. Thus, subtle structural
Î :differences must exist which define isoform-specific behaviour. GLUT2, for example, is
.unique among the GLUT family by virtue of its ability to transport D-fructose in addition to 
D-glucose. In contrast, GLUTS is capable of high affinity D-glucose and D-galactose 
transport, but can not mediate D-fructose transport. Thus, in an effort to address the 
structural basis for substrate recognition and glucose binding to these isoforms, a range of 
chimeric glucose transporters were generated in which regions of GLUTS were replaced 
with the corresponding regions of GLUT2 and vice versa. Characterisation of the GLUTS 
series of chimeras, comprising N-terminal GLUTS sequence and various C-terminal 
portions of the GLUT2 isoform, was previously successful in oocytes. This study revealed 
that the structural information which allows GLUT2 to transport fructose is localised to helix 
7. Furtheimore, this region is an important requirement for high affinity transport of glucose 
and galactose mediated by GLUTS. Other regions that influence the kinetics of fructose '4
transport by GLUT2 are not clear from the existing data, due to the inability of certain 
chimeras containing N-terminal GLUT2 sequence to elevate the transport capacity of oocytes 
sufficiently to undertake any functional or kinetic analyses. Reconstruction of these chimeric 
cDNAs in this study failed to rectify the problems associated with attaining their functional 
expression, and the potential reasons for this were not pursued due to time constraints.
However, on the basis that heiix 7 is essential for fructose recognition, the generation of 
new GLUT2 and GLUTS mutants is currently underway in this laboratory in which the QLS 
motif located within helix 7 (of GLUTs 1, S and 4) has been replaced with the HVA motif of 
the GLUT2 helix 7. Initial analysis of these mutants suggest that the QLS motif is the sole 
determinant for the ability of GLUT2 to accept fructose and for high affinity 2-deoxy-D- 
glucose transport mediated by GLUTS. Further progression of this study will involve the 
use of sugar analogues to study the interaction of individual sugar hydroxyls with the 
existing chimeric transporters and the generation of other GLUT2 and GLUTS mutants in 
which individual helices are sequentially swapped throughout the transporter structure.
Dissection of the molecular mechanism of glucose transport mediated by the GLUT 
isoforms is still in its infancy. However, the future application of molecular biology 
techniques coupled to the use of appropriate heterologous expression systems will no doubt 
contribute to a more comprehensive insight into the function of this important class of 
membrane proteins.
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